Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 150
Encontrada(s) 2 página(s)

Docta Complutense
Publicación Artículo de revisión (ReviewArticle)

Tribbles pseudokinases: Fine tuning of cell signaling with implications in metabolism, inflammation and cancer

  • Velasco Díez, Guillermo
  • Lorente Pérez, María Del Mar
Within the family of protein kinases there is a subgroup of ‘evolutionarily related members of the total human kinome’ that are devoid (or have very limited) enzymatic activity. These proteins, so-called pseudokinases, play important functions thanks to their capacity to establish regulatory protein–protein interactions. Specifically, this opinion article focuses on a group of pseudokinases called Tribbles. Tribbles (Trbl) was originally discovered in Drosophila, followed by the subsequent identification of their orthologs in mammals (TRIB1, TRIB2, TRIB3, and STK40). Work over the last decades has shown how these proteins contribute to fine-tuning key signaling pathways involved in the regulation of proliferation, differentiation, inflammation and adaptation to nutritional changes. Accordingly, dysregulation of Tribbles proteins (TRIBs) contributes to the establishment and progression of insulin resistance, obesity, type II diabetes, atherosclerosis and cancer. Here, we will discuss some of the mechanisms by which Tribbles pseudokinases carry out their functions and the crucial importance of cell context in defining the precise role played by each of the TRIBs, with emphasis on TRIB1 and TRIB3, under different physiopathological situations.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans

  • Caicedo di Filippo, Dolly Andrea|||0009-0009-6523-0265
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Papaseit, Esther|||0000-0003-2620-4274
Cannabis is the most commonly used illicit substance worldwide. Recent years have seen an increase in cannabis consumption, and with new approvals and therapeutic indications, there are challenges in minimizing the risks and interactions between cannabis-based products, cannabis prescription drugs, other approved prescription drugs, and other substances of abuse. Thus, identifying the enzymes metabolizing cannabinoid drugs and their relationship with other prescription drugs is crucial for understanding the potential interactions and effects of their simultaneous use. This article offers a comprehensive review of cannabis and the pharmacokinetic interactions between cannabis products, cannabis prescription drugs, and other approved prescription drugs, as well as other substances of abuse. It also compiles existing evidence of these interactions and describes the clinical outcomes associated with the inhibition or induction of various enzymes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Reduced blood EPAC1 protein levels as a marker of severe Coronary Artery Disease: The role of hypoxic foam cell-transformed smooth muscle cells

  • García Rodríguez, Jesús Eduardo|||0000-0002-7758-6789
  • Claudi, Lene
  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Polishuck, Anna
  • Samouillan, Valerie|||0000-0003-0571-3985
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • Piñero, Janet|||0000-0003-1244-7654
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Leta, Rubén|||0000-0003-4691-381X
  • Viladés Medel, David|||0000-0002-3638-9703
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Background: Vascular smooth muscle cells loaded with cholesterol (foam-VSMCs) play a crucial role in the progression of human atherosclerosis. Exchange Protein Directly Activated by cAMP 1 (EPAC1) is a critical protein in the regulation of vascular tone, endothelial function, and inflammation. Our objectives were to identify proteins specifically secreted by foam human coronary VSMCs (foam-hcVSMC) to evaluate their potential as circulating biomarkers for diagnosing coronary artery disease (CAD), and to ascertain the mechanisms underlying their levels in the blood of patients with CAD. Methods and Results: Differential proteomics identified EPAC1 as a differential foamhcVSMC-secreted protein. Circulating EPAC1 levels were measured by ELISA in blood from 202 patients with suspected CAD who underwent coronary computed tomography angiography (CCTA). Blood EPAC1 levels were significantly lower in CAD patients compared to controls (p < 0.001). EPAC1 levels were reduced in both men and women with severe CAD (SIS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Stability of cytokine and immunoglobulin concentrations in the general population: prepandemic basal concentrations and intraindividual changes until the COVID-19 pandemic

  • Gasull, Magda|||0000-0003-4546-3650
  • Pumarega, José Antonio|||0000-0001-6950-6702
  • Aguilar, Ruth|||0000-0003-3277-3107
  • Campi, Laura
  • Prieto-Merino, David
  • Villar Garcia, Judit|||0000-0002-6767-3424
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Bolúmar, Francisco
  • Trasande, Leonardo|||0000-0002-1928-597X
  • Dobaño Lazaro, Carlota|||0000-0002-6751-4060
  • Moncunill, Gemma|||0000-0001-5105-9836
  • Porta, Miquel|||0000-0003-1684-7428
Background: While there is wide evidence on concentrations of cytokines in patients attending health care facilities, evidence is scant on physiological, basal concentrations of cytokines in the general population and across sociodemographic groups, as well as on their potential stability over time. Furthermore, from a public health perspective it is remarkable that no studies have analyzed intraindividual changes in such concentrations from before the COVID-19 pandemic until its outbreak. Objectives: To investigate: (a) prepandemic concentrations of cytokines and immunoglobulins to viral exposures in a general, non-institutionalized population, and their associated sociodemographic variables; (b) the intraindividual change in such concentrations between a prepandemic period (2016-17) and the initial pandemic period (2020-21); and (c) whether such change was similar in participants who in 2020-21 were SARS-CoV-2 seronegative and seropositive, and between participants who did and did not develop COVID-19. Methods: We conducted a prospective cohort study in 240 individuals from the general population of Barcelona, Spain. Thirty cytokines and 31 immunoglobulins were measured in paired serum samples collected in 2016-17 and 2020-21 in the same individuals. Results: The median value of the relative intraindividual change in cytokine concentrations between 2016 and 2020 was <15% for 29 of the 30 cytokines. A substantial number of participants had an intraindividual increase or decrease ≥15% in some cytokines. No major differences in intraindividual changes of cytokine and immunoglobulin levels between 2016 and 2020 were observed between participants who did and did not develop COVID-19. Conclusion: We provide novel information on physiological, basal ex-vivo concentrations of cytokines and immunoglobulins in a general population, which should be relevant for clinical practice and public health. Intraindividual changes in cytokines and immunoglobulins during the 4 years from 2016-17 to 2020-21 were moderate, and they did not differ between participants who in 2020-21 were SARS-CoV-2 seropositive and seronegative, nor between participants who did and did not develop COVID-19 disease. These findings are also novel and relevant for medicine and public health. In particular, the stability in the biomarkers is relevant to assess the role of the immunological and inflammatory state (measured through baseline levels of cytokines and immunoglobulins) in the development of SARS-CoV-2 seropositivity and COVID-19 disease, as well as in the susceptibility to other infections and pathologies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group

  • Oñate, Guadalupe|||0000-0003-2180-2371
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Arnan, Montserrat
  • Pomares, Helena
  • Alonso, Ester
  • Tormo, Mar|||0000-0001-9622-1649
  • Díaz-Beyá, Marina|||0000-0001-9624-2597
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Sampol, Antonia|||0000-0001-7465-6203
  • Coll, Rosa|||0000-0003-0560-1254
  • Salamero, Olga|||0000-0003-3237-0025
  • Cervera, Marta
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Vall-Llovera, Ferran|||0000-0002-0718-5955
  • Garcia-Avila, Sara|||0000-0002-9293-2029
  • Bargay, Joan|||0000-0002-6739-3916
  • Ortin, Xavier
  • Iranzo, Eva
  • Guijarro, Francesca|||0000-0001-6376-0929
  • Pratcorona, Marta|||0000-0001-6375-596X
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
  • Sierra, Jorge|||0000-0002-7966-0356
Given the heterogeneity of acute myeloid leukemia patients, it is necessary to identify patients considered fit for intensive therapy but who will perform poorly, and in whom alternative approaches deserve investigation. We analyzed 1034 fit adults ≤70 years intensively treated between 2012 and 2022 in the CETLAM group. Young adults ( ≤ 60 years) presented higher remission rates and improved survival than older adults above that age (CR 79% vs. 73%; p = 0.03 and 4-yr OS 53% vs. 33%; p < 0.001). Remission and survival outcomes varied among different genetic subsets. An especially adverse genetic group included complex, monosomal karyotype, TP53 alterations (deleted/mutated), and MECOMr. Transplant feasibility in this very adverse risk group was low, and OS and EFS at 4 years were 14% and 12%, in contrast to 70% and 57% in the favorable group and 38% and 32% in all other patients. We integrated clinical and genetic data into the Intensive Chemotherapy Score for AML (ICSA) with 6-risk categories with significantly different remission rates and OS, validated in another cohort of 581 AML patients from a previous CETLAM protocol. In summary, we identified groups of fit patients that benefit differently from an intensive approach which may be helpful in future treatment decisions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Acute pharmacological effects of α-PVP in humans, a naturalistic observational study

  • Rosa, Georgina de la
  • Papaseit, Esther|||0000-0003-2620-4274
  • Hladun, Olga|||0000-0002-6230-5876
  • Poyatos, Lourdes|||0000-0002-4641-8600
  • Caicedo, Dolly Andrea
  • Argote Oramas, Martha Catalina
  • Martín, Soraya|||0009-0008-3761-9217
  • Ventura, Mireia|||0000-0003-1133-6872
  • La Maida, Nunzia|||0000-0003-0127-4225
  • Di Trana, Annagiulia|||0000-0002-8456-0827
  • Graziano, Silvia|||0000-0002-5609-0872
  • Pichini, Simona
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
Alpha-pyrrolidinopentiophenone (α-PVP) is a commonly consumed analogue of pyrovalerone, a synthetic cathinone with psychostimulant properties similar to those of 3,4-Methylenedioxypyrovalerone (MDPV) and cocaine. Since the pharmacology of α-PVP remains scarcely studied, we aimed to evaluate the acute pharmacological effects and its abuse potential in humans after intranasal administration. We carried out a non-controlled observational study in a naturalistic environment in nine participants (3 women and six men) with a previous history of psychostimulant use. Participants self-administered a single intranasal dose of 10mg or 20mg of α-PVP. The outcomes included physiological effects (systolic and diastolic blood pressure, heart rate, and temperature) and subjective effects (Evaluation of Subjective Effects of Substances with Abuse Potential questionnaire_VESSPA-SSE, the short form of the Addiction Research Center Inventory questionnaire_ARCI and visual analog scales_VASs) and were measured at different time points (0, 20 and 40 minutes and 1, 1.5, 2, 2.5, 3, 4 and 5 hours). An acute increase in blood pressure and heart rate was observed that peaked 40 minutes after administration. Subjective effects also showed a rapid onset and disappeared 3 to 5 hours after administration. α-PVP showed psychostimulant properties similar to those displayed by cocaine and empathogenic effects commonly associated with MDMA and other cathinones (eg. methylone) consumption.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis

  • Cantó-Santos, Judith|||0000-0002-0272-7014
  • Valls-Roca, Laura|||0000-0001-5956-6752
  • Tobías, Ester|||0000-0002-9968-3651
  • García García, Francesc Josep|||0000-0001-9021-0324
  • Guitart-Mampel, Mariona
  • Andújar-Sánchez, Félix
  • Vilaseca-Capel, Adrià
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Martín-Mur, Beatriz|||0000-0002-6006-3295
  • Padrosa, Joan
  • Peruga, Emma
  • Madrigal, Irene|||0000-0002-7229-1199
  • Segalés, Paula
  • García-Ruiz, Carmen
  • Fernández-Checa, José Carlos
  • Moreno-Lozano, Pedro J.
  • Selva O'Callaghan, Albert|||0000-0003-2823-9761
  • Sevilla, Ana|||0000-0002-9251-4759
  • Milisenda, José César|||0000-0003-0151-7872
  • Garrabou, Glòria|||0000-0001-8973-9933
Inclusion body myositis (IBM) is an inflammatory myopathy that displays proximal and distal muscle weakness. At the histopathological level, the muscles of IBM patients show inflammatory infiltrates, rimmed vacuoles and mitochondrial changes. The etiology of IBM remains unknown, and there is a lack of validated disease models, biomarkers and effective treatments. To contribute to unveil disease underpins we developed a cell model based on myotubes derived from induced pluripotent stem cells (iPSC-myotubes) from IBM patients and compared the molecular phenotype vs. age and sex-paired controls (n = 3 IBM and 4 CTL). We evaluated protein histological findings and the gene expression profile by mRNA-seq, alongside functional analysis of inflammation, degeneration and mitochondrial function. Briefly, IBM iPSC-myotubes replicated relevant muscle histopathology features of IBM, including aberrant expression of HLA, TDP-43 and COX markers. mRNA seq analysis identified 1007 differentially expressed genes (DEGs) (p-value adj < 0.01; 789 upregulated and 218 downregulated), associated with myopathy, muscle structure and developmental changes. Among these, 1 DEG was related to inflammation, 28 to autophagy and 28 to mitochondria. At the functional level, inflammation was similar between the IBM and CTL groups under basal conditions (mean cytokine expression in IBM 4.6 ± 1.4 vs. 6.7 ± 3.4 in CTL), but increased in IBM iPSC-myotubes after lipopolysaccharide treatment (72.5 ± 21.8 in IBM vs. 13.0 ± 6.7 in CTL). Additionally, autophagy was disturbed, with 40.14% reduction in autophagy mediators. Mitochondrial dysfunction was strongly manifested, showing a conserved respiratory profile and antioxidant capacity, but a 56.33% lower cytochrome c oxidase/citrate synthase ratio and a 66.59% increase in lactate secretion. Overall, these findings support patient-derived iPSC-myotubes as a relevant model for IBM, reflecting the main muscle hallmarks, including inflammation, autophagy dysfunction and mitochondrial alterations at transcriptomic, protein and functional levels.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

LRP1 immunotherapy enhances cardiomyocyte respiration by restricting cholesteryl ester accumulation in mitochondria

  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • Garcia, E.
  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Polishchuk, A.
  • Zegrí-Reiriz, Isabel|||0000-0001-9742-8537
  • Viladés Medel, David|||0000-0002-3638-9703
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Fernández-del-Rio, L.
  • Mirabet Pérez, Sonia|||0000-0001-5955-2748
  • Samouillan, V.
  • Shirihai, Orion S.|||0000-0001-8466-3431
  • Liesa, M.
  • Enrich, Carlos|||0000-0003-0382-2993
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Antibodies (Abs) targeting the P3 sequence (Gly 1127 -Cys 1140) of LDL receptor-related protein 1 (anti-P3 Abs) inhibit the interaction between ApoB100 in cholesteryl ester (CE)-enriched lipoproteins and the CR9 domain in LDL receptor-related protein 1, preventing intracellular CE accumulation induced by a high-fat high-cholesterol (HFHC) diet in cardiomyocytes. This study examines (i) whether HFHC induces cholesterol accumulation in mitochondria, and impacts cardiac bioenergetics, and (ii) the effectiveness of anti-P3 Abs in mitigating HFHC-induced mitochondrial alterations. Cardiac tissue was homogenized, and mitochondria were isolated through subcellular fractionation. Thin layer chromatography demonstrated that HFHC induced the accumulation of CE in cardiac mitochondria, and that this process was significantly reduced by anti-P3 Abs. In line, transmission electron microscopy studies revealed that morphological changes induced by HFHC in cardiomyocyte mitochondria were reversed, at least in part, by anti-P3 Abs. Additionally, anti-P3 Abs promoted more extensive interactions between mitochondria and lipid droplets (LDs), accompanied by an increase in LD diameter and electrodensity in cardiomyocytes. Cardiac mitochondrial respiratory capacity assessed by Seahorse analysis showed that HFHC reduced CI/CIV and CII/CIV activity ratios, while anti-P3 Abs restored complex II/IV activity. In conclusion, by blocking CE uptake from lipoproteins, anti-P3 Abs reduce CE accumulation in the cardiomyocyte mitochondria and LDs, enhance bioenergetically favorable mitochondria/LD interactions, and improve cardiomyocyte respiratory function in hypercholesterolemic rabbits. These findings highlight the therapeutic potential of anti-P3 Abs in metabolic diseases by limiting CE loading of mitochondria and LDs in the heart and restoring cardiac bioenergetics.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty

  • Díaz Ruíz, Raquel|||0000-0002-2259-0289
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Roman, Eva|||0000-0001-9084-8555
  • Cuyàs, Berta|||0000-0001-9988-7163
  • Bañares, Irene
  • Morales, Ángela
  • Hernández Martínez-Esparza, Elvira|||0000-0002-9736-9052
  • Panadero, Rocío
  • Velasco, Cristina
  • Rapado-Castro, Marta|||0000-0001-8484-6051
  • Breton, Irene|||0000-0003-0263-3728
  • Bañares, Rafael|||0000-0002-0412-8437
  • Soriano, German|||0000-0002-9267-6811
  • García Martínez, Rita|||0000-0003-2159-2757
Background/aim : Frailty is increasingly recognized as a relevant prognostic factor in patients with cirrhosis, regardless of liver failure. Vitamin D deficiency is frequent in these patients and has been related to frailty and sarcopenia, but the impact of its supplementation on frailty in cirrhosis is unknown. The aim was to evaluate the effect of vitamin D supplementation on frailty in patients with decompensated cirrhosis and vitamin D deficiency or insufficiency. Methods : We included patients with cirrhosis who had vitamin D deficiency or insufficiency following their hospitalization for acute decompensation. Vitamin D was supplemented according to current recommendations, as were other micronutrients if necessary. Patients were followed for one year to evaluate changes at 6 and 12 months in frailty (Fried frailty index), health-related quality of life (SF-36, CLDQ) and mood (HADS). Body composition was assessed by DXA at baseline and at 12 months. Results : We included 39 patients, 27 of whom reached the 6-month follow-up. Serum vitamin D increased at 6 and 12 months (p < 0.001 compared to baseline). Fried frailty index improved at the 6-month visit (p = 0.004), and handgrip strength improved at 6 (p = 0.001) and 12 (p = 0.002) months, similarly in women and men. At 12 months, we observed an increase in body mass index, right arm lean mass and total fat mass. Conclusions : A multifactorial nutritional intervention, especially vitamin D supplementation after discharge in decompensated, vitamin D-deficient patients with cirrhosis, was associated with an improvement in frailty, muscular strength and lean muscle mass. However, the increase in fat mass strengthens the recommendation for diet, exercise and weight supervision.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis

  • Díaz Ruíz, Raquel|||0000-0002-2259-0289
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Roman, Eva|||0000-0001-9084-8555
  • Panadero, Rocío
  • Cuyàs, Berta|||0000-0001-9988-7163
  • Bañares, Irene
  • Morales, Ángela
  • Puerto, Marta|||0000-0002-1263-9296
  • Lopez-Esteban, Rocio
  • Blazquez, Elena
  • Fernández-Castillo, Marta
  • Correa-Rocha, Rafael|||0000-0003-3456-9986
  • Rapado-Castro, Marta|||0000-0001-8484-6051
  • Breton, Irene|||0000-0003-0263-3728
  • Bañares, Rafael|||0000-0002-0412-8437
  • Soriano, German|||0000-0002-9267-6811
  • García Martínez, Rita|||0000-0003-2159-2757
Background/Objectives: Decompensated cirrhosis is characterized by systemic inflammation and innate and adaptive immune dysfunction. Hepatic encephalopathy (HE) is a prevalent and debilitating condition characterized by cognitive disturbances in which ammonia and inflammation play a synergistic pathogenic role. Extraskeletal functions of vitamin D include immunomodulation, and its deficiency has been implicated in immune dysfunction and different forms of cognitive impairment. The aim was to assess changes in cognitive function and inflammation in decompensated patients with cirrhosis receiving vitamin D supplementation. Methods : Patients with cirrhosis discharged from decompensation in two tertiary hospitals in Spain (from September 2017 to January 2020) were assessed before, at 6 and 12 months after vitamin D supplementation. A comprehensive neuropsychological battery and neuroinflammatory markers were examined. In a subgroup of patients, peripheral immune blood cells were analyzed. Results : Thirty-nine patients were recruited. Of those, 27 completed the 6 months evaluation and were analyzed [age 62.4 ± 11.3 years; 22 men; Model for End-Stage Liver Disease (MELD) 11.7 ± 4.0; prior overt HE 33%; median 25-hydroxyvitamin D (25OHD) plasma level 12.7 µgr/L] and 22 achieved 12 months assessment. At baseline, learning and memory (R = 0.382; p = 0.049) and working memory (R = 0.503; p = 0.047) subtests correlated with plasma 25OHD levels. In addition, processing speed (R = -0.42; p = 0.04), attention (R = -0.48; p = 0.04), Tinnetti balance (R = -0.656; p < 0.001) and Tinnetti score (R = -0.659; p < 0.001) were linked to neuroinflammation marker IL-1β. Patients with lower 25OHD had a greater proportion of TH1cells at baseline and a larger amelioration of IL-1β and IL-6 following supplementation. An improvement in working memory was found after 25OHD replacement (46.7 ± 13 to 50 ± 11; p = 0.047). Conclusions : This study supports that vitamin D supplementation modulates low-grade inflammation in decompensated cirrhosis providing cognitive benefits, particularly in working memory.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis

  • Álvarez-Sánchez, Esther|||0009-0002-8760-2153
  • Carbayo Viejo, Álvaro|||0000-0001-9282-8603
  • Valle-Tamayo, Natalia|||0000-0001-9322-3710
  • Muñoz, Laia|||0000-0003-0578-3094
  • Aumatell Escabias, Joaquim
  • Torres Alcalá, Soraya|||0000-0002-7054-2046
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Garcia Castro, Jesús|||0000-0003-1503-4775
  • Selma Gonzalez, Judit|||0009-0006-1021-4653
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Turon-Sans, Janina|||0000-0002-8842-4646
  • Lleó, Alberto|||0000-0002-2568-5478
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Fortea, Juan|||0000-0002-1340-638X
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
  • Dols Icardo, Oriol|||0000-0003-2656-8748
Neuroinflammation plays a major role in amyotrophic lateral sclerosis (ALS), and cumulative evidence suggests that systemic inflammation and the infiltration of immune cells into the brain contribute to this process. However, no study has investigated the role of peripheral blood immune cells in ALS pathophysiology using single-cell RNA sequencing (scRNAseq). We aimed to characterize immune cells from blood and identify ALS-related immune alterations at single-cell resolution. For this purpose, peripheral blood mononuclear cells (PBMC) were isolated from 14 ALS patients and 14 cognitively unimpaired healthy individuals (HC), matched by age and gender, and cryopreserved until library preparation and scRNAseq. We analyzed differences in the proportions of PBMC, gene expression, and cell-cell communication patterns between ALS patients and HC, as well as their association with plasma neurofilament light (NfL) concentrations, a surrogate biomarker for neurodegeneration. Flow cytometry was used to validate alterations in cell type proportions. We identified the expansion of CD56 dim natural killer (NK) cells in ALS (fold change = 2; adj. p -value = 0.0051), mainly driven by a specific subpopulation, NK_2 cells (fold change = 3.12; adj. p -value = 0.0001), which represent a mature and cytotoxic CD56 dim NK subset. Our results revealed extensive gene expression alterations in NK_2 cells, pointing towards the activation of immune response (adj. p -value = 9.2 × 10 - 11) and the regulation of lymphocyte proliferation (adj. p -value = 6.46 × 10 - 6). We also identified gene expression changes in other immune cells, such as classical monocytes, and distinct CD8 + effector memory T cells which suggested enhanced antigen presentation via major histocompatibility class-II (adj. p -value = 1.23 × 10 - 8) in ALS. The inference of cell-cell communication patterns demonstrated that the interaction between HLA-E and CD94:NKG2C from different lymphocytes to NK_2 cells is unique to ALS blood compared to HC. Finally, regression analysis revealed that the proportion of CD56 bright NK cells along with the ALSFRS-r, disease duration, and gender, explained up to 76.4% of the variance in plasma NfL levels. Our results reveal a signature of relevant changes occurring in peripheral blood immune cells in ALS and underscore alterations in the proportion, gene expression, and signaling patterns of a cytotoxic and terminally differentiated CD56 dim NK subpopulation (NK_2), as well as a possible role of CD56 bright NK cells in neurodegeneration. The online version contains supplementary material available at 10.1186/s12974-025-03347-0.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine, towards integrated management strategies

  • García-Castillo, María Clara
  • Sierra Mencia, Álvaro|||0000-0002-0022-6064
  • Caronna, Edoardo|||0000-0001-5525-0267
  • Toledo-Alfocea, Daniel|||0000-0003-3651-1614
  • Jaimes, Alex|||0000-0002-0890-9484
  • Urtiaga, Saray
  • Casas-Limón, Javier|||0000-0002-7353-4084
  • Muñoz-Vendrell, Albert|||0000-0001-8221-865X
  • Santos Lasaosa, Sonia|||0000-0002-4141-7705
  • García Martín, Valvanuz
  • Martín Ávila, Guillermo
  • Polanco Fernández, Marcos
  • Villar-Martínez, Maria Dolores|||0000-0003-3920-0176
  • Trevino-Peinado, Cristina|||0000-0001-8711-4884
  • Rubio-Flores, Laura|||0000-0001-5570-8055
  • Sánchez-Soblechero, Antonio|||0000-0002-7098-8494
  • Portocarrero Sánchez, Leonardo
  • Luque-Buzo, Elisa|||0000-0002-7983-9268
  • Lozano Ros, Alberto|||0000-0002-5186-8657
  • Gago-Veiga, Ana Beatriz|||0000-0002-0038-3406
  • Díaz de Terán, Javier|||0000-0003-0064-6269
  • Recio García, Andrea
  • Canales Rodríguez, Javiera
  • Gómez García, Andrea
  • González Salaices, Marta
  • Campoy Diaz, Sergio|||0000-0002-8135-4139
  • Mínguez-Olaondo, Ane|||0000-0002-7742-3920
  • Maniataki, Stefania
  • González-Quintanilla, Vicente|||0000-0003-0902-3906
  • Porta-Etessam, Jesús|||0000-0002-7034-682X
  • Cuadrado, María Luz|||0000-0001-8246-3743
  • Guerrero Peral, Ángel Luis|||0000-0001-7493-6002
  • Pozo-Rosich, Patricia|||0000-0003-0796-4702
  • Rodríguez-Vico, Jaime|||0000-0001-9360-5444
  • Huerta, Mariano|||0000-0003-0181-5335
  • Pascual Gómez, Julio|||0000-0002-3189-7573
  • Goadsby, Peter J.|||0000-0003-3260-5904
  • Gonzalez-Martinez, Alicia|||0000-0002-1228-1503
Preclinical evidence supports the immunoregulatory role of calcitonin gene-related peptide (CGRP) in migraine pathophysiology. The increasing use of anti-CGRP therapies in patients with migraine and other comorbidities raises the question whether the potential use of anti-CGRP monoclonal antibodies (CGRP-mAbs) therapies in combination with other immunological therapies is effective and safe. This multicenter study included patients with migraine receiving CGRP-mAbs combined with immunosuppressive and immunomodulatory treatments. Clinical and demographic data, treatment history, laboratory markers and treatment-emergent adverse events (TEAEs) were analyzed. Effectiveness outcomes included the change in monthly migraine days (MMD) and monthly headache days (MHD) at 3, 6, 9 and 12 months, alongside the.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study

  • Puig, Rocío
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Ponomarenko, Julia|||0000-0002-1477-9444
  • Amézqueta, Susana
  • Vendrell, Joan|||0000-0002-6994-6115
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Torres, Josep Lluís|||0000-0002-5072-8265
  • Mauricio, Didac|||0000-0002-2868-0250
  • Ramos-Romero, Sara|||0000-0002-9293-4454
Background/Objectives: Gut microbiota is profoundly influenced by dysglycemic states, including prediabetes (preDM) and type 2 diabetes (T2D). Although short-chain fatty acids (SCFAs) may serve as proxies reflecting these microbial changes, their predictive role remains elusive. This study aimed to evaluate the association between fecal SCFA concentrations and glycemic status (preDM and T2D), using individuals with normoglycemia (NonDM) as the reference group in a Mediterranean adult population. Methods: This study included a total of 88 participants from the Di@bet.es study who were classified into three groups according to the American Diabetes Association criteria: NonDM (45%), preDM (27%), and T2D (28%), respectively. We evaluated gut microbiota populations through massive sequencing and determined SCFAs concentration using gas chromatography-mass spectrometry. Adjusted multiple logistic regression models were used to estimate associations between SCFAs and metabolic status. Results: The mean age of subjects with preDM and T2D was approximately 68 years, older than that of NonDM participants (about 60 years). About 50% of the subjects in the NonDM and preDM groups were female, whereas in the T2D group, females represented about 25%. The analysis revealed that only fecal acetic acid was significantly reduced in T2D compared to NonDM (p = 0.036) and preDM (p = 0.018) groups. Remarkably, fecal acetic acid was negatively associated with T2D risk when taking preDM as the reference state (OR = 0.561 [95% CI: 0.371-0.846], p = 0.009). Intriguingly, fecal acetic acid was identified as a significant positive predictor of preDM risk, taking the NonDM group as reference (OR = 1.422; p = 0.028), while propionic acid was inversely associated with preDM (OR = 0.714; p = 0.028). Conclusions: Our analysis showed that fecal acetic acid levels were associated with a reduced risk of T2D but also with an increased risk of preDM; however, the biological relevance of these findings remains uncertain.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Neurocognitive Impairment in Inherited Metabolic Disorders due to Intoxication and Energy Defects, A Systematic Review

  • Gil-González, Marta
  • Arias, Carolina
  • Saudubray, Jean-Marie
  • Colomé-Roura, Roser
  • García-Cazorla, Ángeles
Inherited metabolic disorders (IMD) can disrupt brain development and functioning, leading to cognitive and behavioral abnormalities. This systematic review aims to provide a comprehensive synthesis of the evidence regarding neurocognitive impairments in intoxication IMD due to the accumulation of small molecule disorders and energy-related IMD. A search was conducted in the PubMed database until August 2024, using the term "cognition" and up to 421 energy-related IMD and 196 intoxication IMD. Reviews, animal models, studies with non-standardized measures, and studies that focused on complex molecule disorders, small molecule deficiencies, and phenylketonuria were excluded. In total, 163 studies were included in the final analysis. The cognitive domains assessed were executive functions, attention, processing speed, language, speech, visual performance, fine motor dexterity, memory, behavioral and emotional regulation, and social cognition. Most available evidence focused on intoxication IMD (83%), which exhibited better global cognitive functioning than energy defects. The cognitive domains most frequently reported as impaired were fine motor dexterity (80.9%), behavioral and emotional regulation (80%), executive functions (73.3%), attention (72.4%), and social cognition (65.6%). After applying the chi-square test with a 95% confidence level, no statistically significant differences were found between intoxication and energy-related IMD. However, language impairments were slightly more pronounced in intoxication disorders, while visuospatial deficits were more common in energy disorders. Individuals with IMD are at a higher risk of neurodevelopmental disorders, which can persist despite early detection and treatment. Although the number of cognitive studies has increased in recent years, further research with standardized measures is necessary to understand the underlying pathophysiology of neurocognitive impairments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Novel Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration

  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Bernal, Sara|||0000-0003-4427-0574
  • Almenta Gallego, David|||0000-0001-9069-8948
  • Perez Blanco, Josefina|||0000-0002-6489-8871
  • Camacho, Valle|||0000-0003-0748-0847
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Garcia Castro, Jesús|||0000-0003-1503-4775
  • Selma Gonzalez, Judit|||0009-0006-1021-4653
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Carbayo Viejo, Álvaro|||0000-0001-9282-8603
  • Turon-Sans, Janina|||0000-0002-8842-4646
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
C-truncating variants in the charged multivesicular body protein 2B (CHMP2B) gene are a rare cause of frontotemporal lobar degeneration (FTLD), previously identified only in Denmark, Belgium, and China. We report a novel CHMP2B splice-site variant (c.35-1G>A) associated with familial FTLD in Spain. The cases were two monozygotic male twins who presented at ages 62 and 66 years with a slowly progressive behavioral variant of frontotemporal dementia and a syndrome mimicking dementia with Lewy bodies, respectively. Functional and in silico analyses supported the pathogenicity of this variant. Our findings contribute new insights into the genetic landscape and clinical heterogeneity of FTLD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

From Genetics to Psychosocial Functioning, Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis

  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Clougher, Derek|||0000-0001-7631-3845
  • González-Segura, Àlex|||0000-0002-9398-2183
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Vieta, Eduard|||0000-0002-0548-0053
  • Garriga, Marina|||0000-0001-7312-4969
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Diaz-Caneja, C.M.
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • de la Serna, Elena|||0000-0002-7869-9881
  • Mané, Anna|||0000-0003-2127-349X
  • Mas, Sergi|||0000-0003-3336-6298
  • Torrent, Carla|||0000-0003-0335-582X
  • Allot, K.|||0000-0002-0640-4634
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Pérez, Antonio|||0000-0001-5528-1143
  • Meseguer, A.
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Ruiz-Lazaro, P.M.
  • Calvo, L.
  • Estébanez, M.J.
  • Ferrer, Marta
  • Echevarría, A.
  • Escarti, M.J.
  • Rivero, O.
  • Trabsa, Amira|||0000-0002-8669-0676
  • Legido, Teresa|||0000-0002-1175-2641
  • Serra, M.
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Castro Gutiérrez, Jorge
  • Parra, S.M.
  • Santo, F.D.
  • García-Portilla, María Paz
  • Echevarría, R.S.
  • Rabadán, A.Z.
  • Martínez-Gras, I.
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Usall, J.
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Clotet, E.P.
  • Salvador, R.
  • Ibañez, Angela|||0000-0003-2751-0150
  • Cuesta, M.J.
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
Background: Studies have shown associations between polygenic risk scores for educational attainment (PRS), cognitive reserve (CR), cognition, negative symptoms (NS), and psychosocial functioning in first-episode psychosis (FEP). However, their specific interactions remain unclear. This study aimed to investigate the mediating roles of CR, cognition, and NS in the relationship between PRS and psychosocial functioning one year after a FEP. Additionally, we sought to explore the impact of two NS subtypes on this relationship: diminished Expression (EXP-NS) and Motivation and Pleasure (MAP-NS). Methods: A total of 138 FEP participants, predominantly male (70%), with a mean age of 24.77 years (SD = 5.29), underwent genetic, clinical, and cognitive assessments two months after study enrollment. Functioning evaluation followed at one-year follow-up. To investigate the mediating role of CR, cognition, and NS in the relationship between PRS and functioning, a serial mediation model was employed. Two further mediation models were tested to explore the differential impact of EXP-NS and MAP-NS. Mediation analysis was performed using the PROCESS macro version 4.1 within SPSS version 26. Results: The serial mediation model revealed a causal chain for PRS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Validation of the 12-item World Health Organization Disability Assessment Schedule (WHODAS 2.0) in adults with attention-deficit hyperactivity disorder

  • Amoretti, Silvia|||0000-0001-6017-2734
  • Crespín, Juan Jesús
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Torrent, Carla|||0000-0003-0335-582X
  • Clougher, Derek|||0000-0001-7631-3845
  • Biel, Santiago
  • Ramos-Sayalero, Carolina
  • Ibáñez, Pol|||0000-0003-0714-8908
  • Mestres, Ferran
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
Background Attention deficit hyperactivity disorder (ADHD) is often associated with psychosocial functioning difficulties and valid measures of disability are needed for this population. The 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) is widely used to measure disability but has not been validated in the adult ADHD population. Aims This study aims to assess the psychometric properties of the WHODAS 2.0 in adults with ADHD, and to examine differences in disability levels between ADHD subtypes and gender. Method A cross-sectional study was conducted with 577 adults with ADHD (mean age: 38.24, s.d = 12.23; 52.3% male). ADHD severity was assessed using the ADHD Rating Scale (ADHD-RS) and Clinical Global Impression-Severity (CGI-S) Scale, while functionality was measured with the WHODAS 2.0 and the Functioning Assessment Short Test (FAST). Analyses included: (a) Cronbach's α for internal consistency, (b) Pearson's correlation for convergent validity, (c) Confirmatory Factor Analysis (CFA) for factor structure and (d) t-tests to compare disability levels across ADHD subtypes and gender. Results The WHODAS 2.0 demonstrated good internal consistency (Cronbach's α = 0.89). Scores were significantly correlated with psychosocial functioning (FAST, r = 0.476, p < 0.001) and clinical measures. CFA supported the original six-factor structure (root mean square error of approximation 0.039, Comparative Fit Index 0.998, Tucker-Lewis Index 0.996). When comparing ADHD subtypes, participants with the combined subtype had higher WHODAS 2.0 total scores than those with the inattentive subtype (p = 0.006). Additionally, gender differences were identified, with females displaying higher disability levels (p = 0.005). Conclusions The WHODAS 2.0 demonstrates psychometric properties that suggest it is a valid and reliable tool for assessing disability in adults with ADHD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in the efficacy of cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder

  • Crespín, Juan Jesús
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Parramón Puig, Gemma|||0000-0002-6861-7678
  • Biel, Santiago
  • Mestres, Ferran
  • Ramos-Sayalero, Carolina
  • Ibáñez, Pol|||0000-0003-0714-8908
  • Nieva, Gemma|||0000-0003-2630-1218
  • Torrent, Carla|||0000-0003-0335-582X
  • Clougher, Derek|||0000-0001-7631-3845
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
Background and objectives: Cognitive Behavioral Therapy (CBT) is an effective adjunctive treatment for AttentionDeficit/Hyperactivity Disorder (ADHD). This study examined sex differences in the efficacy of a brief 6-session CBT program versus a traditional 12-session format, combined with stable pharmacotherapy, in adults with ADHD. Methods: A total of 81 adults (58 % male; 41.27 ± 9.26 years) were randomly assigned to 6- or 12-session CBT. ADHD symptoms, psychopathology, and functioning were assessed at baseline, post-treatment, and 3- and 6-month follow-up. Mixed-effects models analyzed interactions between time, treatment group, and sex. Results: At baseline, females exhibited greater symptom severity (p = 0.019), higher inattention (p < 0.001), and more pronounced impairments (p = 0.004). CBT led to significant clinical improvements regardless of sex. A significant time-by-sex interaction emerged for inattention (CAARS:O:L, p = 0.043), although it did not remain significant after adjusting for baseline severity. Regarding time × group × sex interactions, females in the 6-session group showed smaller reductions in clinical severity during follow-up (CGI-S, p = 0.047); however, this effect was no longer statistically significant after controlling for baseline ADHD severity. Findings should be interpreted with caution given the limited female sample at follow-up and the significant influence of initial symptom burden on long-term trajectories. Conclusions: CBT improves ADHD symptoms and related impairments in adults, with comparable overall benefits across sexes. Treatment response follow-up differences were better explained by baseline severity and treatment intensity rather than sex-specific differences.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein

  • Álamo, Patricia|||0000-0003-0510-5701
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
Endocrine-like dynamic protein depots can be fabricated in vitro through the coordination of divalent zinc ions (Zn) with solvent-exposed histidine residues on functional proteins, leading to their controlled aggregation. The resulting microparticles, under physiological conditions, undergo progressive disintegration due to spontaneous Zn dilution, enabling a time-sustained release of the protein components. These chemically pure protein-based materials represent promising drug delivery platforms, with demonstrated efficacy in oncology, vaccinology, tissue regeneration, and antibacterial therapies. To enable systemic delivery of the embedded protein, alternative administration routes are potentially suited, but their effectiveness in terms of biodistribution and accumulation in target tissues remains unexplored. Using a CXCR4 cancer mouse model, we investigated the tumor targeting and permanence of a self-assembling, CXCR4-binding fluorescent protein administered in the form of secretory granules via subcutaneous, intramuscular, or intraperitoneal injection. Our data reveal that subcutaneous administration supports prolonged protein retention at the injection site, its release within the local draining lymphatic vessels, extended circulation time, and significantly higher tumor accumulation 10 days post-injection. Compared to intramuscular and intraperitoneal routes, the subcutaneous pathway presents clear advantages, potentially allowing reduced dosing frequency in protein-based therapies aimed at maintaining steady systemic and target tissue levels.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancer

  • Sánchez-Menéndez, Clara
  • Rodríguez-Pérez, Jaime
  • Fuertes, Daniel
  • Leguizamon, Valentina
  • González-Sanmartín, María
  • Mateos, Elena
  • Cervero Jiménez, Miguel|||0000-0001-9387-7917
  • San José, Esther
  • Sanz, Gonzalo
  • Álvaro, Edurne
  • Ballestero-Pérez, Araceli
  • Marti-Gallostra, Marc|||0000-0002-0783-6359
  • Rueda, José Antonio
  • Hurtado-Caballero, Elena
  • Pastor, Carlos
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Spinelli, Antonino
  • Martínez-Laso, Jorge
  • Torres Tarrés, Montserrat
  • Perea, José
  • Coiras, Mayte
Colorectal cancer (CRC) is a leading cause of cancer-related mortality. While screening has reduced incidence in older adults, cases of early-onset CRC (EOCRC), diagnosed before age 50, are rising, highlighting the need to understand its unique biology. Immune responses, particularly T-cell infiltration measured by the tumor-based Immunoscore, are known predictors of CRC prognosis, but less is known about systemic immune differences by age at diagnosis. Peripheral blood mononuclear cells (PBMCs) from EOCRC (n=19) and late-onset CRC (LOCRC; n=19) participants recruited in Madrid (Spain) were analyzed for immune cell phenotypes, exhaustion markers, soluble cytokines, and metabolic activity. Our study revealed distinct peripheral blood immune profiles differentiating EOCRC from LOCRC. EOCRC patients exhibited a heightened proinflammatory environment, with increased functional capacity of CD4+ Th1, Th9, and Th17 subsets to produce IFNg, IL-9, and IL-17A, respectively, and increased plasma levels of IFNg and CXCL8/IL-8. This suggests an active but potentially ineffective immune response. Conversely, LOCRC patients showed hallmarks of immunosenescence and chronic inflammation, including impaired cytokine production, higher frequencies of CD8+ Tgd and Th22 cells, and increased plasma CCL13/MCP-4, consistent with tissue remodeling and immune suppression. Biomarkers distinguishing EOCRC included reduced Th22 and CD8+ Tgd cell frequencies and higher NKT-like cells with increased IL-13 production by Th22 cells. EOCRC and LOCRC involved different immune mechanisms, where EOCRC showed an altered proinflammatory environment with preserved regulatory pathways, while LOCRC reflected age-related immune decline and inflammaging. Peripheral blood immune profiling offers a minimally invasive liquid Immunoscore for early detection and enables personalized immunotherapies for age-related immune landscapes, particularly benefiting younger individuals at risk of EOCRC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates

  • Rueda, Ariana|||0000-0001-7588-9279
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Arena, Lourdes Ailen|||0009-0006-1863-3895
  • Mendoza, Julian Ignacio|||0000-0002-1975-3606
  • Aviñó, Ana|||0000-0003-3047-738X
  • Fabrega, Carme|||0000-0003-3816-7634
  • Eritja, Ramon|||0000-0001-5383-9334
  • Paez, David|||0000-0002-5596-6588
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
Precision targeting is a hot topic in cancer nanomedicine, as conventional chemotherapies cause systemic toxicities, creating an urgent need for more selective treatments. Although antibody-drug conjugates (ADCs) are the current gold standard in targeted therapy, their clinical performance remains limited. As an alternative, we previously developed a multivalent protein nanocarrier (T22-GFP-H6) displaying the CXCR4-targeting peptide T22, which offers super-selective tumor accumulation driven by CXCR4 overexpression. This innovative nanovehicle showed favorable biodistribution for targeted delivery of antitumor drugs, including monomethyl auristatin E (MMAE), in a first-generation stochastic nanoconjugate format. However, unlike ADCs, where conjugation strategy is known to influence pharmacokinetics and efficacy, these parameters remain largely unexplored in non-antibody multivalent nanocarriers. Here, we evaluated the impact of precise payload accommodation using two site-specific strategies that attach a single MMAE molecule at distinct structural sites, and we compared them with first-generation nanoconjugates. The conjugation strategy substantially affected the biodistribution and antitumor efficacy, with a solvent-exposed cysteine-conjugation distal to the targeting ligand proving most effective. At equimolar nanocarrier dosing, this construct achieved tumor control similar to the stochastic conjugate in a disseminated hematologic malignancy despite an approximately 4-fold lower MMAE load (drug-to-protein ratio, DPR = 1 vs DPR ≈ 4). Moreover, at equimolar MMAE dosing, it clearly outperformed both the stochastic conjugate and the alternative site-directed design. These findings align with trends in advanced ADCs and provide practical design rules for rational, site-specific conjugation in next-generation protein-based nanomedicines aimed at enabling dose-sparing in oncology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Case of Hyperinsulinemic Hypoglycaemia Associated with Atypical Fanconi Renal Tubulopathy Syndrome Caused by an HNF4A Variant

  • Garriga-Edo, Sarai
  • Peris-Serra, Lydia
  • Ríos Duro, Héctor
  • Giralt, Marina
  • Díaz-Troyano, Noelia|||0000-0002-9392-0142
  • Ferrer, Roser
  • Ferrer, Roser
  • Antolín, María|||0000-0001-5623-6862
  • Pérez Dueñas, Belén
  • Clemente, Maria|||0000-0002-3721-5043
Introduction: This case illustrates the challenges in the diagnosis of a rare disease with an intricate orientation. The definitive genetic diagnosis was carried out after establishing crucial correlations between the preliminary clinical indications and the laboratory findings. Case Presentation: The initial presentation was myoclonic jerks. This was a direct consequence of hyperinsulinaemic hypoglycaemia (HH), and not a phenotypic characteristic described in previous case reports. Linking this to glycaemia led to the evaluation of response to fasting, where inadequate insulin suppression resulted in hypoketotic hypoglycaemia. The diagnosis of chronic kidney dysfunction associated with atypical Fanconi renal tubulopathy syndrome type 4 (FRTS4) was indicated on the basis of a decreased estimated glomerular filtration rate, nephrocalcinosis, millimetric lithiasis, rickets, and complex proximal tubulopathy. This indicated atypical FRTS4 as associated with HH and necessitated further molecular genetic testing. Conclusion: The patient was identified as a carrier of the c.187C>T (p.Arg63Trp) variant in the HNF4A gene, which is a heterozygous missense variant classified as pathogenic. This entity is rare, and the published literature reporting HNF4A gene variants associated with atypical FRTS and HH is limited. It is therefore important to report such cases to contribute to the growing body of evidence and help identify pathogenic HNF4A variants and their implications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association between dietary niacin intake and diabetic retinopathy in a Catalonian population, a cross-sectional study

  • Torres-Méndez, Jeimy Katherine|||0000-0001-6299-8222
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Antentas Peraile, María|||0009-0005-8140-203X
  • Vendrell Tito, Pau|||0009-0003-2020-5126
  • Ortega, Emilio|||0000-0002-2217-8905
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Muscarà, Andrea
  • Rubinat, Esther|||0000-0003-0232-9777
  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Hernández García, Marta|||0000-0003-1237-298X
  • Rossell, Joana|||0000-0003-1500-6379
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Mauricio, Didac|||0000-0002-2868-0250
  • Julve i Gil, Josep|||0000-0002-6531-2246
Background: Accumulating evidence suggests that niacin interventions may have a beneficial role in preventing ophthalmological microangiopathic remodeling. This study aimed to assess the impact of niacin intake on the presence of diabetic retinopathy (DR) in two independent Mediterranean cohorts of individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D). Methods: Cross-sectional, population-based epidemiologic study. A total of 243 individuals with T1D, and 291 individuals with T2D. All participants underwent an eye examination. Dietary niacin intake was analyzed using a validated Spanish 101-items food frequency questionnaire consumption. The association between niacin intake and DR was assessed using a multivariate logistic regression, with potential non-linear associations further explored through restricted cubic spline regression. DR diagnostic was established via multifield stereoscopic retinal photography, in accordance with the international consensus on DR. Results: DR was identified in 103 out of 243 individuals with T1D and 144 out of 291 with T2D. Dietary niacin intake did not differ within the study groups according to DR status. Multivariate logistic regression models also revealed no association between dietary niacin intake and DR. As previously described, the duration of diabetes for T1D and T2D, [OR (95%CI), 1.02 (1.01-1.03), and 1.02 (1.02-1.03), respectively] and glycated hemoglobin (HbA1c) [OR (95%CI), 1.16 (1.09-1.24), and 1.14 (1.09-1.18), respectively] were identified as the main determinant variables for DR in both groups. Conclusions: We found that dietary niacin intake was not associated with the presence of RD in subjects with either T1D or T2D. Further research is needed to better understand the potential role of niacin in the development or prevention of DR.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs

  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Arena, Lourdes Ailen|||0009-0006-1863-3895
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
The biological activity of therapeutic proteins, upon intracellular delivery, is dramatically minimized by lysosomal proteolytic digestion. This is a limitation when developing cell-targeted pharmaceuticals that penetrate target cells via receptor recognition and endosomal engulfment. Since proteins benefit from functional and conformational versatility, editable by genetic engineering, endosomolytic protein domains are often fused to the functional polypeptide to promote their cytosolic delivery, aiming at minimizing proteolysis in mature lysosomes. This straightforward strategy has, however, rendered irregular results, linked to the fusogenic nature of most of the tested domains. Alternatively, proteolysis of protein drugs might be controlled by bypassing the lysosomal route, forcing an unconventional traffic of the uptaken protein material to be secreted from the endoplasmic reticulum (ER). This possibility, used in nature by several plant and microbial proteins, has been evaluated here by functionalizing a protein-only antitumoral drug, based on a cell-targeted diphtheria toxin, with a C-terminal KDEL motif. Thus, if KDEL were able to reprogram the intracellular trafficking, KDEL-tagged cell delivered proteins would be expected to avoid the lysosomal degradation, resulting in enhanced stability and activity. The obtained results validate this hypothesis and point out KDEL as a promising functional agent in cell-targeted protein drugs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biomimetic Protein Materials for Adjuvant-Free Dermal Penetration

  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Escribano-Ferrer, Elvira|||0000-0001-7837-9506
  • Huaca, Vanesa
  • Miranda-Tovar, Eva
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Parladé, Eloi|||0000-0001-5750-550X
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
The effective dermal delivery of functional proteins could substantially improve therapeutic options for common skin disorders, in which current lipid-based or invasive strategies face efficacy and safety limitations. We report a biomimetic protein depot platform based on granular, nontoxic amyloids generated through Zn-mediated coordination of hexahistidine-tagged proteins. Functionalization of these materials with either the cell-penetrating peptide R9 or the tight junction modulator c-CPE, the C-terminal region of the Clostridium perfringens enterotoxin, enabled a systematic evaluation of transdermal penetration in mouse models. Whereas plain and R9-functionalized granules showed restricted permeation, c-CPE-functionalized granules achieved consistent distribution through the dermis into the hypodermal layers. These findings establish self-assembled protein amyloids as a promising and adaptable class of biomaterials for dermal protein delivery. Also, the ability of c-CPE to enhance permeability without auxiliary adjuvants, lipids, or invasive methods highlights the translational potential of this system for clinically applicable, noninvasive management of cutaneous conditions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Does Attention-Deficit/Hyperactivity Disorder Predominant Presentation Matter? Examining Functional and Symptom Changes After Cognitive Behavioural Therapy

  • Crespín, Juan Jesús
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Parramón Puig, Gemma|||0000-0002-6861-7678
  • Querol, Paula
  • Mestres, Ferran
  • Ramos-Sayalero, Carolina
  • Boix, Maria
  • Torrent, Carla|||0000-0003-0335-582X
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Amoretti, Silvia|||0000-0001-6017-2734
Background: Cognitive behavioural therapy (CBT) is an effective intervention for adults with attention-deficit/hyperactivity disorder (ADHD). While both brief (6-session) and standard (12-session) formats show efficacy, it remains unclear whether treatment response differs between distinct ADHD clinical presentations. Methods: This secondary analysis of a randomized trial included 80 adults with ADHD (57.5% male; mean age = 41.26 ± 9.32 years) allocated to brief or standard CBT. Clinical and functional outcomes were assessed at baseline, posttreatment, as well as 3- and 6-month follow-ups. Linear mixed-effects models and the Reliable Change Index (RCI) evaluated interactions between time, treatment format and ADHD presentation (inattentive vs. combined). Results: CBT yielded significant improvements across all domains, with 94.5% of participants achieving reliable symptomatic improvement. A significant time × presentation interaction (p = 0.001, ηp2 = 0.135) revealed a steeper core symptom reduction in the combined group, which survived sensitivity analyses controlling for baseline severity. Regarding format, the brief version produced greater observer-rated symptom improvement, whereas the standard format yielded greater long-term functional gains (p = 0.009, ηp2 = 0.061). Improvements were sustained at the 6-month follow-up. No robust three-way interactions emerged. Conclusions: CBT is highly effective and durable across ADHD presentations and formats. Although the combined presentation exhibited a more pronounced reduction in core symptoms, this differential trajectory represents a promising clinical trend requiring cautious interpretation. While brief formats efficiently address core symptoms, standard programs may better optimize long-term functional recovery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Systematic Assessment of Matrix Effect, Recovery, and Process Efficiency Using Three Complementary Approaches, Implications for LC-MS/MS Bioanalysis Applied to Glucosylceramides in Human Cerebrospinal Fluid

  • Castillo-Ribelles, Laura|||0000-0001-9380-7839
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Martinez-Vicente, Marta|||0000-0001-7053-2625
  • Carnicer-Cáceres, Clara
  • Arranz-Amo, Jose Antonio|||0000-0002-2236-4185
The evaluation of matrix effect, recovery, and process efficiency is essential in the validation of LC-MS/MS bioanalytical methods, as they impact assay accuracy, precision, and sensitivity. However, guidelines on bioanalytical method evaluation are not harmonized and can occasionally be ambiguous. To address this need, the study presents an integration of three different approaches to assess these parameters within a single experiment. The first approach examined the variability of peak areas and standard-to-internal standard (IS) ratios between different matrix lots to assess the influence of the analytical system, relative matrix effects, and recovery on method precision. The second strategy evaluates the influence of the overall process on analyte quantification. The third approach calculates both the absolute and relative values of matrix effect, recovery, and process efficiency, as well as their respective IS-normalized factors, to determine the extent to which the IS compensates for the variability introduced by the matrix and recovery fraction. Applying these strategies to an LC-MS/MS method for quantifying glucosylceramides in cerebrospinal fluid addresses the challenges posed by limited sample volume and endogenous analytes, while providing a comprehensive understanding of the factors that influence method performance and promoting adherence to different guideline recommendations. This study supports the importance of a systematic evaluation of matrix effect, recovery, and process efficiency during method validation. Standardized evaluation methodologies would improve data interpretation, enhance method reliability, and contribute to harmonization in in-house bioanalysis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis

  • Monreal, Enric|||0000-0003-3293-0125
  • Fernández Velasco, José Ignacio|||0000-0001-9148-671X
  • Sainz De La Maza, Susana
  • Espiño, Mercedes
  • Villarrubia, Noelia
  • Roldán, Ernesto
  • Aladro, Yolanda|||0000-0001-9459-5452
  • Cuello, Juan Pablo
  • Ayuso-Peralta, Lucía
  • Rodero-Romero, Alexander
  • Chico-García, Juan Luís
  • Rodríguez-Jorge, Fernando
  • Quiroga-Varela, Ana
  • Rodríguez-Martín, Eulalia
  • Pilo, Belén
  • Martín Ávila, Guillermo
  • Martínez Ginés, María Luisa
  • García Domínguez, José Manuel
  • Rubio, Lluïsa
  • Llufriu, Sara|||0000-0003-4273-9121
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Montalban, Xavier|||0000-0002-0098-9918
  • Álvarez Bravo, Gary|||0000-0003-0342-0177
  • Veiga-Gonzalez, José Luis
  • Masjuan, Jaime|||0000-0003-1329-0943
  • Costa-Frossard, Lucienne|||0000-0002-6512-4413
  • Villar, Luisa M.|||0000-0002-9067-3668
The combined use of serum and CSF biomarkers for prognostic stratification in multiple sclerosis (MS) remains underexplored. This multicenter observational study investigated associations between serum neurofilament light chain (sNfL), glial fibrillary acidic protein (sGFAP), and CSF lipid-specific IgM oligoclonal bands (LS-OCMB) with different forms of disability worsening, such as relapse-associated worsening (RAW), active progression independent of relapse activity (aPIRA), and non-active PIRA (naPIRA). A total of 535 patients with MS were included, all sampled within one year of disease onset. Biomarkers were quantified using single-molecule array and immunoblotting techniques, and CSF cell subsets were analyzed by flow cytometry. High sNfL z-scores and LS-OCMB positivity were independently associated with increased risk of RAW and aPIRA, collectively termed inflammatory-associated worsening (IAW), while elevated sGFAP levels predicted naPIRA. Patients with both high sNfL and LS-OCMB positivity had the highest risk of IAW. Among LS-OCMB-positive patients, higher regulatory T cell percentages were associated with lower sNfL levels, suggesting a protective role. Conversely, in LS-OCMB-negative patients, sNfL levels correlated with CSF C3 concentrations. These findings support the complementary role of sNfL, sGFAP, and LS-OCMB in identifying distinct mechanisms of disease worsening and may inform early personalized management strategies in MS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Deep learning to predict progression independent of relapse activity at a first demyelinating event

  • Coll, Llucia|||0000-0003-2224-1246
  • Pareto, Deborah|||0000-0001-7356-3769
  • Aparicio Serrano, Francisco
  • Otero-Romero, Susana|||0000-0002-6798-568X
  • Cobo-Calvo, Álvaro|||0000-0002-2574-0721
  • Reinders, Evy
  • Alberich, Manel|||0000-0002-4132-0620
  • Arévalo, María Jesús|||0000-0003-0626-5555
  • Arrambide, Georgina|||0000-0002-2657-5510
  • Auger, Cristina|||0000-0001-9846-4767
  • Castilló, Joaquín|||0000-0002-8951-6315
  • Comabella López, Manuel|||0000-0002-2373-6657
  • Galan, Ingrid|||0000-0001-5774-4260
  • Midaglia, Luciana|||0000-0001-7981-2228
  • Nos, Carlos|||0000-0002-3830-4910
  • Novak, Frederik
  • Oliver, Arnau
  • Río, Jordi|||0000-0003-4546-7627
  • Rodríguez Acevedo, Breogán|||0000-0002-0314-753X
  • Sastre-Garriga, Jaume|||0000-0002-1589-2254
  • Vidal-Jordana, Angela|||0000-0002-7270-5507
  • Zabalza, Ana|||0000-0003-3860-5251
  • Montalban, Xavier|||0000-0002-0098-9918
  • Rovira, Alex|||0000-0002-2132-6750
  • Tintoré, Mar|||0000-0001-9999-5359
  • Lladó, Xavier
  • Tur, Carmen|||0000-0003-1849-3184
Progression independent of relapse activity is the main cause of irreversible disability in multiple sclerosis and is strongly associated with older age at symptom onset. Early and accurate prediction, at symptom onset, of which patients are at highest risk of progression independent of relapses, is an unmet need. This study aimed to develop a deep learning survival model using only routine MRI acquired at the first demyelinating attack to predict the risk of progression independent of relapses, and assess its ability to improve classical age-adjusted predictions. We analysed a prospective cohort of patients under 50, clinically assessed within three months of symptom onset, with available MRI (T1- and T2-Fluid-Attenuated Inversion Recovery sequences). An independent early multiple sclerosis cohort (≤1 year from symptom onset) from the Multiple Sclerosis Partners Advancing Technology and Health Solutions database (N = 32) was used for external validation. Patients were assessed for progression independent of relapse activity, defined as a 6-month confirmed increase in the Expanded Disability Status Scale without relapses. Our deep learning model used EfficientNet to estimate the cumulative probability of progression independent of relapses at 1-year intervals. We employed 5-fold cross-validation for model training and testing, assessing performance with the time-dependent concordance index. We also investigated the optimal cumulative probability threshold for binary risk stratification. The model's ability to improve a classical Cox regression model was evaluated. Additionally, we identified brain regions most relevant to deep learning-based progression independent of relapse activity predictions using an interpretability algorithm. A total of 259 patients were evaluated, 58 (22%) of whom experienced at least one event of progression independent of relapse activity over a median follow-up of 4.2 years. The deep learning model demonstrated high performance (time-dependent concordance index = 0.72) with an accuracy of 78% in the original cohort and 72% in the external cohort for predicting the risk of progression independent of relapse activity. Incorporating the deep learning-derived cumulative probability of progression independent of relapses significantly improved an age-adjusted Cox regression model, raising Harrell's C index from 0.62 to 0.74. Interpretability revealed the frontoparietal cortex as a key region in predicting progression independent of relapse activity. In conclusion, our deep learning survival model, based on routine MRI at the first demyelinating attack, can accurately identify patients at high risk of progression independent of relapses and may serve as a valuable tool in clinical practice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial

  • Rojo, Federico|||0000-0001-9989-0290
  • Torrecillas, Laura
  • Ruiz-Borrego, Manuel
  • Bines, Jose
  • Torres, Roberto
  • de la Haba Rodríguez, Juan Rafael|||0000-0001-5111-1702
  • Llombart, Antonio
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
  • Bermejo, Begoña
  • Martín Jiménez, Miguel
  • Taylor, Clive R.
  • Barrios, Carlos
  • Perez-Buira, Sandra
  • Guerrero-Zotano, Ángel L.
  • García-Sáenz, José A.|||0000-0001-6880-0301
  • Ayala de la Peña, Francisco|||0000-0001-6311-920X
  • Gómez, Henry L.
  • Rodríguez de la Borbolla, María
  • Baena-Cañada, Jose Manuel
  • Calvo Martínez, Lourdes
  • Herranz, Jesús|||0000-0003-2469-357X
  • Rincon, Raul
  • Caballero, Rosalía
  • S. Ray, Partha
Purpose: In a prespecified GEICAM_CIBOMA trial (NCT00130533) correlative analysis, PAM50 non-basal-like breast cancer (non-BLBC) status distinguished patients with triple-negative breast cancer (TNBC) who are most likely to benefit from adjuvant capecitabine. The standardized forkhead box C1 (FOXC1) IHC test has demonstrated strong reliability in classifying the BLBC subtype throughout TNBC cohorts. This translational analysis aimed to evaluate the prognostic/predictive significance of BLBC classification by FOXC1 IHC in the phase III GEICAM_CIBOMA clinical trial. Experimental Design: Tumor tissues from patients with TNBC randomized to standard (neo)adjuvant chemotherapy followed by capecitabine versus observation were analyzed using the standardized FOXC1 IHC test to assess its BLBC/non-BLBC TNBC subtyping capacity as a distant relapse-free survival clinical outcome predictor of capecitabine benefit (exploratory endpoints: disease-free survival, overall survival, and recurrence-free survival). Results: A total of 705 (80.5%) patients from the GEI-CAM_CIBOMA trial were evaluable for FOXC1 expression analysis, with balanced distribution between the trial's treat-ments. FOXC1 proportion/intensity (VFOXC1) score-based subtyping demonstrated a strong association [AUC ¼ 0.87; 95% confidence interval (CI), 0.84-0.91] and agreement (κ index ¼ 0.43; P < 0.0001) with PAM50 molecular subtyping. VFOXC1 non-BLBC TNBC subtype was a significant independent predictor of clinical benefit with capecitabine for distant relapse-free survival (HR, 0.44; 95% CI, 0.25-0.76; P ¼ 0.003). This predictive effect of VFOXC1 non-BLBC on capecitabine efficacy was further confirmed at disease-free survival (HR, 0.47; 95% CI, 0.28-0.78; P ¼ 0.003), overall survival (HR, 0.48; 95% CI, 0.24-0.96; P ¼ 0.038), and recurrence-free survival (HR, 0.39; 95% CI, 0.22-0.72; P ¼ 0.002). Conclusions: This ambispective GEICAM_CIBOMA translational analysis validated FOXC1-based basal-like/non-basal-like subtyping as a pragmatic alternative to PAM50 subtyping and independently predicted the benefit of adding capecitabine to standard (neo)adjuvant chemotherapy in TNBC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model

  • Garcia León, Annabel|||0000-0003-3007-9306
  • Mendoza, Julian Ignacio|||0000-0002-1975-3606
  • Rueda, Ariana|||0000-0001-7588-9279
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Sierra, Jorge|||0000-0002-7966-0356
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Acute myeloid leukemia (AML) presents major clinical challenges due to chemoresistance and high relapse rates, primarily driven by therapy-resistant leukemic stem cells (LSCs) within the bone marrow. To address this issue, we developed T22-HSNBT-H6-MMAE, a novel humanized nanoconjugate designed to target CXCR4 cells while delivering the cytotoxic payload monomethyl auristatin E (MMAE). CXCR4 signaling pathway plays a critical role in LSC survival by preserving stem-like properties and activating protective mechanisms that promote treatment resistance. Moreover, CXCR4 is overexpressed in approximately 50 % of AML patients and is associated with poor prognosis and high relapse rates. We evaluated the therapeutic potential of T22-HSNBT-H6-MMAE using in vitro assays with AML cell lines and primary patient samples, as well as in vivo studies in a disseminated AML mouse model. Our results demonstrated that T22-HSNBT-H6-MMAE exerts a CXCR4-dependent cytotoxic effect through mitotic catastrophe and apoptosis induction in CXCR4 AML cell lines. In vivo evaluation in a disseminated CXCR4 AML mouse model showed potent antineoplastic activity, with complete suppression of leukemic dissemination and significantly prolonged survival, all without systemic toxicity. Notably, the nanoconjugate remained effective even in models with extensive bone marrow involvement and exhibited activity against diverse patient-derived CXCR4 AML blasts, while sparing healthy donor bone marrow and peripheral blood mononuclear cells (PBMCs) from significant toxicity. Collectively, these findings highlight T22-HSNBT-H6-MMAE as a promising therapeutic candidate for a broad range of AML patients, offering selective antineoplastic activity against CXCR4 leukemic cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparative mortality of dominant Staphylococcus aureus lineages in human bacteremia and animal infection models

  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Bravo Bravo, Marc|||0000-0002-3173-2242
  • Cañas, María Alexandra|||0000-0002-0521-7204
  • Gómez, Andromeda-Celeste|||0000-0002-0075-6903
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • Miró, José M.|||0000-0001-8057-7755
  • Gibert, Isidre|||0000-0003-1442-2258
  • Gasch, Oriol|||0000-0001-8518-458X
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Yero, Daniel|||0000-0002-6234-4082
  • Pich, Oscar Q.|||0000-0003-3561-630X
Staphylococcus aureus is a major human pathogen responsible for severe infections, including infective endocarditis. While host factors influencing disease outcome are well characterized, lineage-specific virulence mechanisms remain poorly defined. Herein, we investigated eighty-nine bacteremic S. aureus isolates from nine globally distributed lineages using Galleria mellonella and rabbit infection models, alongside phenotypic and transcriptomic analyses. Despite marked genotypic and phenotypic heterogeneity, mortality in G. mellonella varied significantly between lineages and correlated with hemolytic activity. ST398 isolates demonstrated heightened larval virulence linked to increased α- and δ-hemolysin production, whereas CC30 strains exhibited reduced growth, biofilm formation and infectivity. The ST398 agrC mutant Sau7 displayed a distinct phenotype, with elevated biofilm production but attenuated larval virulence. However, in the rabbit endocarditis model, Sau7 exhibited mortality rates similar to other ST398 isolates and was associated with larger vegetations and higher bacterial burdens, underscoring the role of the agr system in colonization and biofilm development. Transcriptomic profiling highlighted quorum-sensing pathways and hemolysin expression as key drivers of virulence in ST398 strains. Our findings reveal clear lineage-specific differences in S. aureus pathogenicity and demonstrate that virulence is context dependent, varying across infection models. These results emphasize the importance of using complementary in vivo systems to capture the multifaceted nature of S. aureus disease potential and to better predict infection outcomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible Enterococcus faecium?

  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Capilla, Silvia|||0000-0002-7274-2973
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Espasa, Mateu|||0000-0003-4822-1024
  • Novais, Carla|||0000-0002-3826-6731
  • Miró, José M.|||0000-0001-8057-7755
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Gasch, Oriol|||0000-0001-8518-458X
Objectives: Enterococcus faecium, a significant hospital associated pathogen, poses substantial treatment challenges. While combinations of ampicillin with cephalosporins are first-line therapies to treat Enterococcus faecalis high-mortality-rates infections, their efficacy against ampicillin-susceptible E. faecium (ASEfm) is less clear. This study evaluates the effectiveness of combining ampicillin with ceftriaxone or ceftaroline against ASEfm strains. Methods: Ten ASEfm bloodstream isolates from complicated infections were analyzed. Susceptibility to several antibiotics, including ceftriaxone, ceftaroline, and cefotaxime, was determined using standard methods. Time-kill assays were conducted to assess the synergistic and additive effects of ampicillin in combination with ceftriaxone or ceftaroline. Results: Time-kill studies revealed that ampicillin combined with ceftaroline demonstrated synergistic and/or additive effects in 7 out of 10 strains analyzed. In contrast, ampicillin combined with ceftriaxone showed less pronounced synergy, with only 3 out of 10 strains exhibiting synergistic and/or additive effects. Conclusions: Our findings indicate that ampicillin combined with ceftaroline, or ceftriaxone provides synergistic activity against some but not all ASEfm clinical isolates. The observed synergy suggests that these combinations could offer a potential therapeutic option for challenging ASEfm infections.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

mGem, Population genomics of Staphylococcus aureus bacteremia and the impact of the COVID-19 pandemic

  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Buiatte, Ana Beatriz Garcez
  • Wang, Rebecca
  • Gasch, Oriol|||0000-0001-8518-458X
  • Martin, Isabella W.|||0000-0001-7974-9767
  • Andam, Cheryl P.|||0000-0003-4428-0924
  • Pich, Oscar Q.|||0000-0003-3561-630X
The pressure of the coronavirus disease 2019 (COVID-19) pandemic on global healthcare systems and societies was unprecedented in the modern era. Social restrictions, containment measures, and disruptions in antimicrobial prescriptions and consumption during the pandemic have been reported to alter the epidemiology of bacterial diseases, although these effects likely differed markedly between locations. Here, we compare the clinical, clonal distribution, and genomic features of Staphylococcus aureus bloodstream isolates before, during, and after COVID-19 in two hospitals on different continents: Parc Taulí University Hospital (Spain) and Dartmouth-Hitchcock Medical Center (USA). We hypothesize that pandemic-related environmental perturbations, such as those due to infection control practices and antimicrobial exposure, may have contributed to shifts in the diversity of circulating bacterial lineages and genomic elements. Our findings revealed changes in the distribution of low-frequency clones, antimicrobial resistance genes, and virulence factors, potentially reflecting changes in selective pressures in clinical environments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Nanotoxin induces in situ pyroptosis to sensitize αPD1 to ablate metastases in microsattellite stable colorectal cancer

  • Carrasco-Díaz, Luis Miguel|||0000-0003-0567-2802
  • Otero-Mateo, Marc
  • Álamo, Patricia|||0000-0003-0510-5701
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Virgili Manrique, Anna Cristina|||0000-0001-9733-6034
  • Paez, David|||0000-0002-5596-6588
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Mangues, Ramon|||0000-0003-2661-9525
Nanomedicine has not generated anticancer immunotherapies because of insufficient targeted specificity, lack of immunity, and associated toxicity. We developed a T22-DITOX-H6 (TDX) nanotoxin to selectively release the diphtheria toxin in the cancer cells in immunosuppressed CXCR4-overexpressing (CXCR4 +) colorectal (CRC) models, inducing pyroptosis and anticancer effect. Microsatellite stable (MSS) CRC patients do not respond to current immunotherapy. Since pyroptosis is highly immunogenic, we treated with TDX immunocompetent CXCR4 + CT26 MSS metastatic CRC models to selectively deliver the toxin to induce in situ pyroptosis mediated by the activation of NLRP3, Caspase-1 GSDMD and IL-1β. In contrast to immunosuppressed, in situ pyroptosis by TDX in immunocompetent models trigger CD8 + T cell recruitment, activation and killing of cancer cells in tissues, mimicking the pyroptosis that the host induces to kill diphtheria-infected cells. The combination of TDX and αPD1 further increases CD8 + recruitment and perforin secretion, achieving a tissue-specific antimetastatic activity in mesentery, peritoneum, and lung, and especially in liver metastases, without systemic toxicity. This is the first time that a novel nanomedicine achieves local T cell activation and antimetastatic effect mediated by pyroptosis and immunogenic cell death, whereas the combination with αPD1 enhances T cell activation, reaching a synergistic response in MSS CRC models.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Single point mutations in global regulatory genes restore cephalosporin resistance in a low-MIC Enterococcus faecium natural isolate

  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • Guitart-Matas, Judith|||0009-0009-9329-9139
  • Monsálvez, Víctor|||0009-0003-0126-3224
  • Rabanal, Patricia
  • Pereira, Ana P.
  • Freitas, Ana R.|||0000-0002-7326-4133
  • Peixe, Luisa
  • Espasa, Mateu|||0000-0003-4822-1024
  • Gasch, Oriol|||0000-0001-8518-458X
  • Novais, Carla|||0000-0002-3826-6731
  • Pich, Oscar Q.|||0000-0003-3561-630X
Enterococcus faecium exhibits intrinsic resistance to cephalosporins (CPHs), yet the genetic determinants of this phenotype remain incompletely understood. To date, E. faecium strains with low minimum inhibitory concentrations (MICs) of CPH have only been described following genetic manipulation. At Parc Taulí University Hospital, we identified a clinical isolate of ampicillin-susceptible E. faecium (Efm5) that exhibited unusually low MICs to cefotaxime (1 mg/L), ceftriaxone (3 mg/L), and ceftaroline (0.19 mg/L). Upon single exposure to ceftriaxone (100 mg/L), Efm5 rapidly yielded variants with markedly increased MICs of ceftriaxone (>256 mg/L) and cefotaxime (>32 mg/L), while MICs of ampicillin and ceftaroline were unaffected. Whole-genome sequencing revealed that the high-MIC variants carried single-nucleotide polymorphisms leading to non-synonymous mutations in croS, nusG, or rpoB genes. Phenotypic assays confirmed that these mutations were associated with ceftriaxone resistance, and immunoblots revealed increased expression of penicillin-binding protein 5 (PBP5) in all the high-MIC variants. Transcriptional profiling showed upregulation of the pbp5 operon, which includes ftsW, psr, and pbp5, in the croS variants. This study provides evidence that E. faecium isolates with low MICs to CPH can arise in clinical settings without laboratory manipulation, enabling further investigation of resistance pathways.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases

  • Valero Martínez, Cristina|||0000-0003-2013-1545
  • Pardines-Ortiz, Marisa
  • Montes, Nuria
  • Dauden, Esteban|||0000-0002-0676-1260
  • Fernández-Gutiérrez, B.|||0000-0002-6126-8786
  • García-Planella, Esther|||0000-0002-4325-0697
  • Gomollón, Fernando|||0000-0003-0076-3529
  • Gratacós, Jordi|||0000-0003-4007-4103
  • Marsal, Sara|||0000-0001-5515-3854
  • Lamana, Amalia|||0000-0001-8779-5034
  • García-Vicuña, Rosario
  • González-Alvaro, Isidoro
  • Triguero-Martínez, Ana|||0000-0003-1580-2893
  • Pérez-Venegas, José J.
  • Julià Cano, Antonio|||0000-0001-6064-3620
Galectin-1 and -9 (Gal1/9) are essential mediators of immune-inflammatory responses, which makes these proteins potential biomarkers for immune-mediated diseases (IMIDs), such as rheumatoid arthritis (RA), psoriasis (PS), psoriatic arthritis (PsA), inflammatory bowel disease, and systemic lupus erythematosus (SLE). Our aim was to evaluate plasma Gal1/9 differences between IMID patients and healthy donors (HD). We analyzed 980 plasma samples divided into two analytical cohorts (600 discovery group and 380 validation group). Generalized linear models estimated Gal1/9 levels, adjusting for sex, age, storage time, and plate variability. In the overall IMID group, plasma Gal1 levels were comparable to those of HD, while Gal9 levels were significantly elevated. Levels varied across individual diseases: SLE patients consistently showed the highest Gal1/9 levels compared to both HD and other IMIDs, and RA patients had elevated Gal9 levels versus HD. Both Gal1 and Gal9 plasma levels correlated positively with higher disease activity, and Gal1 was higher in patients with longer disease duration. After adjustment for these confounders, SLE and RA patients maintained the highest Gal9 levels compared to HD. Our study demonstrates that Gal1 and Gal9 are differentially expressed across IMIDs, with particularly elevated levels in SLE, and both galectins are associated with disease activity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old

  • Ceriello, Chiara
  • Torres Bonafonte, Olga H.|||0000-0002-0305-8211
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Garcia Castro, Jesús|||0000-0003-1503-4775
  • Selma Gonzalez, Judit|||0009-0006-1021-4653
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Vera-Campuzano, Elena
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Álvarez-Sánchez, Esther|||0009-0002-8760-2153
  • Lorente, Oriol
  • Carreras, Mireia
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Belbin, Olivia|||0000-0002-6109-6371
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
Background and Objectives: Alzheimer disease (AD) is increasingly viewed as a clinical-biological continuum, but the utility of biomarkers in individuals aged ≥80 years, the so-called “very old,” remains uncertain, because of concerns about its clinical usefulness. This study aimed to determine the clinical impact and prognostic value of AD biomarkers in very old individuals. Methods: We performed a retrospective longitudinal cohort study within the Sant Pau Initiative on Neurodegeneration (SPIN, Barcelona, Spain), a memory clinic–based research cohort. Patients were referred from primary care physicians or community neurologists for evaluation within a public universal health care catchment area. We included SPIN participants evaluated between October 2013 and May 2024 who were aged ≥80 years and had mild cognitive impairment (MCI) at the baseline visit. Participants underwent standardized clinical and neuropsychological assessments and had CSF and plasma biomarker measurements available. AD biology was defined by the CSF phosphorylated tau at threonine 181/amyloid-β 42 ratio. Plasma phosphorylated tau at threonine 217 (p-Tau217) was evaluated for (1) diagnostic accuracy for AD biology and (2) prognostic associations with longitudinal cognitive change (Mini-Mental State Examination [MMSE]) and progression to dementia. Analyses used linear mixed-effects models for MMSE trajectories and Cox regression for dementia conversion. Results: A total of 167 participants were included (mean age 82.3 years, 59% women) with a mean follow-up of 35.8 months; the ones with AD biology (n = 116, 69%) had worse baseline cognitive performance, particularly in memory, compared with those without (Cohen d = 0.34, p = 0.03). Plasma p-Tau217 showed excellent diagnostic accuracy for detecting AD biology (0.93, 95% CI 0.88–0.98; cutoff 0.19 pg/mL; sensitivity 94.5%; specificity 84%). Over time, participants with AD biology declined faster on the MMSE than those without (−0.47 vs −0.18 points per year; p < 0.01). Cox models showed an increased risk of progression to a dementia stage among individuals with higher plasma p-Tau217 concentrations (hazard ratio 1.49, 95% CI 1.05–2.13, p = 0.026). Discussion: In very old individuals with MCI, AD biology (CSF) and plasma p-Tau217 identify individuals at higher risk of faster cognitive decline and progression to dementia. Limitations of this study include the single-center design and the modest sample size.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inhibition of ATP-citrate lyase by bempedoic acid protects against abdominal aortic aneurysm formation in mice

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Galán, María|||0000-0002-4758-8388
  • Roglans, Nuria
  • Laguna, Joan Carles|||0000-0002-2357-1186
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Blanco-Casoliva, Laia
Abdominal aortic aneurysm (AAA) is a prevalent degenerative disease characterized by an exacerbated inflammation and destructive vascular remodeling. Unfortunately, effective pharmacological tools for the treatment of this disease remain a challenge. ATP-citrate lyase (ACLY), the primary enzyme responsible for acetyl-CoA biosynthesis, is a key regulator of inflammatory signaling in macrophages and lymphocytes. Here, we found increased levels of the active (phosphorylated) form of ACLY (p-ACLY) in the inflammatory infiltrate of AAA from patients and in aneurysmal lesions from angiotensin II (Ang II)-infused apolipoprotein E-deficient mice (ApoE). Furthermore, plasma ACLY levels positively correlates with IL6 and IFNγ levels in patients with AAA, while inflammatory stimuli strongly upregulated ACLY expression in macrophages and Jurkat cells. The administration of the ACLY inhibitor bempedoic acid (BemA) protected against Ang II-induced AAA formation in ApoE mice, limiting the progression of aortic dilatation and reducing mortality due to aortic rupture. BMS-303141, another ACLY inhibitor, also ameliorated AAA formation, although to a lesser extent. BemA attenuated vascular remodeling and the disorganization and rupture of elastic fibers induced by Ang II, as well as vascular inflammation, decreasing the recruitment of macrophages (CD68 +) and neutrophils (Ly-6G+) into the aortic wall. Moreover, BemA shifted splenic monocytes toward a functionally anti-inflammatory phenotype, and increased the percentage of CD4CD69 cells. Taken together, these results support the contribution of ACLY to AAA and point to BemA as a promising tool to be considered for future clinical trials addressing the management of this disease which is quite often associated with disorders of lipoprotein metabolism.
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publicación Artículo científico (JournalArticle)

Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization tool

  • Matilla-Cabello, Gonzalo
  • Remesal-Doblado, Ángela
  • Celebi-Cinar, Muzzez
  • Bodoque-García, Ana
  • Betul Metin, Fatma
  • Rezaei, Aida
  • Aftab, Moiz
  • De los Santos-Fernández, Romina
  • Segovia-Zafra, Antonio
  • Álvarez-Álvarez, Ismael
  • Andrade-Bellido, Raúl Jesús
  • Cakan-Akdogan, Gulcin
  • Lucena-González, María Isabel
  • Konu, Ozlen
  • Villanueva-Paz, Marina
Idiosyncratic drug-induced liver injury (iDILI) is a rare, dose-independent and unpredictable adverse reaction occurring at therapeutic drug exposure, and it presents a significant challenge for drug development and patient safety. Despite extensive research, genetic susceptibility to iDILI remains poorly understood. We conducted a comprehensive systematic study of 139 human genetic studies to identify and characterize genetic polymorphisms associated with increased risk or protection against iDILI. Our study included candidate gene studies and genome-wide association studies (GWAS), encompassing 83 risk and 25 protective genes, with NAT2, HLA-B, and SLCO1B1 among the most frequently reported. We performed functional enrichment analyses using KEGG and Gene Ontology, revealing key biological pathways related to immune response, xenobiotic metabolism, and bile secretion. To enhance data accessibility and interpretation, we developed iDILInet, a publicly available web application that enables interactive exploration and network-based visualization of iDILI-associated gene-variant-drug relationships, enriched with liver-specific expression data from the Human Protein Atlas (HPA). Our work provides a novel integrative resource that supports ongoing efforts in precision medicine and pharmacogenomics and represents a significant advancement in implementing living systematic reviews in toxicogenomics., Consejería de Salud de Andalucía, Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional, Agencia Española del Medicamento y Productos Sanitarios, Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación, Universidad de Málaga
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publicación Artículo científico (JournalArticle)

Epigenetic modifications in drug-induced liver injury: A systematic review

  • de los Santos-Fernández, Romina Lorena
  • Segovia-Zafra, Antonio
  • Paz-López, Guillermo
  • Matilla-Cabello, Gonzalo
  • Niu, Hao
  • Álvarez-Álvarez, Ismael
  • Stephens, Camilla
  • Lucena-González, María Isabel
  • Andrade-Bellido, Raúl Jesús
  • Medina-Cáliz, Inmaculada
Genetic susceptibility has been identified in idiosyncratic drug-induced liver injury, a potentially severe adverse reaction towards drugs, herbal products and dietary supplements. However, its occurrence cannot be fully explained by the presence of genetic variants in specific genes, suggesting that other factors are involved. Druginduced liver injury epigenetic signatures could help explain genetic regulatory mechanisms behind this disease and might provide disease biomarkers. This systematic review aims to analyse all available information on epigenetic risk association studies in drug-induced liver injury. The main inclusion criterion was population studies on idiosyncratic drug-induced liver injury with significant risk association analysis between drug-induced liver injury and an epigenetic regulation mechanism. Out of the 7 included articles, 6 focused on DNA methylation and 1 on long noncoding RNA. All of the studies were on antituberculosis drug-induced liver injury and came from Asia. CpG site methylation in the CYP2D6 (odds ratio: 9.19, 95% confidence interval: 3.26–25.89, P < .001) and NAT2 (odds ratio: 8.37, 95% confidence interval: 2.39–29.32, P = .001) promoters conferred the highest risk. Hypomethylation of LINE-1 and Alu transposable elements has potential as antituberculosis drug-induced liver injury biomarkers, showing an area under the curve value of 0.94. To conclude, the studies mainly focused on DNA methylation modifications associated with antituberculosis drug-induced liver injury, with all of them coming from Asia, where tuberculosis is a public health burden. Despite the lack of knowledge in this area, the evidence has shown that DNA methylation alterations in antituberculosis drug-induced liver injury could have potential as a new diagnostic and therapeutic target., Instituto de Salud Carlos III, Agencia Estatal de Investigación, CIBER, European Comission
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publicación Artículo científico (JournalArticle)

DILI Differences and Similarities between the US and Europe

  • Toro-Ortiz, Juan Pedro
  • Andrade-Bellido, Raúl Jesús
  • Pinazo-Bandera, José
Purpose of review To evaluate the critical role of international registries in understanding idiosyncratic drug-induced liver injury (DILI) by comparing clinical and epidemiological data from the Spanish DILI Registry, the Pro-Euro DILI registry, and the US DILIN. Recent findings Although amoxicillin-clavulanic acid remains the leading global DILI trigger, DILI cases in the US show higher severity and more herbal supplement involvement. Immune checkpoint inhibitors present new toxicity phenotypes. Registry collaborations have yielded advanced prognostic tools like the nR criteria for predicting liver failure, and RECAM, a novel electronic causality assessment scale offering greater diagnostic precision than RUCAM. Summary Registries are crucial for identifying rare DILI events that are missed by clinical trials, as well as for highlighting regional differences in triggers and outcomes. These networks are essential for identifying diagnostic biomarkers, and their findings benefit not only clinicians, but also regulators. Future research should prioritize the global validation of RECAM and utilize multinational biobanks to identify genetic risk factors, ultimately improving drug safety., Funding for open access charge: Universidad de Málaga / CBUA, Instituto de Salud Carlos III, European Union, Agencia Española de Medicamentos y Productos Sanitarios
Repisalud
Publicación Artículo científico (JournalArticle)

Molecular epidemiology and surveillance of imported dengue in travellers returning to Spain, 2022-2024.

  • Sánchez-Mora, Patricia
  • Molero-Sanz, Francisca
  • Navascués, Ana
  • Zurita, Nelly Daniela
  • Zamarrón, Pilar
  • Lagarejos, Eduardo
  • Gómez, Sara
  • Cardona, Pere Joan
  • Carrasco, Blanca
  • López-Lomba, Marta
  • Escribano, Isabel
  • Martínez-Expósito, Óscar
  • Del Peso, Teresa
  • Herrero-Romero, Laura
  • Negredo, Anabel
  • Guillén-Calvo, Laura
  • Peña Gallego, Ana
  • Gutiérrez-López, Rafael
  • Labiod, Nuria
  • Vazquez, Ana
  • Sánchez-Seco, María Paz
  • Gutiérrez-López, Rafael
Introduction: Dengue is the most significant vector-borne viral disease in global morbidity and mortality, and it is considered a re-emerging disease spreading into new regions. The risk of autochthonous dengue virus transmission in Spain remains high due to the increasing number of travellers returning from endemic areas and the presence of Aedes albopictus within our territory. Conducting epidemiological and molecular studies on returning travellers from endemic areas may be crucial to discern transmission patterns and track the global spread of the virus. This study focuses on the molecular characterization of suspected imported dengue cases from 2022 to 2024. Methods: We analysed 600 samples from 539 suspected dengue-infected travellers between 2022 and 2024. All samples were tested by a quantitative RT-PCR, and PCR-positive cases were confirmed by performing a non-overlapping nested RT-PCR, going under subsequent sequencing to identify viral diversity. Results: Of the 539 suspected cases, 183 were confirmed as DENV-positive, with Cuba as the most common travel origin associated with infections. Molecular analysis of positive samples identified all four DENV serotypes and ten genotype groups, with DENV-3 genotype III as the most predominant. Additionally, among confirmed cases reported from regions with Aedes albopictus presence, 73% (94/129) occurred during the vector's active season (May-November), increasing the risk of local transmission. Conclusion: Our results highlight the importance of returning travellers as sentinels for ongoing dengue outbreaks and epidemiology in endemic regions. Additionally, these emphasize the importance of early case identification through sentinel surveillance to prevent potential autochthonous transmission.
Repisalud
Publicación Artículo científico (JournalArticle)

Second-season Impact of Nirsevimab: Clinical Outcomes of RSV Disease in Patients Immunized During Their First Season.

  • González-Bertolín, Isabel
  • Alcolea, Sonia
  • Alonso, Patricia
  • Arroyas, María
  • Fernández Castiella, Isabel
  • Echavarren, Iciar
  • Iglesias-Caballero, Maria
  • Casas Flecha, Inmaculada
  • García-García, María Luz
  • Calvo, Cristina
Nirsevimab provides passive immunization against respiratory syncytial virus, yet concerns exist regarding its long-term impact. This study analyzed respiratory syncytial virus-associated lower respiratory tract infection severity in hospitalized children immunized with nirsevimab more than 6 months prior. No significant differences were found compared with nonimmunized children. Findings suggest no increased risk in the following season, supporting nirsevimab's safety as a preventive strategy.
Repisalud
Publicación Artículo científico (JournalArticle)

Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort study.

  • Pita-Martínez, Carlos
  • Jimenez-Sousa, Maria Angeles
  • Martinez-Picado, Javier
  • Rodríguez, Carmen Elena Gómez
  • Fariñas, Carmen
  • Galindo, Pepa
  • Roca-Oporto, Cristina
  • Santos, Jesús
  • Muñoz-García, Paula
  • Rava, Marta
  • Resino, Salvador
  • Martín-Escolano, Rubén
Introduction: People with HIV (PWH) on effective antiretroviral therapy (ART) have an increased risk of developing Non-AIDS Defining Cancers (NADCs) compared to the general population, partly due to chronic inflammation and immune dysregulation. This study aimed to identify plasma biomarkers associated with the risk of developing NADCs in a cohort of PWH on ART. Methods: A case-cohort study was conducted within the Spanish CoRIS cohort, including 316 PWH on ART (71 cases and 245-individuals subcohort). Plasma levels of 24 immune regulation and senescence-associated secretory phenotype (SASP) biomarkers were quantified using Luminex technology. Cox proportional hazards regression models with Borgan II weights were used to assess the association between biomarker levels and the risk of NADC development (hazard ratios), adjusting for confounders. Effect modification by gender was also evaluated. Results: Higher baseline plasma levels of twelve biomarkers were significantly associated with increased NADC risk. The strongest associations were found for PD-L2 (aHR=3.33), PAI-1 (aHR=2.27), and MMP-1 (aHR=2.32). However, a distinct, gender-specific pattern was observed, with significant interactions found for nine biomarkers. Most interactions indicated a higher NADC risk increase in females, with the exception of CD80, TNF-β and IP-10, which indicated a relatively lower risk in females compared to males. Discussion: Plasma biomarkers of immune regulation and SASP are associated with NADC risk in PWH on long-term ART, highlighting the importance of gender-specific pathways in NADC development among PWH. Understanding these distinct profiles may guide future strategies for risk stratification, early detection, and personalized preventive care.
Repisalud
Publicación Artículo científico (JournalArticle)

Plasma biomarkers of immune regulation and senescence are associated with incident skeletal-related events in people with HIV: a case-cohort study.

  • Pita-Martínez, Carlos
  • Rava, Marta
  • Virseda-Berdices, Ana
  • Martinez, Isidoro
  • Moreno, Santiago
  • Gómez Rodríguez, Carmen Elena
  • Armiñanzas, Carlos
  • Mena de Cea, Álvaro
  • Gisbert Pérez, Laura
  • Rodríguez-Rosado, Rafael
  • Jimenez-Sousa, Maria Angeles
  • Resino, Salvador
  • Martín-Escolano, Rubén
Background: persistent immune dysregulation in people with HIV (PWH) on antiretroviral therapy (ART) contributes to an increased risk of skeletal-related events (SREs), serving as a critical paradigm for understanding accelerated aging and age-related diseases. We investigated the association between plasma biomarkers of immune regulation and senescence with incident SRE risk and evaluated potential effect modification by sex. Methods: in a case-cohort study nested within the Spanish CoRIS cohort (65 incident SRE cases; 252 subcohort, including 5 overlapping cases), we quantified 24 baseline biomarkers of immune checkpoints and senescence-associated secretory phenotype factors. We estimated adjusted hazard ratios (aHR) using Borgan II-weighted cause-specific Cox regression models adjusted for clinical confounders (age, region of origin, prior AIDS diagnosis, CD4 + T-cell count, coinfections, and lifestyle factors). Sex-biomarker interactions were assessed as exploratory endpoints. Results: nineteen biomarkers were independently associated with increased SRE risk (p < 0.05 & q < 0.10). Angiogenic factors (VEGF-A; aHR = 1.94; 95% CI, 1.40–2.68), immune checkpoints (PD-L2; aHR = 1.95; 95% CI, 1.09–3.49), and tissue remodeling markers (MMP-1; aHR = 1.91; 95% CI, 1.08–3.39) displayed independent associations, alongside consistent signals for TIM-3, PD-L1, and IL-8. Pairwise correlation analysis demonstrated clustering between checkpoints and inflammatory cytokines. Exploratory interaction analysis indicated that sex modified these associations; signals for seven markers (e.g., IL-1α, VEGF-A) were stronger in females, although the limited number of events warrants caution. Conclusions: circulating biomarkers of immune exhaustion, inflammation, and senescence are independently associated with incident SREs in PWH on long-term ART. Our findings indicate a systemic pro-inflammatory signature and suggest that females exhibit higher sensitivity to inflammatory damage.
Repisalud
Publicación Artículo científico (JournalArticle)

HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis.

  • Martín-Escolano, Rubén
  • Fernandez-Rodriguez, Amanda
  • Tarancon-Diez, Laura
  • Berenguer, Juan
  • Codina Márquez, Helena
  • Amigot-Sánchez, Rafael
  • González-García, Juan
  • Hontañón, Víctor
  • Pérez-Latorre, Leire
  • Ibañez-Samaniego, Luis
  • Llop-Herrera, Elba
  • Olveira, Antonio
  • Díaz, Laura
  • Martinez, Isidoro
  • Jimenez-Sousa, Maria Angeles
  • Resino, Salvador
Introduction: The immunological drivers of portal hypertension regression after hepatitis C virus (HCV) cure are poorly understood, particularly in the context of human immunodeficiency virus (HIV) coinfection We aimed to identify baseline immune signatures predicting the evolution of the hepatic venous pressure gradient (HVPG) in people with and without HIV (PWH/PWoH). Methods: We prospectively followed 41 individuals with advanced cirrhosis (18 PWoH, 23 PWH) who were cured of HCV with direct-acting antivirals (DAA). Baseline plasma and cellular immune markers were extensively profiled using multiplex assays and flow cytometry. We used mixed-effects modeling to test for associations between these baseline immune features and the change in HVPG over a 48-week follow-up period, with q-values controlling for false discoveries. Results: Two distinct immunological profiles of impaired HVPG regression emerged. In PWoH, impaired regression was linked to a broad proinflammatory profile [TNF-α (AMR = 1.13; q=0.012), IL17A (AMR = 1.28; q=0.012), and IL10 (AMR = 1.2; q=0.028)], a widespread total CD4+ T-cell activation [HLA-DR+ (AMR = 1.44; q<0.001) and CD38+HLA-DR+ (AMR = 1.3; q=0.007)], and robust activation across central memory (CM) and effector memory (EM) subsets. Conversely, in PWH, impaired HVPG regression was associated with sVCAM-1 (AMR = 1.58; q=0.096), and a more focused activation within EM (HLA-DR+, AMR = 1.08; q=0.030) and TemRA (CD38+HLA-DR+, AMR = 1.12; q=0.030) CD4+ T-cells. Discussion: HIV coinfection fundamentally reshapes the immunological landscape of post-cure portal hypertension recovery. The shift from systemic inflammation in PWoH to endothelial dysfunction and T-cell exhaustion in PWH reveals distinct pathological pathways. Understanding these signatures is a crucial step toward developing targeted therapies to promote complete hepatic recovery.
Repisalud
Publicación Artículo científico (JournalArticle)

Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study.

  • Virseda-Berdices, Ana
  • Requena, Belen
  • Berenguer, Juan
  • González-García, Juan
  • Gonzalez-Riano, Carolina
  • Díez, Cristina
  • Hontañon, Victor
  • Fernandez-Rodriguez, Amanda
  • Barbas, Coral
  • Resino, Salvador
  • Martín-Escolano, Rubén
  • Jimenez-Sousa, Maria Angeles
Introduction: People with HIV and chronic hepatitis C may develop metabolic complications after sustained virologic response (SVR), possibly due to persistent molecular alterations induced by HCV. This study aimed to identify baseline (pre-treatment) lipid and immune biomarkers associated with post-SVR metabolic events in HIV/HCV-coinfected participants with compensated advanced chronic liver disease (cACLD) receiving long-term suppressive antiretroviral therapy. Methods: We conducted a retrospective study of 56 HIV/HCV-coinfected participants with cACLD. Untargeted lipidomic profiling was performed on baseline plasma samples using a liquid-chromatography-mass spectrometer. The outcome was the development of metabolic events (diabetes mellitus and/or hyperlipidemia) during follow-up, up to seven years post-HCV treatment. Statistical analyses included orthogonal partial least squares discriminant analysis (OPLS-DA), Cox regressions models, and Spearman correlations with inflammation-related biomarkers and immune checkpoint proteins, with multiple comparison corrections using the false discovery rate. Results: 25% participants developed metabolic events after SVR. OPLS-DA identified 163 lipid species (VIP scores≥1) associated with these events, and adjusted Cox regression confirmed significant associations for 24 of them. Lysophosphatidylcholines (LPCs) were the most prevalent, with higher baseline levels linked to increased metabolic risk. Participants who developed events also had higher levels of plasmalogens LPC (O-LPC), lysophosphatidylethanolamine (LPE), lysophosphatidylinositol (LPI), lysophosphatidic acid (LPA), and phosphosphatidylcholine (PC). Several lipid species correlated positively with the pro-inflammatory cytokine IL-18, the anti-inflammatory suppressor IL-1RA, and the immune checkpoint proteins IDO and S100A8/A9. Discussion: Pre-treatment lipid and immune dysregulation was associated with post-SVR metabolic events in HIV/HCV-coinfected participants, suggesting that HCV may leave a lasting metabolic imprint that contributes to adverse outcomes after viral clearance.
Repisalud
Publicación Artículo científico (JournalArticle)

Long-term effects of HCV eradication on lipid profiles associated with MASLD among people with HIV with advanced fibrosis or cirrhosis.

  • Virseda-Berdices, Ana
  • Requena, Belen
  • Berenguer, Juan
  • Gónzalez-García, Juan
  • Gonzalez-Riano, Carolina
  • Díez, Cristina
  • Hontañón, Victor
  • Muñoz-García, Paula
  • Fernandez-Rodriguez, Amanda
  • Barbas, Coral
  • Resino, Salvador
  • Martín-Escolano, Rubén
  • Jimenez-Sousa, Maria Angeles
  • the Marathon Study Group
Background: Despite successful hepatitis C virus (HCV) clearance, some individuals continue to experience liver disease progression. Metabolic dysfunction-associated steatotic liver disease (MASLD) may play a key role in this ongoing progression. This study aims to characterize the lipidomic profiles associated with MASLD in individuals coinfected with human immunodeficiency virus (HIV) and HCV with advanced fibrosis or cirrhosis after sustained virologic response (SVR). Methods: We conducted cross-sectional studies in fifty-two HIV/HCV-coinfected individuals. Untargeted lipidomics was performed on plasma samples collected at 1 year and 6 years post-SVR using liquid chromatography-mass spectrometry. The primary outcome was MASLD. Statistical analyses included orthogonal partial least squares discriminant analysis (OPLS-DA) and generalized linear models (GLM), with corrections for multiple comparisons. Results: The prevalence of MASLD was 28.9 % one year after SVR, increasing to 44.8 % six years after SVR. OPLS-DA models identified 225 lipids at 1 year and 167 at 6 years, with a VIP score ≥ 1, distinguishing individuals based on MASLD status. Adjusted GLMs confirmed significant associations between MASLD and 116 lipids at 1 year and 49 at 6 years. At 1 year, most significant lipids were glycerophospholipids (GP), with increased phosphatidylcholines (PC) and phosphatidylethanolamines (PE), and decreased lysophosphatidylcholines (LPC) and lysophosphatidylethanolamines (LPE). By 6 years, LPC was the most abundant differential lipid, while triglycerides increased significantly. Conclusions: MASLD was common during follow-up, with changes in lipidomic profiles over time suggesting ongoing metabolic disturbances that may contribute to liver disease progression despite SVR. These findings highlight the need for long-term metabolic and liver health monitoring after HCV eradication in these individuals.
Repisalud
Publicación Artículo científico (JournalArticle)

Elevated Zonulin-1 is Associated With an Increased Risk of Non-AIDS-Defining Cancers in People With HIV With Suboptimal Immune Recovery: A Case-Cohort Study.

  • Pita-Martínez, Carlos
  • Muñoz-García, Paula
  • Martinez, Isidoro
  • Rava, Marta
  • Bautista Hernández, Azucena
  • Pérez-Somarriba, Juncal
  • Campins, Antoni
  • Novella Mena, María
  • Vera, Francisco
  • Montero-Alonso, Marta
  • Jimenez-Sousa, Maria Angeles
  • Resino, Salvador
  • Martín-Escolano, Rubén
  • CoRIS cohort
People with HIV (PWH) on antiretroviral therapy (ART) exhibit a heightened risk of non-AIDS-defining cancers (NADCs), linked to chronic inflammation driven by microbial translocation. We investigated whether plasma biomarkers of gut barrier dysfunction are associated with NADC risk, hypothesizing this association is modified by immune status. We conducted a case-cohort study nested within the Spanish CoRIS cohort. Plasma levels of zonulin-1, lipopolysaccharide, LPS-binding protein, and flagellin were measured in 71 incident NADC cases and a 261-individuals subcohort. Multivariable Cox proportional hazards models were used to estimate NADC risk, testing for effect modification by baseline CD4 + T-cell count. Zonulin-1 was not independently associated with NADC risk. However, a strong statistical interaction with baseline CD4 + T-cell count was detected (p = 0.001). Among individuals with suboptimal immune recovery (defined as CD4 + T-cell count < 500 cells/mm³), higher zonulin-1 levels were associated with a nearly threefold increased NADC risk (aHR = 2.94 (1.28-6.76)). Conversely, no association was observed in those with robust immune reconstitution (≥ 500 cells/mm³; aHR= 0.84 (0.41-1.72)). Other biomarkers showed no association. This supports a "two-hit" model of carcinogenesis where a compromised gut barrier and impaired immune competence are associated with an increased risk of cancer. Zonulin-1 is a key biomarker for identifying this high-risk phenotype, suggesting targeted cancer prevention strategies restoring gut integrity.
Repisalud
Publicación Artículo científico (JournalArticle)

High prevalence of azole resistance among environmental isolates from outdoor air in Madrid, Spain.

  • Soto-Debrán, Juan Carlos
  • Sanchez Iñigo, Francisco Javier
  • Calvo-López, Alejandro B
  • Alguacil-Cuéllar, Laura
  • Hrynzovska, Anastasiia A
  • Mellado, Emilia
  • Garcia Dos Santos-Alves, Saul
  • Alastruey-Izquierdo, Ana
Introduction: Aspergillus fumigatus has been designated by the World Health Organization (WHO) as a critical fungal pathogen. Its spores are commonly present in the air and are inhaled daily. Azoles are the first-line treatment for Aspergillus infections, but the emergence of resistance is a growing concern. However, limited data exist on the occurrence of azole-resistant A. fumigatus in the outdoor environment in Spain. Methods: This study aimed to investigate the prevalence of azole-resistant A. fumigatus isolates in outdoor air at two distinct locations in Madrid. We characterized the isolates using TRESPERG genotyping and examined the underlying molecular mechanisms responsible for azole resistance development. Results: Azole-resistant A. fumigatus isolates were found in 55% of the 20 air samples collected. Among the 200 A. fumigatus isolates analyzed, 38.5% were azole resistant and were classified into 10 different genotypes. Notably, the TR34/L98H mutation in Cyp51A was found in 77% of the resistant isolates, while 23% showed no mutations in the screened targets (cyp51A, cyp51B, or hmg1). Discussion: This study revealed a high prevalence of azole-resistant A. fumigatus in outdoor environmental air, with the TR34/L98H mutation being the main mechanism of azole resistance. A close genetic relationship was observed among the resistant isolates. This research underscores the need for continued monitoring of environmental azole-resistant A. fumigatus isolates and highlights the importance of understanding genetic diversity and resistance mechanisms to develop effective strategies for fungal infection control.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Modeling human embryo adhesion using a microfluidic platform

  • Zaragozano, Sofía
  • Pardo-Figuerez, María
  • Monteagudo-Sánchez, Ana
  • Quirant, Anna
  • Moncayo-Arlandi, Javier
  • Gonzalez-Fernandez, Javier
  • Llera-Oyola, Jaime
  • Volkov, Petr
  • Maggi, Sara
  • Quintero, Luis
  • Raga, Fransciso
  • Grases, Pablo
  • Santamaría, Xavier
  • Moreno, Inmaculada
  • Plachta, Nicolas
  • Simon, Carlos
  • Vilella, Felipe
[EN] Embryo adhesion represents a critical step of implantation, yet understanding this process has been hindered by the lackof human in vitro platforms that replicate endometrial physiology. Here, we present a dual-channel microfluidic plat-form containing organoid-derived endometrial epithelium and primary stromal cells. Our model recapitulates impor-tant endometrial hallmarks including epithelial polarization, stromal decidualization, extracellular vesicle release,and hormone-induced receptivity. We validated the model using mouse embryos and human blastocysts, where weshowed that embryos displayed features of initial adhesion. These included establishment of embryo-epithelial con-tacts initiated via the polar trophectoderm, inner cell mass repositioning, and lineage reorganization. Moreover, humanembryos secreted ßhCG indicating a functional trophoblast. Thus, this work provides a platform to study key featuresof embryo adhesion and endometrial receptivity and disorders affecting embryo-endometrium interactions., This work was supported by the Carlos III Institute of Health grants PI21/00235 (I.M.), PI24/00722 (I.M.), PI21/00528 (F.V.), and PI24/01784 (A.M.-S. and F.V.); Spanish State Research Agency (AEI) grant CNS2022-135696 (F.V.); Conselleria de Innovacion, Universidad y Ciencia CIAICO 2022/242 (F.V.); European Commission Grant Agreement 101080219-2 (C.S. and F.V.); Torres Quevedo Grant PTQ2022-012376 (M.P.-F.); and Conselleria d Educació, cultura, universitats i ocupació CIGE 2023 (CIGE/2023/217) (A.M.S.), and CIAPOS 2024 (CIAPOS/2024/226) (A.M.-S.).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Targeted detection of Mycobacterium tuberculosis MPT64 antigen using an antibody-coated nanoporous anodic alumina biosensor: A novel approach for tuberculosis screening

  • Caballos, Isabel
  • Climent Terol, Estela
  • Gil-Brusola, Ana
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
[EN] Tuberculosis (TB) is a chronic condition caused by Mycobacterium tuberculosis. According to WHO's Global Tuberculosis Report 2024, TB has again become the leading cause of death from a single infectious agent, surpassing COVID-19 in 2023 and 2024 in terms of infectious disease deaths. Due to its high infectivity and serious effects, timely diagnosis and treatment are crucial for controlling its spread. This study presents a fluorogenic biosensor for detecting M. tuberculosis MPT64 antigen using gated nanoporous anodic alumina (NAA). NAA material is loaded with rhodamine B and capped with an antibody against MPT64 protein. The presence of MPT64 induces antibody displacement due to the specific recognition and subsequent release of rhodamine B to the medium that is detected by fluorescence measurement. The biosensor is physicochemically characterized by scanning electron microscopy and X-ray spectroscopy. The biosensor achieves a limit of detection (LOD) of 1.32 nM (0.032 mg L-1) for MPT64 protein and demonstrated high selectivity through testing against various antigens from other viral pathogens and bacterial species. The efficacy of the biosensor is further validated with grown mycobacteria from clinical samples. The developed approach offers three key aspects: (i) selective detection of active TB by targeting the secreted MPT64 protein using gated nanomaterials; (ii) a rapid response (60 min); and (iii) a cost-effective design suitable for resource-limited settings. This biosensor shows great potential as a tool for the clinical diagnosis of active tuberculosis., We thank PID2024-155683OB-C41 and PID2021-126304OB-C41 from the Ministerio de Ciencia, Innovacion y Universidades and AEI/10.13039/501100011033 (co-financed by the European Regional Development Fund) , and CIPROM/2021/007 (to R. M.-M.) from the Generalitat Valenciana. This research was also supported by CIBER, Instituto de Salud Carlos III (group CB07/01/2012) . I.-C. thanks the Instituto de Salud Carlos III for her predoctoral fellowship (IFI21/00008) . We thank electron microscopy service of UPV for their support. R.M.M. thanks to the European Union's Horizon EUROPE research and innovation programme under grant agreement No 101093042. E. C. thanks the Instituto de Salud Carlos III for funding the proyects Miguel Servet 2023 CP23/00086 and PI24_01239, both co-funded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Anthracene-Modified Nanoporous Silica Nanoparticles for ATP Detection and Salivary Diagnostics in Parkinson&apos, s Disease

  • Ahi, E.E.
  • Climent Terol, Estela
  • Beyret, Cansu
  • Caglayan, Mehmet Gokhan
  • Coban, Burak
  • Yilmaz, Rezzak
  • Durmus, Mahmut
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] ATP is an essential biological molecule, and abnormal levels are linked to various diseases. In this study, we developed an optical sensor array consisting of an anthracene-modified MCM-41 mesoporous nanoparticle-based hybrid organic-inorganic material to detect ATP in a TRIS-HCl buffer (pH 7). To create the sensor, we synthesized MCM-41 silica nanoparticles and functionalized them with aminoanthracene and imidazolium-anthracene groups. The fluorescence responses of the optical sensor array were recorded and analyzed by using a pattern recognition protocol, specifically linear discriminant analysis, to distinguish between ATP, ADP, AMP, and potential interferents. Quantitative regression analysis of ATP in TRIS-HCl was performed using artificial neural networks, which yielded an acceptable error rate of 7.8%. The sensor array was also evaluated for discrimination of Parkinson's disease (PD) from healthy controls, based on pattern recognition of ATP-related analytes in saliva samples from 24 patients with PD and 23 healthy controls. The results showed that the MCM-41 mesoporous silica nanoparticle-based sensor array can discriminate PD by pattern recognition with 73.7% sensitivity and 83.3% specificity., The diagnostic part of this study is supported by the Ankara University Scientific Research Projects Coordination Office (TSA-2023-2648 and TSA-2025-3825). V.M.-C. acknowledges financial support from the Project CIDEGENT/2020/031 funded by the Generalitat Valenciana, Project ESGENT/2024/ 001 funded by the Generalitat Valenciana, project PID2024- 157188OB-I00 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/ 501100011033, and project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. R.M.-M. acknowledges the European Union s Horizon EUROPE research and innovation program under grant agreement no. 101093042, project PID2024-155683OB-C41 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, and project PROMETEO CIPROM/2021/007 funded by Generalitat Valenciana. E.C. thanks the Instituto de Salud Carlos III for founding the projects Miguel Servet 2023 CP23/00086 and PI24_01239, both cofunded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Test Strips Based on Gated Nanoporous Anodic Alumina for the Rapid and Accurate Detection of Pseudomonas aeruginosa in Clinical Samples

  • Torres-Mesado, Andrea
  • Patricia Bernabé-Quispe
  • Tormo-Mas, María Ángeles
  • Pemán, Javier
  • Climent Terol, Estela
  • Caballos-Gómez, María Isabel
  • López-Palacios, Alba|||0000-0002-4397-277X
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Pseudomonas aeruginosa is a high-priority pathogen responsible for up to 23% of infections in intensive care units, yet current diagnostic methods remain hindered by multiday delays or high technical complexity. In this study, we report a rapid and highly sensitive biosensor based on nanoporous anodic alumina (NAA) capped with a specific oligonucleotide molecular gate targeting the phzA2 gene. The S3 biosensor achieved a limit of detection (LOD) of 0.153 ng mu L-1 for genomic DNA and an exceptional 28 CFU mL(-1) for direct bacterial detection without the need for prior DNA extraction. Validation in 63 clinical urine samples demonstrated a sensitivity of 91.67% and a specificity of 94.87% (AUC: 0.961, p-value < 0.0001). Furthermore, the sensor was integrated into Lateral Flow Assay (LFA), enabling the discrimination of positive and negative clinical samples in only 1 min with 100% specificity and 90.9% sensitivity. These results, combined with a one-year stability at 4 degrees C, position this gated-nanodevice as a robust and low-cost tool for Point-of-care (POC) diagnosis of P. aeruginosa infections., This research was funded by projects PID2024-155683OB-C41, PID2021-126304OB-C41, PID2021-122875OB-I00, and TED2021-132114B-100, supported by MCIN/AEI/10.13039/501100011033, the European Regional Development Fund, the European Union (NextGenerationEU/PRTR), and the Generalitat Valenciana (CIPROM/2021/007). This study is part of the Advanced Materials programme (MFA/2022/053) and was supported by MCIN with funding from the European Union's NextGenerationEU (PRTR-C17. I1) and by the Generalitat Valenciana. The project was also funded by Ayuntamiento de Valencia (SPI2024-096) and Instituto de Salud Carlos III (PI24/01239), cofunded by the European Union. In the same way, A.T. would like to thank the INVESTIGO program of the Ministry of Innovation, Universities, Research, and Digital Society of the Valencian Community for offering this research opportunity (INVEST/2023/443). To conclude, A.T. is grateful to the Asociacion Espanola Contra el Cancer for her 2024 predoctoral fellowship (PRDVA246577TORR (2024-0590-1)), which enabled this research. E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086), cofounded by the European Union. The authors thank Electron Microscopy Service at UPV for support. Funding for open access charge: CRUE-Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Optimisation of Diagnostic and Prognostic Approaches in Spinal Muscular Atrophy through Newborn Screening and Molecular Tools

  • Berzal Serrano, Alba
[ES] La atrofia muscular espinal (AME) es una enfermedad neuromuscular grave caracterizada por la degeneración progresiva de las motoneuronas espinales, causando debilidad y atrofia muscular. Aproximadamente el 95% de los pacientes presentan una deleción bialélica de SMN1 o eventos de conversión génica de SMN1 a SMN2, mientras que el 5% restante porta otras variantes patogénicas en SMN1, generalmente en heterocigosis compuesta con la deleción del segundo alelo. La AME muestra variabilidad clínica, explicada en gran medida por el número de copias de SMN2, un gen parálogo que atenúa la gravedad del fenotipo. No obstante, se han descrito modificadores genéticos adicionales. El desarrollo de terapias que aumentan la producción de proteína SMN mediante la modulación del splicing de SMN2 o la aportación exógena de SMN1 ha transformado el pronóstico de la enfermedad. Su eficacia es máxima cuando se administran antes de la aparición de síntomas, lo que ha impulsado la inclusión de la AME en programas de cribado neonatal. La detección presintomática es especialmente importante en lactantes con dos copias de SMN2, en quienes retrasos diagnósticos mínimos pueden comprometer la supervivencia y el desarrollo motor. El primer capítulo de esta tesis tuvo como objetivo implementar y evaluar un programa piloto de cribado neonatal de la AME en la Comunidad Valenciana. Entre octubre de 2021 y agosto de 2024 se analizaron 31560 muestras de recién nacidos. Mediante PCR cuantitativa se identificaron cuatro casos con deleción homocigota del exón siete de SMN1, lo que corresponde a una incidencia estimada de 1/7890 nacimientos, concordante con lo descrito internacionalmente. Todos los casos fueron confirmados mediante MLPA y el kit AmplideX PCR/CE SMN1/2 Plus, alcanzando un valor predictivo positivo del 100%. Hasta la fecha no se han detectado falsos negativos. Dos de los casos identificados fueron los primeros pacientes presintomáticos con dos copias de SMN2 tratados con Risdiplam en España. A pesar de estos resultados, el estudio evidenció limitaciones propias de un proyecto de investigación, como retrasos en la disponibilidad de muestras y la necesidad de consentimiento informado adicional. La cobertura alcanzó únicamente el 30,5% de los nacimientos de la Comunidad Valenciana y tres lactantes no pudieron ser cribados precozmente, siendo diagnosticados tras el inicio de los síntomas. El segundo capítulo comparó las técnicas MLPA, PCR digital (dPCR) y AmplideX para la determinación del número de copias de SMN2, dada su relevancia pronóstica y terapéutica. Se evaluó la concordancia entre estas metodologías en una cohorte retrospectiva de 78 pacientes con AME y se identificaron discrepancias en siete pacientes entre AmplideX y MLPA/dPCR, poniendo de manifiesto la necesidad de estandarizar los métodos de cuantificación. Aunque el número de copias de SMN2 sigue siendo el principal determinante pronóstico, se han descrito otros potenciales moduladores, como los genes híbridos SMN generados por recombinación entre SMN1 y SMN2. Diez pacientes con genes híbridos detectados por MLPA fueron analizados mediante secuenciación de lectura larga (LRS), identificándose seis nuevas estructuras híbridas. En conjunto, los resultados confirman que MLPA sigue siendo la técnica de referencia para el diagnóstico de AME por su fiabilidad en la cuantificación de SMN1 y SMN2. Aunque las técnicas dPCR y LRS ofrecen ventajas adicionales, sus limitaciones restringen su uso rutinario. En conclusión, esta tesis demuestra la viabilidad y el elevado rendimiento del cribado neonatal para la AME, así como la necesidad de implantar programas universales que garanticen el diagnóstico y tratamiento precoces. Asimismo, aporta nuevos conocimientos sobre la complejidad genética del locus SMN mediante la comparación de metodologías diagnósticas y la caracterización de nuevos genes híbridos, contribuyendo a mejorar su diagnóstico y manejo clínico., [EN] Spinal muscular atrophy (SMA) is a severe neuromuscular disorder characterised by the progressive degeneration of spinal motor neurons, leading to muscle weakness and atrophy. Approximately 95% of patients carry a biallelic deletion of SMN1 or gene conversion events from SMN1 to SMN2, while the remaining 5% harbour other pathogenic variants in SMN1, generally in compound heterozygosity with deletion of the second allele. SMA exhibits considerable clinical variability, largely explained by SMN2 copy number, a paralogous gene that attenuates disease severity. However, additional genetic modifiers have also been described. The development of therapies that increase SMN protein production through SMN2 splicing modulation or exogenous SMN1 replacement has transformed the prognosis of SMA. Their efficacy is greatest when administered before symptom onset, which has promoted the inclusion of SMA in newborn screening programmes. Presymptomatic detection is particularly important in infants with two SMN2 copies, in whom even minimal diagnostic delays may compromise survival and motor development. The first chapter of this thesis aimed to implement and evaluate a pilot newborn screening programme for SMA in the Valencian Community. Between October 2021 and August 2024, 31,560 newborn samples were analysed. Four cases carrying a homozygous deletion of SMN1 exon 7 were identified by quantitative PCR, corresponding to an estimated incidence of 1/7,890 births, consistent with international reports. All cases were confirmed by MLPA and the AmplideX PCR/CE SMN1/2 Plus kit, resulting in a positive predictive value of 100%. No false-negative cases have been detected to date. Two of the identified cases were the first presymptomatic patients with two SMN2 copies treated with Risdiplam in Spain. Despite these results, the study revealed limitations inherent to a research-based project, including delays in sample availability and the need for additional informed consent. Screening coverage reached only 30.5% of births in the Valencian Community, and three infants could not be screened early and were diagnosed after symptom onset. The second chapter compared MLPA, digital PCR (dPCR) and AmplideX for SMN2 copy number determination, given its prognostic and therapeutic relevance. Concordance among these methodologies was evaluated in a retrospective cohort of 78 SMA patients, and discrepancies between AmplideX and MLPA/dPCR were identified in seven patients, highlighting the need for standardisation of quantification methods. Although SMN2 copy number remains the main prognostic determinant, other potential modifiers have been described, including hybrid SMN genes generated by recombination between SMN1 and SMN2. Ten patients with hybrid genes detected by MLPA were analysed using long-read sequencing (LRS), leading to the identification of six novel hybrid structures. Overall, the results confirm that MLPA remains the reference technique for SMA diagnosis because of its reliability in SMN1 and SMN2 copy number quantification. Although dPCR and LRS offer additional advantages, their limitations currently restrict routine use. In conclusion, this thesis demonstrates the feasibility and high performance of newborn screening for SMA, as well as the need to implement universal programmes that ensure early diagnosis and treatment. It also provides new insights into the genetic complexity of the SMN locus through the comparison of diagnostic methodologies and the characterisation of novel hybrid genes, contributing to improved diagnosis and clinical management of SMA., [CA] L'atròfia muscular espinal (AME) és una malaltia neuromuscular greu caracteritzada per la degeneració progressiva de les motoneurones espinals, que provoca debilitat i atròfia muscular. Aproximadament el 95% dels pacients presenten una deleció bial·lèlica de SMN1 o esdeveniments de conversió gènica de SMN1 a SMN2, mentre que el 5% restant presenta altres variants patogèniques en SMN1, generalment en heterozigosi composta amb la deleció del segon al·lel. L'AME mostra variabilitat clínica, explicada en gran mesura pel nombre de còpies de SMN2, un gen paràleg que atenua la gravetat del fenotip. No obstant això, s'han descrit modificadors genètics addicionals. El desenvolupament de teràpies que augmenten la producció de proteïna SMN mitjançant la modulació de l'splicing de SMN2 o l'aportació exògena de SMN1 ha transformat el pronòstic de la malaltia. La seua eficàcia és màxima quan s'administren abans de l'aparició dels símptomes, fet que ha impulsat la inclusió de l'AME en programes de cribratge neonatal. La detecció presimptomàtica és especialment important en lactants amb dues còpies de SMN2, en els quals retards diagnòstics mínims poden comprometre la supervivència i el desenvolupament motor. El primer capítol d'aquesta tesi va tindre com a objectiu implementar i avaluar un programa pilot de cribratge neonatal de l'AME a la Comunitat Valenciana. Entre octubre de 2021 i agost de 2024 es van analitzar 31560 mostres de nounats. Mitjançant PCR quantitativa es van identificar quatre casos amb deleció homozigota de l'exó set de SMN1, la qual cosa correspon a una incidència estimada d'1/7890 naixements, concordant amb la descrita internacionalment. Tots els casos van ser confirmats mitjançant MLPA i el kit AmplideX PCR/CE SMN1/2 Plus, assolint un valor predictiu positiu del 100%. Fins a la data no s'han detectat falsos negatius. Dos dels casos identificats van ser els primers pacients presimptomàtics amb dues còpies de SMN2 tractats amb Risdiplam a Espanya. Malgrat aquests resultats, l'estudi va evidenciar limitacions pròpies d'un projecte d'investigació, com ara retards en la disponibilitat de mostres i la necessitat d'un consentiment informat addicional. La cobertura va assolir únicament el 30,5% dels naixements de la Comunitat Valenciana i tres lactants no van poder ser cribats precoçment, sent diagnosticats després de l'inici dels símptomes. El segon capítol va comparar les tècniques MLPA, PCR digital (dPCR) i AmplideX per a la determinació del nombre de còpies de SMN2, atesa la seua rellevància pronòstica i terapèutica. Es va avaluar la concordança entre aquestes metodologies en una cohort retrospectiva de 78 pacients amb AME i es van identificar discrepàncies en set pacients entre AmplideX i MLPA/dPCR, posant de manifest la necessitat d'estandarditzar els mètodes de quantificació. Encara que el nombre de còpies de SMN2 continua sent el principal determinant pronòstic, s'han descrit altres potencials moduladors, com els gens híbrids SMN generats per recombinació entre SMN1 i SMN2. Deu pacients amb gens híbrids detectats per MLPA van ser analitzats mitjançant seqüenciació de lectura llarga (LRS), identificant-se sis noves estructures híbrides. En conjunt, els resultats confirmen que MLPA continua sent la tècnica de referència per al diagnòstic de l'AME per la seua fiabilitat en la quantificació de SMN1 i SMN2. Encara que les tècniques dPCR i LRS ofereixen avantatges addicionals, les seues limitacions en restringeixen l'ús rutinari. En conclusió, aquesta tesi demostra la viabilitat i l'elevat rendiment del cribratge neonatal per a l'AME, així com la necessitat d'implantar programes universals que garantisquen el diagnòstic i tractament precoços. Així mateix, aporta nous coneixements sobre la complexitat genètica del locus SMN mitjançant la comparació de metodologies diagnòstiques i la caracterització de nous gens híbrids, contribuint a millorar-ne el diagnòstic i el maneig clínic., This research was funded by Novar s Gene Therapies through the project Newborn screening for Spinal Muscular Atrophy and Severe Combined Inmunodeficiency (reference 2020517-1). A.B.-S. is the recipient of a predoctoral contract from the Valencian Government (ACIF/2021/057). G.G.-G acknowledges two grants from the Carlos III Health Ins tute (CP22/00028 and PI22/01371) co-funded by the European Union and is the recipient of a project from Founda on Mutua Madrileña. A.B.-S. is the recipient of a predoctoral contract from the Valencian Government (ACIF/2021/057). G.G.-G acknowledges two grants from the Carlos III Health Ins tute (CP22/00028 and PI22/01371) co-funded by the European Union and is the recipient of a project from Founda on Mutua Madrileña. JF.V.-C acknowledges two grants from the Carlos III Health Ins tute (PI24/01512 and DTS23/00112) co-funded by the European Union. JM.M. received two grants from Ins tuto de Salud Carlos III (ISCIII), PI22/00213 and FORT23/00021 co-funded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Methylome-driven regulation of miRNA expression and its relationship to cardiac dysfunction in idiopathic dilated cardiomyopathy

  • Delgado-Arija, Marta
  • Gallego-Martínez, Alex
  • González-Torrent, Irene
  • Pérez-Carrillo, Lorena
  • Benedicto-Marrero, Carlota
  • Juan Bodí-Miret
  • Portolés, Manuel
  • Roselló-Lletí, Esther
  • Tarazón, Estefanía
[EN] Background Idiopathic dilated cardiomyopathy (iDCM) is a multifactorial disease with a complex pathogenesis involving diverse molecular mechanisms. Among these, epigenetic mechanisms, including both DNA methylation and microRNAs (miRNAs)-mediated regulation, play an important role in determining the disease phenotype. However, the interplay between the DNA methylome and the miRNA transcriptome in iDCM remains largely unexplored. Methods We conducted a cross-cohort multiomic integrative analysis of left ventricular (LV) tissue samples from iDCM patients and control (CNT) donors. DNA methylation profiling was performed using the Infinium MethylationEPIC BeadChip, whereas ncRNA-seq was used to assess transcriptomic changes. Results We identified a subset of three miRNAs exhibiting both differential methylation in their promoter regions and differential expression in their primary and mature forms. Notably, the miRNA hsa-miR-433-3p (r¿=¿0.671, p¿<¿0.01), which is involved in fibrotic pathways, appear to be significantly correlated with the left ventricular ejection fraction (LVEF), an established echocardiographic marker of cardiac function. Conclusions This study enhances our understanding of the epigenetic mechanisms shaping the miRNA transcriptomic landscape in iDCM, suggesting potential roles for these miRNAs in cardiac dysfunction and myocardial fibrosis., This work was supported by the National Institute of Health Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III (Projects: PI20/00071, PI24/00088, PI24/01310) co-funded by European Union; Miguel Servet contract: CP21/00041 co-funded by European Union; contract FI21/00186]; Consorcio Centro de Investigación Biomédica en Red [CIBERCV, under Grant CB16/11/00261]; Ministry of Science and Innovation (MCIN,https://doi. org/10.13039/501100011033) and State Investigation Agency (AEI) (Project CNS2022-135769 and CNS2024-1544396) co-funded by European Union NextGeneration EU and the European Recovery, Transformation and Resilience Plan (PRTR); Conselleria de Educación, Universidades y Empleo (Project CIA&#8209;ICO/2022/246, contract CIACIF/2022/429).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Executive function development between ages 2 and 6 in children exposed to threatened preterm labor

  • Miro-Padilla, Anna
  • Almansa, Belen
  • Ferrin, Maite
  • Lizaran, Marta
  • Andreu-Martinez, Julia
  • Torres-Villasante, Adrian
  • Zapata-de Miguel, Cristina
  • Buesa, Julia
  • Moreno-Gimenez, Alba
  • Ghosn, Farah
  • Diago, Vicente
  • Garcia-Blanco, Ana
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] Children born after threatened preterm labor (TPL) are at increased risk for executive function (EF) difficulties, even when born at term. However, EF development in this population remains understudied, particularly regarding the role of gestational age and early psychosocial adversity. Prenatal stress (e.g., maternal anxiety at TPL diagnosis and trauma history) and postnatal environmental factors may contribute to variability in EF outcomes. In this prospective cohort study with a 6-year follow-up, EF was assessed at ages 2 and 6 using the Behavior Rating Inventory of Executive Function-Preschool Version (BRIEF-P). The sample included 180 mother-child dyads: 120 children born after TPL (full-term n = 27, late-preterm n = 56, very-preterm n = 37) and 60 full-term controls. Bayesian mixed-effects models were used to examine associations between EF outcomes and gestational age group, time, and relevant prenatal and postnatal factors, including child sex, parental education, maternal trauma history, and maternal anxiety. The models showed a group & times; time interaction for global EF scores. At age 2, all TPL groups showed higher EF difficulty scores compared with controls, with the largest differences observed in the very-preterm group. Between ages 2 and 6, EF scores decreased in TPL groups relative to controls, indicating a greater reduction in EF difficulties over time, although patterns varied across EF domains. Higher maternal anxiety (prenatal and postnatal), greater maternal trauma exposure, and lower parental education were associated with higher EF difficulty scores, whereas female sex was associated with lower scores. Children born after TPL show early EF vulnerabilities across gestational ages, including those born at term. EF outcomes change across early childhood and are associated with both biological and environmental factors. These findings support the importance of early monitoring of children exposed to prenatal complications and highlight the role of perinatal maternal mental health and family context in early executive function development., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The authors declare that they received the following financial support for the research, authorship, and/or publication of this article. A.M.-P., C.Z.-dM., and J.A.-M. were supported by the Carlos III Health Institute (CD22/00068, CM22/00097, and CM24/00123). A.T.-V. was supported by the Generalitat Valenciana (CIACIF/2024/002). B.A. and M.L. were supported by the Spanish Ministry of Science and Innovation (FPU18/01997 and FPU20/02548). A.G.-B. also received funding from the Carlos III Health Institute and the European Regional Development Fund ( A way to achieve Europe ) (PI18/01352, PI21/00549, PI24/01259, and CP21/0008), as well as from the Generalitat Valenciana (CIAICO/2022/233). A.M.-P. also received funding from the Generalitat Valenciana (CIGE/2023/163).
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

EPheClass: ensemble-based phenotype classifier from 16S rRNA gene sequences

  • Vázquez González, Lara
  • Peña-Reyes, Carlos
  • Regueira Iglesias, Alba
  • Balsa Castro, Carlos
  • Tomás Carmona, Inmaculada
  • Carreira Nouche, María José
One area of bioinformatics that is currently attracting particular interest is the classification of polymicrobial diseases using machine learning (ML), with data obtained from high-throughput amplicon sequencing of the 16S rRNA gene in human microbiome samples. The microbial dysbiosis underlying these types of diseases is particularly challenging to classify, as the data is highly dimensional, with potentially hundreds or even thousands of predictive features. In addition, the imbalance in the composition of the microbial community is highly heterogeneous across samples. In this paper, we propose a curated pipeline for binary phenotype classification based on a count table of 16S rRNA gene amplicons, which can be applied to any microbiome. To evaluate our proposal, raw 16S rRNA gene sequences from samples of healthy and periodontally affected oral microbiomes that met certain quality criteria were downloaded from public repositories. In the end, a total of 2,581 samples were analysed. In our approach, we first reduced the dimensionality of the data using feature selection methods. After tuning and evaluating different machine learning (ML) models and ensembles created using Dynamic Ensemble Selection (DES) techniques, we found that all DES models performed similarly and were more robust than individual models. Although the margin over other methods was minimal, DES-P achieved the highest AUC and was therefore selected as the representative technique in our analysis. When diagnosing periodontal disease with saliva samples, it achieved with only 13 features an F1 score of 0.913, a precision of 0.881, a recall (sensitivity) of 0.947, an accuracy of 0.929, and an AUC of 0.973. In addition, we used EPheClass to diagnose inflammatory bowel disease (IBD) and obtained better results than other works in the literature using the same dataset. We also evaluated its effectiveness in detecting antibiotic exposure, where it again demonstrated competitive results. This highlights the importance and generalisation aspect of our classification approach, which is applicable to different phenotypes, study niches, and sample types. The code is available at https://gitlab.citius.usc.es/lara.vazquez/epheclass.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Respiratory syncytial virus–related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE‑GAL study

  • Manzanares, Ángela
  • Pardo Seco, Jacobo José
  • Rivero Calle, Irene
  • Dacosta Urbieta, Ana Isabel
  • Mallah, Narmeen
  • Rodríguez-Tenreiro Sánchez, Carmen
  • Salas Ellacuriaga, Antonio
  • Martinón Torres, Federico
As part of the NIRSEGAL study (https://www.nirsegal.es/en), we present the clinical characteristics and course of respiratory syncytial virus (RSV)-related low respiratory tract infection (LRTI) hospitalizations in infants eligible for nirsevimab administration during the 2023–2024 season. Infants eligible for nirsevimab immunization (born between 1 April, 2023, and 30 March, 2024) who were hospitalized due to RSV-related LRTI between September 25, 2023, and April 15, 2024, in a hospital from the Galician Public Health system were included. Clinical and demographic characteristics of RSV-related LRTI hospitalizations were analyzed, with comparisons made between breakthrough cases (those immunized with nirsevimab) and non-breakthrough cases. During the study period, 69 RSV-related LRTI hospitalizations were recorded, with a median hospital stay of 4 (interquartile range (IQR) 3–6) days; 65.2% (N=45) were breakthrough cases. The median age was 2.7 (IQR 1.5–5.2) months, and more than half of them (N=39, 56.5%) were male. The incidence of cases was parallel to the RSV epidemic curve, suggesting no waning of nirsevimab efcacy. Of the total hospitalizations, 16 infants (23.2%) had a high-risk condition, 44 (63.8%) needed oxygen support, 15 (21.7%) were admitted to the intensive care unit (ICU), and 11 (15.9%) received non-invasive mechanical ventilation (NIMV). No statistically signifcant diferences were observed in these characteristics when comparing breakthrough and non-breakthrough cases. Conclusion: In the nirsevimab era, a substantial proportion of children who were hospitalized for RSV-related LRTI needed oxygen support, NIMV, and ICU admission. Clinical characteristics, timing, and outcomes were comparable between breakthrough and non-breakthrough cases. Trial registration: The NIRSE-GAL study protocol was registered on ClinicalTrials.gov (NCT06180993).
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Sleep duration moderates association between screen time and emotional and behavioural problems in young children

  • Iglesias-Vázquez, Lucía
  • Garcidueñas-Fimbres, Tany E.
  • Gómez-Martínez, Carlos
  • Castro-Collado, Cristina
  • Leis Trabazo, María Rosaura
  • Fernández de la Puente, María
  • Moreno, Luis A.
  • Navas Carretero, Santiago
  • Corella, Dolores
  • Moreira Echeverría, Ana
  • Jurado Castro, José Manuel
  • Picáns Leis, Rosaura
  • Ni, Jiaqi
  • Miguel‑Bergse, María L.
  • Martínez, J. Alfredo
  • Benedicto‑Toboso, María I.
  • Llorente Cantarero, Francisco Jesús
  • Vázquez Cobela, Rocío
  • Feliu, Albert
  • Masip, Guiomar
  • Pastor Villaescusa, Belén
  • Gil Campos, Mercedes
  • Escribano, Joaquín
  • Babío, Nancy
Background Preschoolers and young children are vulnerable to psychosocial and behavioral disorders linked to lifestyle factors such as screen time and sleep disturbances. Our study examines the relationship between screen time and adherence to recommendations with children’s behavioral and emotional difculties, with a focus on the role of sleep duration. Methods Cross-sectional analyses were conducted within the multicenter prospective Childhood Obesity Risk Assessment Longitudinal Study (CORALS), which included 1420 children aged 3–6 years. Screen time (hours/day) and adherence to recommendations (≤2 hours/day) were assessed. Behavioral and emotional difculties were measured via the strengths and difculties questionnaire. Multivariable linear and logistic regression models were used to estimate associations between screen time (continuous and dichotomous) and strengths and difculties questionnaire scores, adjusting for potential con‑founders. We also tested the moderating efect of sleep and conducted isotemporal substitution analyses replacing screen time with sleep duration. Results Higher screen time was associated with higher total strengths and difculties questionnaire scores [β 95% confidence interval (CI), 0.35 (0.10, 0.61)], emotional symptoms [0.10 (0.01, 0.19)], conduct problems [0.10 (0.01, 0.18)], and greater odds of exceeding the 16-point strengths and difculties questionnaire cutof for behavioral and emotional difculties [odds ratio (OR) (95% CI), 1.21 (1.04, 1.41)]. Children who adhered to screen time recommendations had lower strengths and difficulties questionnaire total scores [β (95% CI),−0.64 (−1.19,−0.10)] and odds of experiencing behavioral and emotional difculties [OR (95% CI), 0.67 (0.47, 0.95)]. Sleep duration moderated the screen time–strengths and difculties questionnaire association (P=0.020). The isotemporal substitution of screen time for sleep duration was associated with lower strengths and difculties questionnaire scores across all subscales, except for prosocial behavior. Conclusions Higher screen time was associated with greater emotional and behavioral difculties, whereas adherence to screen time recommendations and adequate sleep duration were inversely associated. Managing screen time and promoting sleep are crucial for children’s well-being.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Knowledge, attitudes and practices regarding antibiotic prescribing by dentists: a qualitative study in Chile

  • Juárez Membreño, Antonio
  • Vázquez-Cancela, Olalla
  • Prieto Campo, A.
  • Zapata Cachafeiro, Maruxa
  • Figueiras Guzmán, Adolfo
  • Rodríguez Fernández, Almudena
Background: Antimicrobial resistance (AMR) is one of the greatest threats to public health. As dentists play a major role in the prescription of antibiotics, the aim of this study was to study knowledge, attitudes and practices regarding antibiotic prescribing in dentistry. Methods: We conducted a qualitative study on dentists in Chile, using the focus-group (FG) method. To form the groups, the inclusion criteria required participants: (i) to be graduates in dentistry; and (ii) be practising as dentists or dental surgeons at the date of study. Transcriptions of the FG sessions were analysed using the thematic analysis technique. Results: Six FG with 27 participants were developed. The factors and attitudes identified in antibiotic prescribing were cultural and social context; need of patient expectations; external responsibility; patient pressure; and healthcare burden. Dentists considered the control of medicines and education of the population to be essential. Additionally, the participants stressed the importance of knowledge about antibiotic use. Conclusion: This study identified key factors such as the culture of trivialisation of antibiotic use and the need to prevent the sale of antibiotics in non-healthcare markets. In addition, there is a need for strategies targeted at modifying the knowledge, attitudes and practices.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

In Vitro Analysis of TWEAK/Fn14 Axis in the Blood–Brain Barrier Models during Oxygen–Glucose Deprivation and Reoxygenation

  • Sampedro Viana, Ana
  • Alonso Alonso, María Luz
  • Castillo, José
  • Hervella, Pablo
  • Álvarez Castro, Ezequiel
  • Burek, Malgorzata
  • Iglesias Rey, Ramón
Upregulation of tumor necrosis factor-like weak apoptosis-inducing factor (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) was observed in stroke patients and murine models, contributing to neuronal apoptosis and blood–brain barrier (BBB) disruption. This study aimed to investigate the TWEAK/Fn14 signaling axis in cerebral ischemia and reperfusion using different in vitro oxygen–glucose deprivation (OGD) durations and cellular models. Western blot and RT-qPCR were used to evaluate TWEAK/Fn14 expression in monocultures, co-cultures, and triple-cultures of human immortalized endothelial cells, pericytes, and astrocytes. Six OGD conditions were tested: 4, 8, and 16 h, with or without 24 h reoxygenation. BBB model integrity was evaluated by analyzing occludin, zonula occludens-1, and VE-cadherin. A significant, duration-dependent downregulation of Fn14 was observed in monocultures after OGD (up to 85%, p < 0.05–p < 0.001), with partial recovery after 24 h reoxygenation (p < 0.05). TWEAK levels remained stable with minor fluctuations. Similar Fn14 reductions were seen in co- and triple-cultures (p < 0.01), followed by recovery. Endothelial biomarkers exhibited an initial stress response post-OGD, followed by recovery during reoxygenation. In conclusion, TWEAK remains stable during ischemia without immune cells, while Fn14 is downregulated during OGD and recovers after reoxygenation, indicating time-dependent roles in ischemic response and repair. The findings indicate a time-dependent regulation of Fn14 under ischemic conditions in vitro, highlighting its role in BBB stress and recovery. Nevertheless, further preclinical studies are needed to establish its therapeutic potential.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormonedependent cancers

  • Sacristán Santos, Víctor
  • Pensado López, Alba
  • García Campelo, Rosario
  • Antolín Novoa, Silvia
  • Señarís Rodríguez, Rosa María
  • Torres Andón, Fernando
Hormone-dependent cancers, like breast and prostate cancers, represent a unique challenge in oncology due to their complex interplay between hormone signaling, immune evasion, and therapeutic resistance. While endocrine therapies effectively target hormone signaling to initially control disease, resistance mechanisms frequently emerge, leading to cancer progression and limited survival. These solid tumors further complicate treatment by establishing an immunosuppressive tumor microenvironment (TME), presenting variable numbers of immune cells depending on cancer type and stage, which hinders the efficacy of immune checkpoint inhibitors. In this TME, tumor-associated macrophages (TAMs) are the major cellular source of immunosuppression, supporting tumor growth. The ability of TAMs to hamper the effectiveness of endocrine therapy is becoming increasingly recognized. Reprogramming TAMs within solid tumors can restore their natural ability to fight cancer and also enhance antitumoral efficacy. In this line of research, Al-Janabi et al have recently developed lipid nanoparticles decorated with antibodies that bind to the folate receptor-beta overexpressed in perivascular TAMs and loaded with a STING agonist (cGAMP) for the reprogramming of these TAMs. In preclinical murine models of prostate cancer, this therapeutic approach demonstrated significant synergistic activity with androgen deprivation therapy. This work provides an excellent example of TAM reprogramming combined with endocrine therapy for the treatment of hormone-dependent cancers.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

A curated bacterial and archaeal 16S rRNA Gene Oral Sequences dataset

  • Vázquez González, Lara
  • Regueira Iglesias, Alba
  • Balsa Castro, Carlos
  • Tomás Carmona, Inmaculada
  • Carreira Nouche, María José
In a given species, genomes and 16S rRNA gene sequences, along with their intragenomic copy numbers, can vary greatly across environments. The gene copy numbers are crucial for technologies which estimate microbial abundances based on gene counts, such as polymerase chain reaction and high-throughput sequencing. In these, taxa with fewer genes may be underestimated, while those with more genes might be overestimated. Therefore, it is essential to have accurate gene copy number databases specific to the niche under study. The 16S rRNA Gene Oral Sequences dataset (16SGOSeq) contains the number of 16S rRNA genes and their variants in the complete genomes of the bacterial and archaeal species present in the human oral cavity. It includes 3,192 complete genomes of oral bacteria and 191 complete genomes of oral archaea, from which the 16S rRNA gene sequences were extracted, and the sequence variants were identified. This oral-specific dataset of prokaryotic organisms and the pipeline followed for its construction can be applied by clinical microbiologists, bioinformaticians, or microbial ecologists in future microbiome research.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

From premorbid adjustment dimensions to clinical outcomes: exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypes

  • Perez-Ramos, Anaid
  • Gonzalez-Segura, Àlex
  • Julià, Laura
  • García-Rizo, Clemente
  • Sánchez Torres, Ana María
  • Cavone, Vito
  • Zorrilla, Iñaki
  • Mané, Anna
  • Rodríguez-Jiménez, Roberto
  • Roldán, Alexandra
  • Pomarol-Clotet, Edith
  • Ibáñez, Ángela
  • Usall, Judith
  • Lobo, Antonio
  • Bioque, Miquel
  • Bernardo, Miguel
  • Cuesta, Manuel J.
  • Parellada, Mara
  • González-Pinto, Ana
  • Berrocoso, Esther
  • Amoretti, Silvia
  • Mezquida, Gisela
  • 2EPs Working Group
Introduction Schizophrenia is a complex and multifaceted mental disorder characterized by cognitive, emotional, and behavioral dysfunctions that significantly impact the patients' daily lives. Premorbid adjustment (PA) is a multidimensional framework, the severity of which has been associated with more severe phenotypic traits and unfavorable outcomes, offering insights into the development of this disorder. This study aims to characterize a group of first-episode schizophrenia (FES) patients based on academic (PAA) and social (PSA) PA, explore the overlap across these dimensions, and examine their associations with early clinical, environmental, and epigenetic factors, through methylation profile scores (MPS). Material and methods A total of 218 FES subjects were included. K-means clustering identified "poor" and "good" groups for PAA and PSA. Clusters overlaps were explored using multiple correspondence analysis and were characterized by sociodemographic, clinical, functional, and cognitive features. Associations with clinical, environmental factors and MPS were examined using multivariable models adjusted for key covariates. Results Poor-PAA individuals showed worse cognitive performance (working memory, attention, and executive function), lower educational level, and higher cannabis use. Poor-PSA individuals had more severe negative symptoms. MPS for early-life adversity and cannabis use were associated with PSA clusters, while MPS for birth weight and tobacco use were linked to PAA clusters. Conclusions PAA and PSA dimensions show distinct clinical, cognitive, functional, and epigenetic profiles. These findings support the use of premorbid functioning subtypes for identifying early markers and tailoring interventions., This study is part of a coordinated multicenter project funded by the Ministerio de Economía y Competitividad (PI08/0208, PI11/00325, PI14/00612) (M.B.); the Instituto de Salud Carlos III and the European Regional Development Fund (ERDF), A way to build Europe; the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM); the CERCA Programme/Generalitat de Catalunya; and the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2021 SGR 01120). Furthermore, this study is part of the projects PI24/00196 (C.G.-R. and G.M.) funded by Instituto de Salud Carlos II (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, ERCA Program/Generalitat de Catalunya and Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2017SGR1355). G.M. is a Serra Hunter Fellow, within the Tenure-elegible Lecturer Serra Hunter program (UB-LE-212-024, Generalitat de Catalunya). Supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD-7216 (AGES 3-CM), and CIBERSAM-ISCIII.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Impact of abdominal and thigh intermuscular adipose tissue on glucose and cardiometabolic risk in adults with obesity

  • Camacho-Cardenosa, Alba
  • Clavero-Jimeno, Antonio
  • Gatti, Alessandro
  • Dote-Montero, Manuel
  • Concepción Álvarez, Mara de la Caridad
  • Alfaro-Magallanes, Víctor Manuel
  • Martín-Olmedo, Juan J.
  • Cabeza Laguna, Rafael
  • Idoate, Fernando
  • Martín-Rodríguez, José L.
  • García Pérez, Patricia Virginia
  • Muñoz Torres, Manuel
  • Ruiz, Jonatan R.
  • Labayen Goñi, Idoia
Context: Intermuscular adipose tissue (IMAT) at different anatomical locations may exert distinct effects on cardiometabolic risk. Objective: The present study investigated the relationships of abdominal and mid-thigh IMAT with glucose homeostasis and cardiometabolic risk in adults with overweight or obesity. Design: Multicenter cross-sectional study. Setting: Outpatient clinic. Participants: One hundred eighty-nine adults (50% women; age: 46.8 +/- 6.3 years) with overweight or obesity (body mass index: 32.9 +/- 3.5 kg/m(2)). Main Outcome Measures: IMAT content in abdominal and mid-thigh regions was measured by magnetic resonance imaging. Mean glucose levels were monitored over 24 hours during 14 days using continuous glucose monitoring devices. We computed a cardiometabolic risk score including fasting high-density lipoprotein cholesterol, triglycerides, glucose, waist circumference, and systolic and diastolic blood pressure. Results: No associations were identified between abdominal IMAT and glucose homeostasis or cardiometabolic risk (all P > .05). In contrast, a positive association of mid-thigh IMAT with 24-hour (beta = 0.226; P = .007), diurnal (beta = 0.224; P = .008), and nocturnal mean glucose levels (beta = 0.233; P = .006) as well as with cardiometabolic risk score (beta = 0.324; P < .001) was observed. Participants with greater accumulation of IMAT in the mid-thigh compared to the abdominal region exhibited significantly higher mean glucose levels and cardiometabolic risk (all P < .005). Conclusion: These findings emphasize the importance of distinguishing between adipose tissue depots when evaluating cardiometabolic risk, as specific accumulation patterns-particularly in the mid-thigh region-may significantly influence individual risk profiles., Agencia Estatal de Investigacion, Ministerio de Ciencia, Innovacion y Universidades grant PID2022.141506OB.I00 (J.R.R.). Junta de Andalucia, Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades, grant A-CTS-516-UGR20 (J.R.R.). University of Granada Plan Propio de Investigacion-Excellence actions: Unit of Excellence on Exercise, Nutrition and Health (UCEENS) (J.R.R.). Consejo Superior de Deportes, Ministerio de Cultura y Deporte, Plan de Recuperacion, Transformacion y Resiliencia. Funded by the European Union NextGenerationEU grant EXP_75091 (I.L.). Departamento de Desarrollo Economico y Empresarial, Gobierno de Navarra grant 0011-1365-2021-00070 (I.L.). Ministerio de Ciencia, Innovacion y Universidades, European Union NextGenerationEU EU/PRTR grant FJC2020043385-I and Junta de Andalucia, Consejeria de Salud y Consumo, grant RHJ-0098-2024 (A.C.C.). Ministerio de Universidades grant FPU18/03357 (M.D.M.). Ministerio de Universidades grant FPU21/01161 (A.C.J.). Ministerio de Ciencia, Innovacion y Universidades grant FPU22/01631 (J.J.M.O.). EXERNET, Research Network on Exercise and Health grant DEP2005-00046/ACTI, 09/UPB/19, 45/UPB/20, and 27/UPB/21 (J.R.R. and I.L.). Instituto de Salud Carlos III (ISCIII) grant PI24/01360, cofunded by the European Union (I.L.). Ministerio de Ciencia e Innovacion and by the European Union NextGenerationEU/RRF - Universidad Politecnica de Madrid grant Margarita Salas (V.M.A.M.).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Effects of time-restricted eating and resistance training on skeletal muscle tissue quantity, quality and function in postmenopausal women with overweight or obesity: a study protocol

  • Alfaro-Magallanes, Víctor Manuel
  • Medrano Echeverría, María
  • Echarte Medina, Jon
  • Osés Recalde, Maddi
  • Izquierdo Rodríguez, Claudia
  • Concepción Álvarez, Mara de la Caridad
  • Galbete Jiménez, Arkaitz
  • Idoate, Fernando
  • Zugasti Murillo, Ana
  • Petrina Jáuregui, María Estrella
  • Goñi Gironés, María Elena
  • Ribelles, María Jesús
  • Amasene, María
  • Arenaza Etxeberría, Lide
  • Tejada Garrido, Clara Isabel
  • Elejalde, E.
  • Azcárate Jiménez, Unai Xabier
  • Ruiz Sarrias, Oskitz
  • Sayar-Beristain, Onintza
  • García-Ramos, Amador
  • Martínez Labari, Cristina
  • Armendáriz Brugos, Cristina
  • Villanueva Larre, Arantxa
  • Ruiz, Jonatan R.
  • Cabeza Laguna, Rafael
  • Labayen Goñi, Idoia
Background & aims: time-restricted eating (TRE) shows promise for weight loss and improving menopauserelated body composition and cardiometabolic health, but its effects on skeletal muscle tissue (SMT) in postmenopausal women are unknown. This study investigates the effects of three weight loss interventions over 12 weeks on SMT quantity, quality, function, and cardiometabolic health in postmenopausal women with overweight/obesity, with effects persistence evaluated at a 12-month follow-up. Methods and results: in this randomized controlled trial, 78 postmenopausal women (50–65 years; BMI 25–40 kg/m2; sedentary lifestyle; eating window ≥12 h/day; no severe metabolic impairments) will be recruited. Participants will be randomly assigned to one of three groups for 12 weeks: TRE, TRE + resistance training, or CR + resistance training. The TRE groups will reduce their eating window to 8 h and receive nutritional advice to adhere to a Mediterranean diet. The CR group will follow a personalized hypocaloric diet (− 500 kcal/day). Resistance training groups will perform supervised resistance training 3 times/week. Primary Outcome: Change in SMT quantity measured by MRI at baseline and after 12 weeks. Secondary Outcomes: intermuscular adipose tissue (IMAT), strength, power, body weight and composition, and cardiometabolic risk factors. Conclusion: this study will illustrate the effects of TRE and TRE combined with resistance exercise compared with the currently recommended obesity-lifestyle treatment on SMT quantity, quality, function, and cardiometabolic markers. The results will offer insights into dietary strategies to combat obesity and metabolic diseases without increasing sarcopenia risk in postmenopausal women, a sparsely studied and particularly affected population., This study is supported by the Instituto de Salud Carlos III (ISCIII, PI24/01360), cofunded by the European Union, the Spanish Ministry of Culture and Sport (CSD, grant code: EXP_75091), Recovery, Transformation, and Resilience Plan - Financed by the European Union - NextGeneration EU, and the Department of Industry of the Government of Navarra (0011-1365-2023-000105), European Regional Development Fund (FEDER). Both the Spanish Ministry of Culture and Sport and the Government of Navarra will independently audit the development and execution of the project upon its completion. Margarita Salas grant funded by Ministerio de Ciencia e Innovación and by the European Union NextGenerationEU/RRF - Universidad Politécnica de Madrid.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Effect of diactive-1 mHealth-supported progressive resistance training on insulin requirements, glycemic stability, and muscular strength in children and adolescents with type 1 diabetes: a parallel-group randomized controlled trial

  • Muñoz Pardeza, Jacinto
  • Hormazábal Aguayo, Ignacio
  • Huerta Uribe, Nidia
  • Chueca-Guindulain, María J.
  • Berrade-Zubiri, Sara
  • Martínez Vizcaíno, Vicente
  • Ezzatvar, Yasmin
  • López Gil, José Francisco
  • García Hermoso, Antonio
Datos de investigación alojados en: https://doi.org/10.2337/figshare.29599814, Objetive: to evaluate the effects of resistance training supported by the mobile health application Diactive-1 on the daily insulin dose and glycemic parameters in children and adolescents with type 1 diabetes. Rerearch design and methods: in this 24-week randomized clinical trial, Diactive-1 generated progressive overload resistance training sessions tailored to real-time glycemia and provided educational support. Insulin and glycemic parameters were collected from LibreView or CareLink, whereas glycosylated hemoglobin (HbA1c) was extracted from medical records. Muscular strength was assessed using a handgrip dynamometer and e-GYM machines, targeting pushing, pulling, and lower-limb movements. The effect was analyzed using linear mixed models. Results: sixty-two participants (age: 8–18 years, girls: 48%) with type 1 diabetes (HbA1c: 7.6% [60.4 mmol/mol]) were allocated to the usual care (n = 32) or the Diactive-1 group (n = 30). Daily insulin dose reductions were observed within the Diactive-1 group (mean difference [MD] −0.10 units/kg, 95% CI −0.18 to −0.01) and when compared with usual care (MD −0.17 units/kg, 95% CI −0.26 to −0.07). No adverse effects were observed on the glycemic risk index or the incidence of hypoglycemic events. Finally, handgrip strength (MD 2.90 kg, 95% CI 1.57–4.22), one-repetition maximum strength (MD 1.34, 95% CI 0.21–2.46), and muscular power (MD 0.97, 95% CI 0.01–1.93) increased. Four participants (6.5%) withdrew from the study. Conclusions: Diactive-1 appears to be a safe and feasible adjunct to standard care in children and adolescents with type 1 diabetes. Its resistance training component effectively reduced insulin requirements and improved muscular strength, without increasing the risk of adverse glycemic events., The study received financial support from Instituto de Salud Carlos III (Spain), funded by the European Union under grant number PI21/01238 and PI24/00829. In addition, Instituto de Salud Carlos III supported J.M.-P. with a competitive contract (FI22/00329).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Mitochondria and lipid defects in hereditary progranulin-related frontotemporal dementia

  • Ondaro, Jon
  • Zúñiga Elizari, Jose Luis
  • Zufiría García, Mónica
  • Garciandia-Arcelus, Maddi
  • Sánchez Molleda, Ángela
  • Zulaica Ijurco, Miren
  • Lafarga, Miguel
  • Riancho, Javier
  • López de Munain, Adolfo
  • Moreno, Fermin
  • Gil Bea, Francisco Javier
  • Gerenu, Gorka
Frontotemporal dementia (FTD) is a neurodegenerative disorder predominantly affecting individuals under 65 years of age, characterized by significant behavioral and language disabilities. Despite extensive research efforts, effective treatments for FTD remain elusive. Familial cases of FTD have been linked to genetic mutations in several key genes, among these, mutations in granulin (GRN) account for 5–20% of cases, leading to haploinsufficiency of progranulin (PGRN), a multifunctional glycoprotein. This study investigates the cellular pathology associated with GRN insufficiency by using fibroblasts derived from FTD patients carrying the c.709-1G>A GRN mutation (FTD-GRN). These fibroblasts exhibited pathological hallmarks of FTD, including lysosomes, autophagosomes, and lipofuscin accumulation, mirroring observations in affected patient tissues. Notably, we report mitochondrial abnormalities, characterized by mitochondrial swelling which is associated with decreased mitochondrial respiration, and lipid droplet accumulation, reflecting altered lipid metabolism. Experimental supplementation with recombinant human progranulin (rhPGRN) was associated with recovery of lysosomal acidification and attenuation of mitochondrial and lipid abnormalities in vitro. This study reveals that GRN haploinsufficiency induces mitochondrial and lipid dysfunctions, suggesting that these pathways may contribute to FTD-GRN pathogenesis and could be of interest for therapeutic development., This research was funded by Grant PID2023-153029OA-I00 funded by MICIU/AEI/10.13039/501100011033 and, as appropriate, by 'ERDF A way of making Europe', by 'ERDF/EU', by the 'European Union' or by the 'European Union NextGenerationEU/PRTR'. The Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union through the European Regional Development Fund (ERDF) (grant numbers P18/01066, PI19/01637, PI21/00153, PI24/01025); by CIBERNED-Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (grant number CB06/05/1126, Group 609); by the Diputación Foral de Gipuzkoa (project 2021-CIEN-000020-01); by EiTB Maratoia (BIO17/ND/023/BD); by Fundació La Marató (grant number 202006-32); and by the IKUR strategy of the Basque Government (NEURODEGENPROT project), as well as the Basque Government Department of Health (Eusko Jaurlaritzako Osasun Saila; grant numbers 2017222027, 2018111042, 2019222020, and 2021333050). J.O., J.L., M.Z., and M.G. received predoctoral support from the Department of Education of the Basque Government through grants PRE2018_1_0095, PRE2022_1_0315, PRE2015_1_0023, and PRE2020_1_0122, respectively. F.G. was supported by the Roche 'Stop Fuga de Cerebros' program (BIO19/ROCHE/017/BD). G.G. was funded by the Juan de la Cierva-Incorporación fellowship from the Spanish Ministry of Science and Innovation (IJC2019-039965-I). F.G., and G.G. received additional support from the IKERBASQUE Research Foundation. The APC was funded by the same funding sources, in accordance with the authors' affiliation with the University of the Basque Country (UPV/EHU).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Global index of lifestyle quality and non-suicidal self-injury in the SESSAMO project: a Spanish adolescents cohort

  • Goñi-Sarriés, Adriana
  • Morata-Sampaio, Leticia
  • Díez-Suárez, Azucena
  • Pírez, Guillermo
  • Zorrilla, Iñaki
  • Sánchez Villegas, María Almudena
Adolescents' failure to embrace healthy lifestyles constitutes a serious public health issue, such that its relationship to non-suicidal self-injury (NSSI) merits further research. The aim of the study was to ascertain the association between a Global Index of Lifestyle Quality (GILQ) and the presence of NSSI. Cross-sectional analysis of a sample of 2nd- to 4th-year ESO students (Obligatory Secondary Education, from ages 14 to 16) recruited for the SESSAMO project, a multicenter prospective cohort study. Exposure variables were collected, including eating patterns, physical activity, screen use, the consumption of cannabis, alcohol and tobacco, risky sexual behavior, gambling, spend time with friends, and sleep quality. To determine the presence of NSSI, a validated questionnaire was administered. The association between different lifestyles and the presence of NSSI was analyzed through multivariate logistic regression models. 2042 adolescents were included. Physical activity, screen use, risky sexual behavior, sleep quality, and daytime sleepiness showed inverse and statistically significant associations with the presence of NSSI in multivariate models. A higher lifestyle score was associated with a 71% reduction in the likelihood of engaging in NSSI (OR for extreme quartiles of GILQ adherence =0.29; 95% CI = 0.15-0.57). The result was similar when boys and girls were analyzed separately. A healthy lifestyle was inversely associated with the presence of NSSI in this sample of Spanish adolescents. Lifestyles could function as potential predictors of NSSI., This project was funded by the Institute of Health Carlos III(ISCIII) and co-funded by the European Regional Development Fund (ERDF), Identification code: PI20/00133 and PI24/00028.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Endogenous α-Klotho is a common target in atherosclerosis and calcific aortic valve disease

  • Martín Núñez, Ernesto
  • González-Luis, Ainhoa
  • Perdomo-Ramírez, Ana
  • Tagua, Víctor G.
  • Ferri, Carla
  • Rodríguez-Ramos, Sergio
  • Cerro-López, Purificación
  • López-Castillo, Ángel
  • Delgado-Molinos, Alejandro
  • Martín-Olivera, Alberto
  • Fernández Celis, Amaya
  • Garaikoetxea, Mattie
  • Goñi Olóriz, Miriam
  • San Ildefonso-García, Susana
  • Ibarrola, Jaime
  • Jover, Eva
  • Mora-Fernández, Carmen
  • Donate-Correa, Javier
  • López Andrés, Natalia
  • Navarro-González, Juan F.
Although atherosclerotic vascular disease (ASVD) and calcific aortic stenosis (AS) are distinct clinical entities, inflammation is a common driving force. The contribution of endogenous α-Klotho, an anti-aging protein, in the vasculature and aortic valve (AV) as an inflammatory mediator of such diseases remains unclear. We investigated α-Klotho expression using qPCR, ELISA, and immunohistochemistry in vascular (aorta, carotid, and femoral) and AV tissue samples from patients with ASVD (n = 112) and calcific AS (n = 172), respectively. We also determined circulating levels of soluble α-Klotho. We assessed α-Klotho associations with inflammatory and calcification markers. In vitro, we treated human vascular smooth muscle cells (VSMCs) and valve interstitial cells (VICs) with interleukin (IL)-1a and high-phosphate (HP) medium, respectively, and we evaluated the effects a-Klotho silencing and recombinant a-Klotho (rKlotho) supplementation. α-Klotho expression was significantly reduced in atherosclerotic vessels and stenotic AVs. Vascular expression varied across territories, with the lowest levels in the carotids. In stenotic AVs, α-Klotho expression was lower in fibro-calcified areas compared to "healthy" regions. Endogenous tissue α-Klotho and circulating soluble α-Klotho were inversely associated with local and systemic inflammatory markers and, in AVs, with osteogenic-related markers. In vitro, pro-inflammatory stimuli downregulated α-Klotho gene expression in VSMCs and VICs. α-Klotho silencing amplified inflammatory responses in both cell types and promoted VIC calcification, whereas rKlotho attenuated inflammation and inhibited osteogenic differentiation. These findings suggest endogenous α-Klotho plays a central role in the inflammation underlying ASVD and calcific AS., This work was supported by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union, Fondo Europeo de Desarrollo Regional, "Una manera de hacer Europa" (PI13/01736, PI16/00024, PI19/00035, PI21/01037, PI23/00168, PI24/01020, PI25/00057; RD21/0005/0013 -Plan de Recuperacion, ´ Transformacion ´ y Resiliencia. Union ´ Europea - NextGenerationEU-, RD24/0004/0022-ISCIII and co-funded by the European Union) and Departamento de Salud del Gobierno de Navarra (GNa01/21). E.M.N. is supported by a Sara Borrell fellowship (CD24/00070, ISCIII). A.G.L. is supported by a PFIS PhD studentship (FI22/00213, ISCIII). A.P.R. is supported by a contract from RICORS2040-RENAL (RD24/0004/0025, ISCIII and cofunded by the European Union). J.I. is supported by Ramon y Cajal Fellowship (RYC2023-043288-I). E.J. and J.D.C are supported by contracts from the Miguel Servet Programme (CP24/00091 and CP20/00122 respectively, ISCIII).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Targetable pathways for drug repurposing in gastric cancer

  • Valero Almingol, Alba
  • Montori, Sheyla
  • Felípez, Nayra
  • Santamaría Martínez, Enrique
  • Fernández Irigoyen, Joaquín
  • Luzko, Irina
  • Cuestas, Anabella A
  • Pardo, Carlos
  • Prat, Richard
  • Moreira, Leticia
  • Albéniz Arbizu, Eduardo
Gastric cancer (GC) is both the fifth most common cancer worldwide and the fifth in mortality. Owing to a lack of symptoms in the early stages and unspecific clinical presentation in the later stages, GC is usually diagnosed at advanced stages. This means that only approximately 60% of patients are eligible for curative treatment, and overall, GC patients have a 5-year survival rate of only 28.3%, underscoring the importance of developing new treatment strategies. Drug repurposing involves identifying new therapeutic uses for approved drugs and is a promising strategy for cancer treatment because of its lower cost and faster development time. A variety of targetable pathways are involved in GC progression, including the mitogen-activated protein kinase, phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin, p53, Janus kinase 2/signal transducer and activator of transcription 3, hypoxia-inducible factor-1¿, wingless-type mouse mammary tumor virus integration site family/beta-catenin (Wnt/¿-catenin), nuclear factor kappa B, and Hippo pathways. Therefore, the repurposing of drugs targeting these pathways represents an interesting option in the search for new treatments for GC. In this review, we explore some relevant pathways involved in the development of GC and the possibilities of repurposing drugs that target them., Supported by the Instituto de Salud Carlos III, No. PI24/00784, No. PI24/00737, No. PI21/01181, No. PI21/00333 and No. INT22/00112; and Departamento de Universidad, Innovación y Transformación Digital Gobierno de Navarra, No. 0011-1408-2024-000011 and No. 0011-1408-2022-000010
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Sleep efficiency predicts next-day glycaemia and daytime glycaemia influences sleep in free-living adults at risk of type 2 diabetes

  • Clavero-Jimeno, Antonio
  • Martín-Olmedo, Juan J.
  • Migueles, Jairo H.
  • Camacho-Cardenosa, Alba
  • Molina-Fernández, Marcos
  • Dote-Montero, Manuel
  • Merino, Jordi
  • Muñoz Torres, Manuel
  • Labayen Goñi, Idoia
  • Ruiz, Jonatan R.
Aim: To investigate how sleep features influence next-day diurnal glucose homeostasis and vice versa in free-living adults at risk of type 2 diabetes. Materials and Methods: This observational repeated-measures study included 388 adults aged 25–65years (50% women) with overweight or obesity (BMI ≥25.0–<40.0kg/m2 ). Sleep and glucose homeostasis were simultaneously assessed over 14days using wrist-worn accelerometers and continuous glucose monitors. Linear mixed models evaluated day-level associations between sleep metrics—wake-up time, sleep period time (i.e., time from sleep onset to wake-up) and sleep efficiency ([total sleep time/sleep period time]×100)—and diurnal glucose metrics, including mean glucose and its standard deviation (glycaemic variability). Results: We analysed 3942 valid person-days. Each 1% increase in sleep efficiency was associated with lower next-day mean glucose (B [95% CI]=−0.05 [−0.08, −0.01] mg/dL; p=0.007). Each 1h delay in wake-up time was linked to reduced next-day glucose variability (−0.24 [−0.38, −0.10] mg/dL; p=0.001). Conversely, each 1mg/dL increase in daytime mean glucose was associated with later wake-up time (0.008 [0.002, 0.014]h; p=0.008), longer sleep period time (0.006 [0.000, 0.012] h; p=0.039) and lower sleep efficiency (−0.05% [−0.08%, −0.01%] %; p=0.005) the subsequent night. Each 1mg/dL increase in glucose variability was associated with earlier wake-up time (−0.02 [−0.03, −0.01]h; p<0.001). Conclusions: This study provides evidence that sleep and glucose dynamics are temporally associated in free-living adults at risk of type 2 diabetes. These findings underscore the potential of combining sleep and glucose metrics to inform cardiometabolic risk prevention strategies., This study (Project ref. PID2022.141506OB.I00) is funded by the MCIU/AEI/10.13039/501100011033 and by ERDF, EU a way of making Europe to J.R.R.; Junta de Andalucía, Consejería de Transformación económica, Industria, Conocimiento y Universidades (A-CTS-516-UGR20) to J.R.R.; the University of Granada Plan Propio de Investigación-Excellence actions: Unit of Excellence on Exercise Nutrition and Health (UCEENS) to J.R.R.; the Consejo Superior de Deportes, Ministerio de Cultura y Deporte, Plan de Recuperación, Transformación y Resiliencia, Funded by the European Union -NextGenerationEU (EXP_75091) to I.L.; the Government of Navarra, Departamento de Desarrollo Economico y Empresarial (0011-1365-2021-00070), Plan de Promoción de Grupos de Investigación de la Universidad Pública de Navarra to I.L.; Spanish Ministry of Universities (FPU21/01161 to A.C.-J., FPU22/01631 to J.J.M.-O., FPU23/02158 to M.M.-F., and FPU18/03357 to M.D.M). J.H.M. is supported by grant RYC2024-050453-I funded by MCIN/AEI/10.13039/501100011033. A.C.-C. is supported by the Junta de Andalucía, Consejería de Salud y Consumo (RHJ-0098-2024). J.M. is supported by the Novo Nordisk Foundation grant NNF23SA0084103, the EFSD/Novo Nordisk Foundation Future Leaders Award (no. 0094134) and the European Union (HORIZONEIC-2023-PATHFINDERCHALLENGES-01-101161509). In addition, funding was provided from the EXERNET Research Network on Exercise and Health (DEP2005-00046/ACTI; 09/UPB/19; 45/UPB/20; 27/UPB/21 to I.L. and J.R.R.). Instituto de Salud Carlos III, MCIU/AES and by ERDF, EU a way of making Europe (PI24/01360).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Chemerin activation of Toll-like receptor 4 drives mineralocorticoid receptor-mediated aortic valve remodeling in chronic kidney disease

  • Sánchez-Bayuela, Tania
  • Soulié, Matthieu
  • Garaikoetxea, Mattie
  • Fernández Celis, Amaya
  • López Andrés, Natalia
  • Jaisser, Frederic
BACKGROUND: Aortic stenosis is the most common valvular heart disease, and its progression is accelerated in chronic kidney disease (CKD), where multiple circulating abnormalities worsen its pathophysiology. This study examined the impact of CKD-related aldosterone excess, focusing on mineralocorticoid receptor signaling and its crosstalk with the innate immune pathway mediated by Toll-l ike receptor 4 (TLR4) in aortic valve (AV) interstitial cells and AV tissue. METHODS: For the study, we conducted in vivo studies using a CKD rat model challenged with high phosphate, followed by ex vivo analysis of AVs. In parallel, primary rat and human valve interstitial cells were used in vitro to evaluate inflammatory, fibrotic, and osteogenic responses to aldosterone and to identify the key signaling pathways involved. Human AVs from patients with aortic stenosis were also analyzed. Quantitative polymerase chain reaction, western blot, and ELISA were used to characterize these pathways. RESULTS: Mineralocorticoid receptor activation emerged as a central driver of aortic stenosis progression in CKD, promoting valve interstitial cell differentiation, inflammation, fibrosis, and calcification through activation of the TLR4-myeloid differentiation primary response 88 innate immunity pathway in response to aldosterone. Moreover, chemerin was identified as a downstream effector of the mineralocorticoid receptor that activates TLR4, further enhancing remodeling and calcification in AVs and valve interstitial cells. These results were corroborated in human stenotic AV samples from patients with CKD. CONCLUSIONS: Collectively, the study defines a novel mineralocorticoid receptor-TLR4-chemerin axis that mediates aldosterone-driven inflammatory and calcific processes in CKD, in both a rat model and in vitro systems., This work was funded by grants from Inserm, ANR NGAL-HT (ANR-19-CE14-0013), ANR MIRAVALVE (ANR-23-CE14-0016-01), Instituto de Salud Carlos III, the European Regional Development Fund: 'A way of making Europe' (PI24/01020), the IRP Inserm Miravac-CKD grant, and the Fédération Française de Cardiologie grant (601-FFC-JAISSER-Dotation 2025).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Compositional analysis of the association between 24 h movement behaviours, HbA1c and interstitial glucose in children and adolescents with type 1 diabetes mellitus: a two-year longitudinal analysis of the Diactive-1 cohort study

  • Muñoz Pardeza, Jacinto
  • López Gil, José Francisco
  • Hormazábal Aguayo, Ignacio
  • Huerta Uribe, Nidia
  • Ezzatvar, Yasmin
  • García Hermoso, Antonio
Aims/hypothesis. The aim of this study was to examine the association of physical activity, sedentarism and sleep with HbA1c and interstitial glucose in children and adolescents with type 1 diabetes through a 24 h compositional analysis. Methods. The study involved 83 young people diagnosed with type 1 diabetes (aged 6–18 years; 45% girls, mean HbA1c 57.54 ± 9.22 mmol/mol (7.4 ± 0.8%); median interstitial glucose 9.37 mmol/l [IQR 8.68–10.31]) from the Diactive-1 cohort study, followed up for 2 years. A triaxial accelerometer was used to objectively measure 24 h movement behaviours for 9 days. HbA1c levels were obtained from medical records, and interstitial glucose data were collected through continuous glucose monitoring. Linear mixed models were used to quantify associations between movement behaviours, interstitial glucose and HbA1c, maintaining the relative nature of the data based on the 24 h day. Results. A higher daily amount of sedentary behaviour, at the expense of sleep time, light or moderate-to-vigorous physical activity, was positively associated with HbA1c (unstandardised beta coefficient [B]=14.077 [95% CI 4.244, 23.956]; standardised beta coefficient [β]=0.368) and interstitial glucose (B=1.988; 95% CI 0.153, 3.880; β=0.261), while more sleep time, at the expense of sedentary behaviour, light or moderate-to-vigorous physical activity, was associated with a significant reduction in HbA1c (B=−12.712; 95% CI −25.204, −0.520; β=−0.197). Furthermore, reductions in both interstitial glucose (B=−1.580; 95% CI −2.800, −0.388; β=−0.283) and HbA1c (B=−9.361; 95% CI −15.856, −2.881; β=−0.330) were observed with increased daily time spent in moderate-to-vigorous physical activity at the expense of sedentary behaviour. Overall, the standardised beta coefficients indicated small to moderate effect sizes. Conclusions/interpretation. Our findings indicate that lower sedentary behaviour and more optimal sleep and physical activity patterns are associated with greater metabolic stability in children and adolescents with type 1 diabetes. These findings support the need for further research on balancing these behaviours for better diabetes management, and encourage adoption of a 24 h movement approach in clinical care., This study was funded by grant PI21/01238 and PI24/00829 from the Instituto de Salud Carlos III, and co-funded by the European Union. The project that gave rise to these results received the support of a fellowship from 'Instituto de Salud Carlos III' granted to JM-P (FI22/00329). Open access funding is provided by Universidad Pública de Navarra.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Obstetric complications, cortical gyrification, and cognition in first-episode psychosis

  • Costas-Carrera, Ana
  • Verdolini, Norma
  • Mezquida, Gisela
  • Forte, María Florencia
  • Janssen, Joost
  • García-Rizo, Clemente
  • Martínez-Aran, Anabel
  • Andres-Camazon, Pablo
  • Sánchez Torres, Ana María
  • Bergé, Daniel
  • Serna, Elena de la
  • Penadés, Rafael
  • Valli, Isabel
  • Amoretti, Silvia
  • PEPs Group
Background. Obstetric complications (OCs) are associated with cognitive and brain abnormalities observed in patients with schizophrenia. Gyrification, a measure of cortical integrity sensitive to events occurring during the prenatal and perinatal periods, is also altered in firstepisode psychosis (FEP). We examined the relationship between OCs and gyrification in FEP, as well as whether gyrification mediates the relationship between OCs and cognition. Methods. We examined differences in the Local Gyrification Index (LGI) for the frontal, parietal, temporal, occipital, and cingulate cortices between 139 FEP patients and 125 healthy controls (HCs). Regression analyses explored whether OCs and diagnosis interact to explain LGI variation. Parametric mediation analyses were conducted to assess the effect of LGI on the relationship between OCs and cognition for FEP and HC. Results. Significant LGI differences were observed between FEP patients and HC in the left parietal and bilateral cingulate and occipital cortices. There was a significant interaction between OCs and diagnosis on the left cingulate cortex (LCC) that was specific to males (p = 0.04) and was driven by gestational rather than intrauterine OCs. In HCs, OCs had a direct effect on working memory (WM) (p = 0.048) in the mediation analysis, whereas in FEP, we observed no significant effect of OCs on either verbal or WM. Conclusions. OCs interact with diagnosis to predict LCC gyrification, such that males with FEP exposed to OCs exhibit the lowest LGI. OCs influence WM, and LCC gyrification may mediate this relation only in HC, suggesting a differential neurodevelopmental process in psychosis., This study is part of a coordinated multicenter Project, PEPs study, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigacion Biomédica en Red de salud Mental, CIBERSAM, Instituto de Salud Carlos III, by the CERCA Program/Generalitat de Catalunya and Secretaria d'Universitats i Recerca of the Departament d¿Economia I Coneixement (2017SGR1355). Departament de Salut de la Generalitat de Catalunya (2017), funds from the Pla Estratègic de Recerca i Innovacio en Salut (PERIS 2016¿2020), Projectes de recerca orientats al'atencio primària, SLT006/17/00345. This study has been funded by the Instituto de Salud Carlos III (ISCIII) through the projects 'PI20/00661 and PI24/00196' and co-funded by the European Union.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

The role of muscular fitness on bone mineral content and areal bone mineral density in youth with type 1 diabetes

  • Muñoz Pardeza, Jacinto
  • Gracia-Marco, Luis
  • López Gil, José Francisco
  • Hormazábal Aguayo, Ignacio
  • Huerta Uribe, Nidia
  • Mármol-Pérez, Andrés
  • Ezzatvar, Yasmin
  • Izquierdo Redín, Mikel
  • García Hermoso, Antonio
Context Type 1 diabetes in youth increases the risk of compromised bone health due to glycemic dysregulation. Muscular fitness may play a role in improving bone health during growth. Objective This study aimed to investigate the association between muscular fitness and bone health in youth with type 1 diabetes. Methods A total of 83 young individuals with type 1 diabetes (aged 6-18 years; 44.6% girls) from the Diactive-1 cohort study were followed for 2 years. Dual-energy x-ray absorptiometry whole-body scans were used to assess bone mineral content (BMC) and areal bone mineral density (aBMD) of the total body less head (TBLH), arms, legs, pelvis, and spine. Muscular fitness (handgrip strength, 1 repetition maximum, and muscle power) was assessed with a dynamometer and eGYM devices. Handgrip strength and TBLH bone parameters were age- and sex-standardized using the FitBack Project and BMD Childhood Study, respectively. Results Linear mixed models showed longitudinal associations of handgrip strength with TBLH-BMC (unstandardized beta coefficient [B] = 17.18, 95% confidence interval [CI] 12.47-21.90) and TBLH-aBMD (B = 0.004, 95% CI 0.002-0.006); RM with TBLH-BMC (B = 20.09, 95% CI 10.88-29.31) and TBLH-aBMD (B = 0.007, 95% CI 0.004-0.011); and power with TBLH-BMC (B = 26.80, 95% CI: 17.31-36.28) and TBLH-aBMD (B = 0.009, 95% CI 0.005-0.012). Comparable results were observed across the other regions (P < .05). Additionally, analyses with standardized data confirmed the relationships of handgrip z-scores with TBLH-BMC z-scores (B = 0.19, 95% CI 0.08-0.30) and TBLH-aBMD z-scores (B = 0.350, 95% CI: 0.210-0.490). Conclusion In pediatric patients with type 1 diabetes, higher muscular fitness could serve as a complementary therapeutic strategy to preserve or enhance bone health., This study was funded by grant PI21/01238 and PI24/00829 from the Instituto de Salud Carlos III-ERDF (Spain). The project that gave rise to these results received the support of a fellowship form Instituto de Salud Carlos III granted to Jacinto Munoz-Pardeza (FI22/00329).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam

  • Pérez-Rodríguez, Gloria
  • Aja-Macaya, Pablo
  • González-Pinto, Lucía
  • Taltavull, Biel
  • Tarriño-León, María
  • Gallardo-García, María del Mar
  • Blanco Martín, Tania
  • Rodríguez-Pallares, Salud
  • Sánchez-Peña, Lucía
  • Moscoso, Miriam
  • Beceiro Casas, Alejandro
  • Oliver, Antonio
  • Bou, Germán
  • Arca-Suárez, Jorge
[Abstract] We report an outbreak of KPC-producing Pseudomonas aeruginosa in Spain, involving four patients and an environmental isolate recovered from a hospital sink. All isolates belonged to clone ST253 and exhibited difficult-to-treat resistance, including resistance to imipenem/relebactam and meropenem/vaborbactam. Genomic analysis confirmed a plasmid-encoded blaKPC-2 and OprD deficiency. Functional assays demonstrated synergy between KPC-2 production and porin loss on resistance to carbapenem/β-lactamase inhibitors. The findings highlight the clinical threat posed by KPC-producing P. aeruginosa., This study was supported by the Instituto de Salud Carlos III (ISCIII), through projects PI22/01212, PI23/00851, PI24/00010, and PI24/00920, and co-funded by the European Union. The research was also funded by Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC, CB21/13/00055, and CB21/13/00099). Funding was also provided by Axencia Galega de Innovación (GAIN), Consellería de Innovación and Consellería de Economía, Emprego e Industria, and Xunta de Galicia (IN607D 2021/012 to A.B., IN607A 2024/009 to G.B., and IN607D 2024/008 to J.A.-S.). G.P.-R. was financially supported by GAIN-Xunta de Galicia (IN606A 2025/020). L.G.-P. was financially supported by the ISCIII PFIS program (FI23/00074). T.B.-M. was financially supported by the ISCIII Río Hortega program (CM23/00095). S.R.-P. was financially supported by the ISCIII Río Hortega program (CM23/00104). L.S.-P. was financially supported by GAIN-Xunta de Galicia (IN606A 2024/022). M.M. was financially supported by Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC). J.A.-S. was financially supported by the ISCIII Juan Rodés program (JR21/00026). This work was also supported by the Fundación Pública Galega de Investigación Biomédica INIBIC, which provided financial support for the final publication of the article.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa

  • González-Pinto, Lucía
  • Monge-Olivares, Laura
  • Pérez-Rodríguez, Gloria
  • Aja-Macaya, Pablo
  • Sánchez-Peña, Lucía
  • Gomis-Font, María Antonia
  • Rodríguez-Pallares, Salud
  • Blanco Martín, Tania
  • López-Cerero, Lorena
  • Beceiro Casas, Alejandro
  • Bogaerts, Pierre
  • Oliver, Antonio
  • Bou, Germán
  • Arca-Suárez, Jorge
[Abstract] We aimed to characterize OXA-1054, a novel carbapenem-hydrolyzing class D β-lactamase (CHDL) detected in a multidrug-resistant Pseudomonas aeruginosa clinical isolate. Antimicrobial susceptibility was determined by broth microdilution, and carbapenemase activity was confirmed by hydrolysis assays. Whole-genome sequencing via Illumina and PacBio platforms enabled comprehensive analysis of the resistome and plasmid architecture. The blaOXA-1054 gene was cloned in parallel with blaOXA-48 and blaOXA-198 into the pUCP24 plasmid. β-Lactamases were produced in P. aeruginosa PAO1 for comparative evaluation of the phenotypic impact of each. OXA-48, OXA-198, and OXA-1054 β-lactamases were purified and further subjected to steady-state kinetic analysis, and 50% inhibitory activity of β-lactamase inhibitors was determined. The clinical P. aeruginosa isolate ARGA00461 showed resistance to carbapenems and most β-lactam/β-lactamase inhibitor combinations and tested positive in carbapenem hydrolysis assays. Genomic analysis revealed that the P. aeruginosa isolate ARGA00461 carried a gene coding for a previously uncharacterized CHDL, designated OXA-1054, which is closely related to the OXA-372 enzyme of environmental origin. The blaOXA-1054 gene was located in a small (≈5 kbp) non-conjugative plasmid coexisting with a conjugative IncP plasmid, which likely facilitated its mobilization. Production of OXA-1054 in P. aeruginosa PAO1 conferred a broader spectrum of β-lactam resistance than other CHDLs. Enzyme kinetics confirmed carbapenem hydrolysis with catalytic efficiency comparable to OXA-48 and revealed higher affinity for cefepime compared to OXA-48 and OXA-198. Among the inhibitors tested, only avibactam demonstrated relevant inhibitory activity. OXA-1054 mediates broad-spectrum β-lactam resistance in P. aeruginosa, including carbapenems and β-lactam/β-lactamase inhibitor combinations., This study was supported by Instituto de Salud Carlos III (ISCIII) through projects PI21/00704, PI22/01212, PI24/00010, PI24/00920, and PI25/00116 and co-funded by the European Union. The research was also funded by Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC, CB21/13/00055 and CB21/13/00099). Funding was also provided by Axencia Galega de Innovación (GAIN), Consellería de Innovación and Consellería de Economía, Emprego e Industria, Xunta de Galicia (IN607D 2021/12 to A.B., IN607A 2024/09 to G.B., and IN607D 2024/08 to J.A.-S.). L.G.-P. was financially supported by the ISCIII PFIS program (FI23/00074). G.P.-R. was supported by PI22/01212 and GAIN-Xunta de Galicia (IN606A 2025/020). L.S.-P. was financially supported by GAIN-Xunta de Galicia (IN606A 2024/022). M.A.G.-F. was financially supported by the ISCIII PFIS program (FI22/00039). S.R.-P. was financially supported by the ISCIII Río Hortega program (CM23/00104). T.B.-M. was financially supported by the ISCIII Juan Rodés program (JR25/00031). J.A.-S. was financially supported by the ISCIII Juan Rodés program (JR21/00026).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Comparative activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against recombinant β-lactamase-producing Escherichia coli and contemporary WGS-characterized strains of carbapenemase-producing Enterobacterales

  • Sánchez-Peña, Lucía
  • Rodríguez-Pallares, Salud
  • Blanco Martín, Tania
  • Pérez-Rodríguez, Gloria
  • Aja-Macaya, Pablo
  • González-Pinto, Lucía
  • López-Hernández, Inmaculada
  • Aracil, Belén
  • Beceiro Casas, Alejandro
  • Bou, Germán
  • Arca-Suárez, Jorge
Comparative study, [Abstract] We evaluated the activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against isogenic Escherichia coli and clinical Enterobacterales isolates producing broad-spectrum β-lactamases. Avibactam and ledaborbactam enhanced ceftibuten activity against transformants producing serine-β-lactamases. Ceftibuten/xeruborbactam was also active against VIM and some IMP producers. All combinations were active against OXA-48- and KPC-producing clinical isolates. Ceftibuten/xeruborbactam also retained activity against VIM-producing clinical strains. Susceptibility rates for MBL producers varied, depending on the CLSI or EUCAST breakpoints applied., This study was supported by the Instituto de Salud Carlos III (ISCIII) through projects PI21/00704, PI22/01212, PI23/00851, PI24/00920, and PI25/00116 co-funded by the European Union. The research was also funded by Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CB21/13/00055). Funding was also provided by Axencia Galega de Innovación (GAIN), Consellería de Innovación, Consellería de Economía, Emprego e Industria, and Xunta de Galicia (IN607D 2021/12 to A.B., IN607A 2024/09 to G.B., and IN607D 2024/08 to J.A.-S.). L.S.-P. was financially supported by GAIN-Xunta de Galicia (IN606A 2024/022). S.R.-P. was financially supported by the ISCIII Río Hortega program (CM23/00104). T.B.-M. was financially supported by the ISCIII Río Hortega program (CM23/00095). G.P.-R. was supported by PI22/01212 and GAIN-Xunta de Galicia (IN606A 2025/020). L.G.-P. was financially supported by the ISCIII PFIS program (FI23/00074). J.A.-S. was financially supported by the ISCIII Juan Rodés program (JR21/00026).
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Effect on satiety-related biomarkers of bar snacks containing chickpea flour and pork protein

  • Zomeño, M. Dolores
  • Malcampo, Mireia
  • Pérez-Vega, Karla Alejandra
  • Pastor, Antoni
  • López-Roura, Maria
  • Arrufat, Begoña
  • Atarés, Sergio
  • Ramos, Sergio José
  • Alonso, David
  • Subirana, Isaac
  • Muñoz Aguayo, Daniel
  • Blanchart, Gemma
  • Gaixas Vasallo, Sònia
  • Cabañero Marimón, Marta
  • Tello, Susanna
  • Konstantinidou, Valentini
  • Hernando Redondo, Javier
  • Goday, Alberto
  • Castañer, Olga
  • Schröder, Helmut
  • Fitó Colomer, Montserrat
This project aims to establish the acceptability and satiety of a hybrid snack containing plant protein and a small percentage of animal protein compared to a meat-based snack. Design: Randomised, crossover, double-blind, controlled post-prandial trial involving 24 participants (18–30 years), with two interventions: (a) a hybrid snack containing plant protein derived from chickpeas and 6.6% lean high-quality pork meat; and (b) a meat-based snack containing 90% lean pork meat. Methods: General, life-style, sensory acceptability questionnaire, and the following laboratory analyses were performed: lipid profile, endocannabinoids, and related compounds. Results: Sensory questionnaires showed in general good acceptability for both bars. Additionally, there was a greater increase in glycemia at 30, 60, and 90 min after consuming the hybrid snack compared to the meat-based snack, with no changes in the lipid profile. Regarding the endocannabinoid compounds and related compounds, the compound N-palmitoleoyl ethanolamine in the acylethanolamide group showed higher levels overall following the consumption of the hybrid snack compared to the meat-based snack, particularly at 2 h. Conclusions: The hybrid snack was associated with changes in endocannabinoid-like compounds. Therefore, it may provide a lasting satiating effect, while complementing the protein profile of plant-based foods with the quality of animal protein., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Food group intake trends in the Spanish population (2003–2023) in women and men and by age groups, country of origin, and social class: a time-series analysis of nationally representative surveys

  • Boter, Sofía
  • Carrillo Álvarez, Elena
  • Hernández Hernández, Marta
  • Lassale, Camille
  • Castro-Barquero, Sara
  • Pérez-Vega, Karla Alejandra
  • Castañer, Olga
  • Manidis, Alexios
  • Sandoval, Viviana
  • Zomeño, M. Dolores
  • Salinas-Roca, Blanca
  • Caneda Ferrón, Begoña
  • Orta-Ramirez, Alicia
  • Montane, Joel
  • Rodriguez-Monforte, Miriam
  • Mila, Raimon
  • Vidal, Eulalia
  • Gascón Lecha, M. Pilar
  • Mestres, Concepció
  • Palma-Linares, Imma
  • Fitó Colomer, Montserrat
  • Hernáez, Álvaro
Background We analyzed the intake evolution of 14 food groups (vegetables, fruits, legumes, bread/flours and breakfast cereals, pasta/rice and potatoes, fish, unprocessed meat, processed meat, dairy products, eggs, sweets, snacks, soft drinks, and fresh juices) in Spanish population between 2003 and 2023, for women and men separately and by age groups, country of origin, and social class. Methods Using data from the Spanish National and European Health Surveys (2003–2023), combined with the ENALIA/ENALIA-2 surveys, we converted the consumption frequencies of each group into estimated daily intakes in g/day. We modeled their trends over time using locally estimated scatterplot smoothing regressions. Results We observed: an increase over time in the consumption of vegetables (∆2003–2023: +25%), legumes (+ 10%), eggs (+ 50%), and snacks (+ 44%); and a decrease over time in the intake of soft drinks (-40%) and fresh juices (-24%), sweets (-16%), bread/flours and breakfast cereals (-13%), pasta/rice and potatoes (-11%), fish (-18%), dairy products (-10%), and processed meat (-9%). No large differences were observed between women and men and by social class. A more beneficial evolution was observed in ages 25–34 (with poorer dietary habits in 2003) and in individuals not born in Spain, and a more detrimental evolution was reported in ages ≥ 55 and 5–14. Conclusions The dietary habits of the Spanish population between 2003 and 2023 have improved in some aspects (more vegetables and legumes; fewer soft drinks, juices, sweets, and processed meat) and worsened in others (less fish and dairy products, more snacks), with notable differences by age groups and country of origin but not between women and men and by social class., info:eu-repo/semantics/publishedVersion
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications

  • Cerdó, Tomás
  • Woodridge, Laurel
  • Corrales, Sagrario
  • Muñoz-Castañeda, Juan R.
  • Torralbo, Ana Isabel
  • Rahman, Anisur
  • Farinha, Filipa
  • Ortega-Castro, Rafaela
  • Segui, Pedro
  • Sánchez-Pareja, Ismael
  • Muñoz-Barrera, Laura
  • Merlo, Christian
  • Ruiz-Vilchez, Desirée
  • Ábalos-Aguilera, María del Carmen
  • Font-Ugalde, Pilar
  • Barbarroja, Nuria
  • PRECISESADS Clinical Consortium
  • Alarcón-Riquelme, Marta
  • Escudero-Contreras, Alejandro
  • Aguirre-Zamorano, M. Ángeles
  • Pérez-Sánchez, Carlos
  • Jury, Elizabeth C.
  • López-Pedrera, Chary
Objective: Systemic lupus erythematosus (SLE) shows clinical and molecular heterogeneity, and cardiovascular (CV) complications and lupus nephritis (LN) remain leading causes of morbidity and mortality. This study investigated whether omic profiling can reveal molecular endotypes linked to these outcomes. Methods: Serum from 199 patients with SLE underwent proximity extension assay–based proteomics and targeted nuclear magnetic resonance metabolomics. Unsupervised clustering was performed on proteomic data, followed by integrative multiomic factor analysis, logistic regression, and machine learning models. Cohorts with SLE from the University College London, a subset with expanded Olink Reveal panel and untargeted metabolomics, and in vitro (human umbilical vein endothelial cell and HK2) and ex vivo (rat kidneys) models exposed to patient sera were used for validation and mechanistic exploration. Results: Proteomic clustering identified two molecular subgroups (cluster 1 and cluster 2). Compared with cluster 2, cluster 1 showed damage burden and increased rates of LN (1.8-fold), hypertension (3-fold), dyslipidemia (2-fold), obesity (8-fold), and abnormal C-reactive protein/erythrocyte sedimentation rate (4-fold), consistent with CV risk. A total of 47 inflammatory and organ-damage proteins and multiple metabolites were increased in cluster 1. Neural network models based on metabolites and clinical variables discriminated clusters (area under the curve = 0.77), highlighting citrate and lipoproteins as key features. Multiomic analyses and external cohorts confirmed reproducibility and enrichment in pathways related to leukocyte trafficking, endothelial stress, and nephritis. In vitro, serum from patients with SLE induced NF-κB activation in rat kidneys compared with controls, supporting a proinflammatory effect. Conclusion: Multiomic profiling delineates molecular endotypes in SLE, integrating immune, vascular, and metabolic pathways associated with CV risk and LN, supporting their potential for precision risk stratification.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Systematic Review of Monocyte Transcriptomic Profiles as Diagnostic and Prognostic Biomarkers in Colorectal Cancer

  • Podadera-Herreros, Alicia
  • Pilo, Jesús
  • Rego-Calvo, Alejandro
  • Ortega-Castán, María
  • Muriel López, Carolina
  • Hinojosa Nogueira, Daniel
  • Moreno Indias, Isabel
  • Amaya Campos, María del Mar
  • Alcaide García, Julia
  • Boughanem, Hatim
  • García Flores, Libia Alejandra
  • Macías-González, Manuel
Colorectal cancer (CRC) remains a major global health burden and a leading cause of cancer-related morbidity and mortality. Current blood-based biomarkers lack sufficient sensitivity and specificity, particularly for early detection. In this context, circulating immune-cell transcriptomic profiling has emerged as a promising minimally invasive approach. This systematic review was conducted following a PROSPERO-registered protocol (CRD42024604757) and PRISMA 2020 guidelines to evaluate the diagnostic and prognostic potential of circulating monocyte-related transcriptomic profiles in CRC. Of 295 records identified, six studies met the inclusion criteria. The available evidence consistently supports the diagnostic value of circulating transcriptomic profiles in distinguishing patients with CRC from healthy individuals and in reflecting tumour-associated immune alterations. Monocyte-related signatures, including CXCR2+ monocytes, were associated with disease stage and metastatic features. Epitranscriptomic modifications, such as m6A and m5C, further reinforced their diagnostic relevance, with some studies reporting higher diagnostic accuracy than classical biomarkers. In contrast, evidence for prognostic value remains limited, heterogeneous, and often indirect, largely due to small sample sizes, methodological variability, and reliance on public datasets. Overall, circulating immune-cell transcriptomic profiles are promising non-invasive biomarkers for CRC detection and characterization, although their prognostic utility remains unclear. Methodological heterogeneity limits clinical applicability, highlighting the need for standardized, CRC-specific studies with cell-type-resolved approaches.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Data-driven characterization of distinct cognitive subtypes in Parkinson's disease dementia

  • Labrador-Espinosa, Miguel
  • Silva-Rodríguez, Jesús
  • Mir, Pablo
  • Grothe, Michel J.
Data used in the preparation of this study were obtained from the Parkinson’s Progression Markers Initiative database, which is publicly available to interested researchers (www.ppmi-info.org)., Individual cognitive profiles of patients with Parkinson's disease dementia (PDD) are highly heterogeneous, suggesting possible biological subtypes. We studied 75 PD patients who developed dementia in the course of the Parkinson's Progression Markers Initiative study to investigate data-driven evidence for the existence of distinct cognitive subtypes of PDD. Using Ward's hierarchical clustering on neuropsychological test data, we identified two distinct cognitive subtypes. Despite similar dementia severity (MoCA: 20.6 vs 20.0), cluster-A exhibited more pronounced memory deficits (n = 50), whereas cluster-B showed greater visuospatial impairments (n = 25). The subtypes did not differ in demographic, motor, or MRI-based neurodegeneration measures. However, the visuospatial-predominant cluster-B had a higher prevalence of GBA mutations (p = 0.003) and hallucinations (p = 0.009). No differences were found in APOE-ε4 prevalence or cerebrospinal fluid biomarkers of Alzheimer's pathology. These findings reveal distinct memory-predominant and visuospatial-predominant PDD subtypes, which associate with different clinical and genetic features but are independent of comorbid Alzheimer's pathology., Data used in the preparation of this manuscript were obtained from the Parkinson’s Progression Markers Initiative database (www.ppmi-info.org/data). For up-to-date information on the study visit www.ppmi-info.org. Parkinson’s Progression Markers Initiative—a public-private partnership—is funded by The Michael J. Fox Foundation for Parkinson’s Research. Corporate funding partners include AbbVie, Allergan, Amathus, Avid, Biogen, BioLegend, Bristol-Myers Squibb, Celgene, Denali, GE Healthcare, Genentech, GlaxoSmithKline, Janssen Neurosciene, Lilly, Lundbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Prevail, Roche, Sanofi Genzyme, Servier, Takeda, Teva, UCB, Verily, and Voyager, and the philanthropic funding partner is Golub Capital. This work was supported by research grants from the Spanish Ministry of Science, Innovation and Universities (CNS2024-154295; RYC2023-043746-I), the Instituto de Salud Carlos III – Fondo Europeo de Desarrollo Regional (ISCIII-FEDER: PI22/01704; PI24/00089; CP19/00031), and the Reina Sofia Foundation (E.6.4 FRS-CUERPOS DE LEWY)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Defective Mitochondrial Respiration in Hereditary Thoracic Aneurysms

  • Marcos-Ríos, Daniel
  • Rochano-Ortiz, Antonio
  • Méndez-Barbero, Nerea
  • Oller, Jorge
This article belongs to the Special Issue Molecular and Cellular Mechanisms of Marfan Syndrome., Thoracic aortic aneurysms are life-threatening vascular conditions linked to inherited disorders such as Marfan syndrome, Loeys–Dietz syndrome, vascular Ehlers–Danlos syndrome, and familial thoracic aortic aneurysms and dissections. While traditionally associated with the extracellular matrix and contractile defects in vascular smooth muscle cells, emerging evidence suggests the key role of mitochondrial dysfunction. Here, we show that the overexpression of ACTA2R179H and TGFBR2G357W in murine aortic VSMCs reduces Mitochondrial Transcription Factor A (Tfam) expression, decreases mitochondrial DNA (mtDNA) content, and impairs oxidative phosphorylation, shifting metabolism toward glycolysis. Notably, nicotinamide riboside, a NAD+ precursor, restores mitochondrial respiration, increases Tfam and mtDNA levels, and promotes a contractile phenotype by enhancing actin polymerization and reducing matrix metalloproteinase activity. These findings identify mitochondrial dysfunction as a shared feature in hereditary thoracic aortic aneurysm, not only in Marfan syndrome, but also in other genetic forms, and highlight mitochondrial boosters as a potential therapeutic strategy., A.R.-O. is supported by the Conchita-Rábago Foundation 2024 grant. N.M.-B. is supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCiii/FEDER, PI21/01126 and PI24/00180, CP19/00151 Miguel Servet contract), Sociedad Española de Arteriosclerosis, and CIBERCV, Spain. J.O. is supported by a Ramón y Cajal contract (RYC2021-033343-I), and grant from Spanish Science Ministry (PID2022-137730OA-I00/ AEI/10.13039/501100011033/ FEDER, UE) and Marfan Spanish association (SIMA, www.Marfan.es)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Restorative potential of ciliary body cells in a retinal ganglion cell degeneration model

  • Lucas-Ruiz, Fernando
  • Fernández-Nogales, Marta
  • Valiente-Soriano, Francisco J
  • Herrera, Macarena
  • Nadal-Nicolás, Francisco M.
  • Agudo-Barriuso, Marta
  • Herrera, Eloisa
The ciliary body (CB) has been proposed as a niche of neural stem cells because, in vitro, cells from this area are able to form neurospheres, proliferate and differentiate. Here, we explore the potential of CB cells to differentiate and replace degenerated retinal ganglion cells (RGCs) in vivo. CB cells and cells from the subventricular zone (SVZ) were isolated from adult or postnatal C57BL/6Tg(CAG-EGFP) mice, respectively, and intravitreally injected into intact retinas, immediately after optic nerve crush or 45 days after the lesion of adult C57/BL/6 mice. Retinas were analysed in whole mounts or cross sections at different time points. Controls were matched untreated retinas. Neither cell type caused gliosis or toxicity when injected into intact retinas. When CB or SVZ cells were injected right after axotomy, they formed an epimembrane without integrating in the retina. However, when CB cells were administered in retinas depleted of RGCs, they integrated into the ganglion cell layer and expressed RGC and neuronal markers. Although SVZ cells were also able to integrate into RGC depleted retinas they did so more slowly than CB cells. These results shed light in the long-standing question of whether cells in the CB have the potential to transdifferentiate in vivo and point to the CB as a suitable source of cells that could be used in cell-replacement therapies for neurodegenerative diseases of the retina., Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional “Una Manera de Hacer Europa” PI19/00071, PI24/00040 (MAB). Fundació La Marató de TV3 20142130 (EH) and 20142131 (MAB). The laboratory of E. H. is supported by grants from the Valencia Regional Government (PROMETEO/2020/007), the Spanish Government (PID2022-138245 NB-I00), Fundacion La Caixa (HR21-00824) and Fundacion ICAR (CelMa-ENVEJECE). E. H. laboratory is located at the Instituto de Neurociencias which is a Severo Ochoa Excellence Center CEX2021-001165-S., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HMGCR genetic variability in Parkinson's disease in a Spanish cohort: associations with lipid metabolism and early onset

  • Díaz-Belloso, Rafael
  • Martín Bórnez, Miguel
  • Macías García, Daniel
  • García-Díaz, Sergio
  • Bonilla-Toribio, Marta
  • Buiza-Rueda, Dolores
  • Pineda-Sánchez, Rocío
  • Muñoz-Delgado, Laura
  • Ojeda, Elena
  • Jesús, Silvia
  • Adarmes-Gómez, Astrid
  • Carrillo, Fátima
  • Mir, Pablo
  • Gómez-Garre, Pilar
Lipid metabolism has emerged as a key factor in the pathophysiology of Parkinson’s disease (PD). While 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the rate-limiting enzyme in cholesterol biosynthesis, has been implicated in neurodegenerative disorders, such as Alzheimer disease, its role in PD remains unexplored. Given the shared pathological features between these neurodegenerative disorders (such as lysosomal dysfunction and lipid dysregulation) we hypothesized that HMGCR genetic variability could influence PD susceptibility and/or phenotypic expression, particularly in early-onset cases (EOPD). Therefore, we performed targeted sequencing of HMGCR in 1162 Spanish PD patients and analyzed associations with PD risk or age at onset. Replication was attempted in 436 PD cases from Parkinson’s Progression Markers Initiative (PPMI). We identified 21 HMGCR variants, including a likely pathogenic variant affecting the splice site of exon 4 (c.278-1G > A) in a patient with early-onset PD (EOPD), rapid progression, and severe dyslipidemia. The rs5908 variant was significantly associated with EOPD in our cohort (OR = 2.22, p = 0.025). Further analysis revealed rs5908 is in linkage disequilibrium with rs115169875, an intronic variant with putative regulatory impact. Our findings nominate HMGCR as a candidate gene for PD development, particularly in early-onset cases. The metabolic profile of the c.278-1G > A carrier parallels GBA-associated PD, suggesting convergent lipid-lysosomal pathways in neurodegeneration. While cohort differences highlight population-specific genetic effects, these findings underscore the importance of lipid pathways in PD and the need to explore HMGCR’s role in PD subtypes with metabolic comorbidity., Funding for open access publishing: Universidad de Sevilla/CBUA. This work was supported by the Spanish Ministry of Science and Innovation (RTC2019-007150–1), and funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI14/01823, PI16/01575, PI18/01898, PI19/01576, PI21/01875, PI24/00632), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685, PY20_00896), and the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0471–2013, PE-0210–2018, PI-0459–2018, PE-0186–2019). Pilar Gómez-Garre was supported by the “Nicolás Monardes” program (C-0048–2017) from Andalusian Regional Ministry of Health. Rafael Díaz Belloso and Miguel Martín Bornez were supported by pre-doctoral contracts for training in health research (PFIS) from Instituto de Salud Carlos III, with grant numbers FI20/00173 and FI22/00226, respectively. Daniel Macías-García was supported by the “Juan Rodés” program (JR22/00073) from the Instituto de Salud Carlos III (ISCIII- FEDER). Laura Muñoz-Delgado was supported by the “Río Hortega” program (CM21/00051) from the Instituto de Salud Carlos III (ISCIII- FEDER). Sergio García Díaz was supported by a University Teacher Programme (FPU20/00723) from the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no competing interests to declare that they are relevant to the content of this article., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease"

  • Muñoz-Delgado, Laura
  • Williams-Gray, Caroline H.
  • Garraux, Gaetan
  • Clemente, Diego
  • Öztop-Çakmak, Özgür
  • Greenland, Julia C.
  • Figueira, Inês
  • Machín-Díaz, Isabel
  • Pirovano, Elenamaria
  • Di Flora, Alessia
  • Tournerie, Clotilde
  • Papoutsopoulou, Stamatia
  • Ertan, Sibel
  • Mir, Pablo
  • Comi, Cristoforo
Growing evidence supports the importance of immune processes in Parkinson’s disease (PD). However, there is a need to improve the quality of observational clinical studies investigating the role of immunity in PD. In this context, an expert panel from the COST Action IMMUPARKNET (CA21117) aimed to develop guidance recommendations for conducting optimal immune profiling in PD. Firstly, criteria for inclusion and exclusion of participants, clinical data collection and participant stratification have been considered. Secondly, brain imaging of neuroinflammation has been reviewed. Finally, this review discusses sample collection, handling and storage of biological samples. In conclusion, this document aims to guide the scientific community in the optimal design of immune profiling studies in PD, so that we can generate robust and reliable data to advance our knowledge in this field., This publication is based upon work from COST Action CA21117, The role of IMMUnity in tackling PARKinson’s disease through a Translational NETwork [IMMUPARKNET], supported by COST (European Cooperation in Science and Technology) (www.cost.eu). Laura Muñoz-Delgado is financially supported by the “Juan Rodés” programme (JR23/00016) from the Instituto de Salud Carlos III and receives funding support from the Consejería de Salud y Consumo de la Junta de Andalucía (NEU-0005-2022). Caroline Williams-Grey receives financial support from the NIHR Cambridge Biomedical Research Centre (NIHR203312) and the Cambridge Centre for Parkinson-Plus, and grant funding from the UKRI Medical Research Council (MR/W029235/1), Cure Parkinson’s, Parkinson’s UK, and the Rosetrees Trust. Gaetan Garraux is supported by ‘Fonds Rahier’, University of Liège and Fonds de la Recherche Scientifique (F.R.S.-FNRS) de Belgique. Gaëtan Garraux has also received support for travel or honorarium from AbbVie, Eurogenerics and Zambon. Diego Clemente has received funding support from Instituto de Salud Carlos III (PI18/00357, PI21/00302, PI24/00447, co-funded by the European Union, CIBERNED CB22/05/00016, “INVESTIGO” programme in the frame of the Plan para la Recuperación, Transformación y Resiliencia (European Union Next Generation funds), and EMD Serono R&D Agreement). Ines Figueira is supported by the the ERC—Grant No. 804229; through PeX—2022.02127.PTDC (PERCEPT) and through the R&D unit iNOVA4Health (LISBOA-01-0145-FEDER-007344; UIDB/04462/2020), and LS4FUTURE Associated Laboratory (LA/P/0087/2020).Pablo Mir has received financial support from the Spanish Ministry of Science and Innovation (RTC2019-007150-1), the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) (PI16/01575, PI18/01898, PI19/01576, PI20/00613, PI21/01875, PI22/01704 and PI23/00512), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía (CVI-02526, CTS-7685), the Consejería de Salud y Bienestar Social de la Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018 and PE-0186-2019), the Consejería de Transformación Económica, Industria, Conocimiento y Universidades de la Junta de Andalucía (PY20_00896). Pablo Mir has also received support for attending meetings and/or travel or honorarium for lecturing from Abbott, Allergan, AbbVie, Bial, Britannia, Italfarmaco, Merz, UCB, Teva and Zambon. Cristoforo Comi is supported by the AGING PROJECT—Department of Excellence—Università del Piemonte Orientale. Cristoforo Comi has received travel grants for meeting participation from Ecupharma, Bial and Novartis., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease

  • Priego-Parra, Bryan Adrián
  • Gallego-Durán, Rocío
  • Román-Calleja, Berenice M.
  • Velarde-Ruiz Velasco, José Antonio
  • Romero-Gómez, Manuel
  • Gracia-Sancho, Jordi
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), has become a pressing global health concern. The complexity of MASLD and the lack of universally effective treatments expose the limitations of current interventions, which focus mainly on lifestyle modifications. Here, we explore the multilayered nature of MASLD, emphasizing its pathophysiology in shaping future medical and lifestyle interventions from a personalized medicine perspective, based on individual molecular profiles. Additionally, we address the limitations of current animal models in reflecting human metabolic syndrome and sex-specific differences. We argue that a holistic approach, integrating social determinants of health, patient preferences, and adherence patterns, is essential for advancing MASLD management effectively., Authors acknowledge continuous funding from the Instituto de Salud Carlos III (ISCIII; currently PI23/00945, DTS22/00010 & DTS24/00035 to J.G.-S., CD21/00095, PI22/01342, PI22/01345 and PI24/02008 to R.G.-D. and M.R.-G., all co-funded by the European Union), the AGAUR-Generalitat de Catalunya (2021 SGR 01322 & 2021 PROD 00036) to J.G.-S and the CIBEREHD. CIBEREHD is funded by the Instituto de Salud Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human iPSC-derived APOE4/4 Alzheimer´s disease astrocytes exhibit a senescent and pro-inflammatory state that compromises neuronal support

  • Cáceres-Palomo, Laura
  • Sánchez-Mejias, Elisabeth
  • Trujillo-Estrada, Laura
  • Pérez-Moreno, Juan J.
  • Lopez-Oliva, Elba
  • Lim, Tau En
  • DeFlitch, Leah
  • Chang, Serena H.
  • Kampman, Lucas
  • Corces, M. Ryan
  • Blurton-Jones, Mathew
  • Moreno-González, Inés
  • Pascual Bravo, Alberto
  • Vitorica, Javier
  • García-León, Juan Antonio
  • Gutiérrez, Antonia
Alzheimer´s disease (AD) is dominated by a complex cellular pathology which involves most brain cell types with glial cells increasingly recognized as playing fundamental roles in neurodegeneration. Astrocytes, which perform essential functions in preserving brain homeostasis, present a reactive phenotype in the AD brains with still unknown consequences. In this study, we generated and characterized human induced pluripotent stem cell (hiPSC)-derived astrocytes from AD patients harboring the APOE4/4 genotype, the greatest genetic risk factor for late-onset AD. Disease astrocytes showed a reactive phenotype. In addition, they showed altered mitochondrial network including perinuclear clustering of mitochondria, enhanced mitochondrial fusion and higher production of reactive oxygen species which, unexpectedly, were coincident with increased oxidative phosphorylation and glycolysis. As these mitochondrial features are related to the acquisition of cell senescence, we evaluated this at the transcriptome level and found that these AD-derived astrocytes significantly upregulated gene signatures of cellular senescence and displayed a senescence-associated secretory phenotype (SASP). To verify this finding, we observed senescence-related DNA damage response in a significant proportion of cells in the cerebral cortex of AD patients, with most of these cells being astrocytes. Finally, we confirmed that this astrocytic senescent and proinflammatory phenotype is associated with a reduced neuronal support, evidencing that APOE4/4 AD astrocytes present intrinsic features that may compromise brain homeostasis and promote neurodegeneration. Addressing the causes and consequences of this astrocytic dysfunctionality should help to elucidate novel therapeutic targets able to modify the neurodegeneration present in AD., This study was supported by Instituto de Salud Carlos III (ISCiii) of Spain, co-financed by FEDER funds from European Union, through grants PI21/00915 and PI24/00274 (to AG) and PI21/00914 and PI24/00308 (to JV); by CIBERNED (to AG and JV); by Junta de Andalucia through Consejeria de Economia y Conocimiento grants UMA20-FEDERJA-048 (to JAGL), PY18-RT-2233 (to AG) co-financed by Programa Operativo FEDER 2014–2020, Consejeria de Salud grant PI-0276-2018 (to JAGL); University of Malaga (B1-2020_04) to JAGL and Programa Operativo de Empleo Juvenil SNGJ4-11 to LCP. The UCI-ADRC is funded by NIH/NIA Grant P30 AG066519. Transcriptome studies were funded by NIH P01AG073082, U01AG072573, and UM1HG012076 to MRC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Circulating miRNA Signatures Associated with Atherosclerosis and Cardiometabolic Comorbidities in People with HIV

  • Martinez-Velasco, Marina
  • Sánchez-Herrero, José F.
  • Ibáñez, Laura
  • Velli, Pablo
  • Muñoz López, Francisco
  • Cairó, Mireia
  • Jaén, Ángeles
  • Font, Roser
  • Martinez-Lacasa, Xavier
  • Royo, Josep
  • Peraire, Joaquim
  • Faro, Naya
  • Rivero, Antonio
  • Olalla, Julián
  • Ruiz-Seco, Pilar
  • López-Cortés, Luis F.
  • Sumoy, Lauro
  • Massanella, Marta
  • Dalmau, David
This article belongs to the Section Translational Medicine., [Data Availability Statement] The data supporting the findings of this study contain sensitive clinical and molecular information from human participants and are therefore not publicly available due to ethical and privacy restrictions. De-identified data may be made available from the corresponding author upon reasonable request and subject to approval by the relevant ethics committees and data governance bodies of the HUMT and CoRIS cohorts., [Background:] People with HIV (PWH) experience increased cardiovascular disease driven by chronic inflammation despite suppressive antiretroviral therapy. Circulating microRNAs (miRNAs) have emerged as potential biomarkers of cardiometabolic dysfunction, yet their relevance to HIV-associated atherosclerosis remains unclear., [Methods:] We analyzed PWH PBMC-derived miRNAs in two independent cohorts: the HUMT cohort (N = 185), characterized by carotid ultrasound assessment of atheroma plaque and carotid intima–media thickness (cIMT), and the CoRIS cohort (N = 119), stratified by cardiometabolic comorbidity burden (≥3 comorbidities vs none). An exploratory miRNA microarray comparing individuals with and without atheroma plaque (AP+ vs. AP−, N = 72) identified candidate miRNAs, a subset of which was selected for validation by RT-qPCR. Associations with atherosclerosis, cardiometabolic comorbidities and the HIV-adapted COMVIH-CoR clinical cardiovascular risk score were examined., [Results:] Forty-four miRNAs were differentially expressed in AP+ vs. AP– in the microarray. RT-qPCR validation showed sex-specific miRNA association with miR-638 was consistently downregulated in AP+ and pathological cIMT among men, while reduced expression of miR-27b-5p and miR-3613-5p was observed in women. Associations between miRNAs and cardiometabolic comorbidities differed by cohort: in HUMT, miR-638 was reduced in diabetes and obesity, while miR-140-5p and miR-27b-5p were decreased in smokers and individuals with low HDL. CoRIS participants with multiple comorbidities showed a generalized miRNAs upregulation. Notably, miR-140-5p was consistently elevated in individuals with high COMVIH-CoR scores across both cohorts., [Conclusions:] PBMC-derived miRNAs capture heterogeneous, context-dependent dimensions of cardiovascular risk in PWH, likely reflecting cumulative immune-metabolic stress rather than universal diagnostic markers of subclinical atherosclerosis and supporting a phenotype-specific role., This work was supported by the Instituto de Salud Carlos III (ISCIII), Subdirección General de Evaluación y Fomento de la Investigación, and co-funded by the European Regional Development Fund (ERDF, “A way to make Europe”), through the Accion Estratégica en Salud project PI17/02169 and PI24/02029. The HIV BioBank is supported by Instituto de Salud Carlos III (PT20/00138) and Networking Research Center on Bioengineering, Biomaterials and Nanomedicine, CIBER-BBN (CB22/01/00041). CoRIS cohort is supported by CIBER—Consorcio Centro de Investigación Biomédica en Red- (CB21/13/00091), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea—NextGenerationEU. MMV was supported by the Agustí Pumerola fellowship from the Societat Catalana de Malalties Infeccioses i Microbiologia Clínica (SCMIMC) MM received funding from grant RYC2020-028934-I/AEI/10.13039/501100011033 issued by the Spanish Ministry of Science and Innovation and State Research Agency and the EU’s “investing in your future” Social Fund., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mechanistic insights into the liver-brain axis during chronic liver disease

  • Siddle, Matthew
  • Gallego-Durán, Rocío
  • Goel, Deepika
  • Renquist, Benjamin J.
  • Holt, Marie K.
  • Hadjihambi, Anna
The liver is a metabolically flexible tissue, adapting its functions to changes in nutrient availability and physiological states. This adaptability is crucial for maintaining metabolic homeostasis and likely involves communication with the central nervous system through the liver–brain axis. The liver also receives a constant influx of nutrients, hormones and microbial metabolites from the gastrointestinal tract in a multifaceted communication network, the gut–liver–brain axis. Dysregulation of this communication can lead to hepatic encephalopathy and cognitive impairments in early-stage chronic liver disease, such as metabolic dysfunction-associated steatotic liver disease, substantially affecting patient quality of life. This Review examines key signalling pathways along the liver–brain axis: humoral signalling, including metabolites, hepatokines, toxins and inflammation, and neural pathways, focusing on afferent signalling through the common hepatic branch of the vagus nerve. We discuss how each pathway might contribute to behavioural and mood changes in chronic liver disease and the development of hepatic encephalopathy. Although the humoral effects have been studied more extensively, we propose that the afferent vagus nerve is central to liver disease-associated cognitive and behavioural complications. Finally, we highlight how new techniques and tools could advance our understanding of the gut–liver–brain communication that affects behaviour., M.S. is funded by the Wellcome Trust as part of the Neuro-Immune Interactions in Health & Disease Wellcome Trust PhD Programme (218452/Z/19/Z). R.G.D. acknowledges support to ISCIII from grants CD21/00095, PI22/01342, PI19/01404, PI24/02008. B.J.R. is funded by the NIH (NIDDK R01DK132281) and the US Department of Defense (W81XWH-22-2-0043 and PR221455 HT9425-23-1-0810). M.K.H. is funded by the British Heart Foundation (FS/IPBSRF/20/27001) and the Royal Society (RG\R1\241213). A.H. is funded by UKRI, Future Leaders Fellowship (MR/X033287/1) and the Foundation for Liver Research., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Severe hypertension with thrombotic microangiopathy: the need for pathogenically targeted treatments

  • Praga, Manuel
  • Caravaca-Fontán, Fernando
  • Cavero, Teresa
  • Fernández-Juárez, Gema
  • Gutiérrez, Eduardo
  • Goicoechea de Jorge, Elena
Malignant hypertension with acute kidney injury or acute kidney disease is a life-threatening condition requiring urgent antihypertensive treatment and which carries a serious risk of kidney function loss. The presence of thrombotic microangiopathy (microangiopathic hemolytic anemia and thrombocytopenia) further challenges the diagnosis and treatment of these patients. As shown by recent studies, a high proportion of patients with complement-mediated thrombotic microangiopathy present with severe and malignant hypertension; however, extreme elevation of blood pressure by itself can induce vascular lesions of thrombotic microangiopathy. To resolve this conundrum, it is essential to rapidly investigate and exclude forms of secondary hypertension (in which hematologic features are rare) and secondary thrombotic microangiopathies, both of which require treatment of the specific underlying etiology. Definitive differentiation of essential hypertension and complement-mediated thrombotic microangiopathy requires complement genetic testing, the results of which usually take weeks to months. In this review, we analyze the clinical and histologic data that would support the diagnosis of complement-mediated thrombotic microangiopathy before the results of genetic tests, prompting the rapid initiation of complement blockers. However, there are numerous unmet gaps in the pathogenesis, diagnosis, and treatment of this disorder that require further research., FC-F is supported by the Instituto Carlos III grant PI24/00140. EGdJ is supported by Ministerio de Ciencia e Innovación grant PID2022-138819OB-I00, European Union’s Horizon 2020 Framework Programme grant 899163, and Autonomous Region of Madrid grant P2022/BMD-7278., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer's disease patients

  • Gea-González, Adriana
  • Valle-Pedroso, Renata
  • López-Font, Inmaculada
  • Zetterberg, Henrik
  • Blennow, Kaj
  • Sáez-Valero, Javier
  • García-Ayllón, María-Salud
ADAM10 and ADAM17, members of the membrane-bound disintegrin metalloproteinase (ADAM) family, act as α-secretases in the non-amyloidogenic processing of the amyloid precursor protein. While alterations in ADAM10, the primary α-secretase, have been reported in Alzheimer’s disease (AD), with certain controversy between studies, ADAM17 changes remain less understood. Both enzymes display a complex pattern of expression that includes immature zymogen and mature full-length, assigned as the active form, and soluble cleaved species. We reported for the first time that ADAM10 is present in human cerebrospinal fluid (CSF), and levels of the full-length and soluble fragments decrease in samples from AD patients., This work was supported by grants from Fundació para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (UGP-21-217 to M-S.G-A.); Fondo de Investigaciones Sanitarias (PI22/01329 to J.S-V and PI24/01421 to M-S.G-A)co-funded by the Fondo Europeo de Desarrollo Regional, FEDER “Investing in your future”); CIBERNED (Instituto de Salud Carlos III, Spain); Direcció General de Ciència i Investigació, Generalitat Valenciana (CIAICO/2024/313 to J.S-V). HZ is a Wallenberg Scholar and a Distinguished Professor at the Swedish Research Council supported by grants from the Swedish Research Council (#2023 − 00356, #2022 − 01018 and #2019–02397), the European Union’s Horizon Europe research and innovation programme under grant agreement No 101053962, Swedish State Support for Clinical Research (#ALFGBG-71320), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809–2016862), the AD Strategic Fund and the Alzheimer’s Association (#ADSF-21-831376-C, #ADSF-21-831381-C, #ADSF-21-831377-C, and #ADSF-24-1284328-C), the European Partnership on Metrology, co-financed from the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States (NEuroBioStand, #22HLT07), the Bluefield Project, Cure Alzheimer’s Fund, the Olav Thon Foundation, the Erling-Persson Family Foundation, Familjen Rönströms Stiftelse, Stiftelsen för Gamla Tjänarinnor, Hjärnfonden, Sweden (#FO2022-0270), the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860197 (MIRIADE), the European Union Joint Programme – Neurodegenerative Disease Research (JPND2021-00694), the National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre, the UK Dementia Research Institute at UCL (UKDRI-1003), and an anonymous donor. KB is supported by the Swedish Research Council (#2017 − 00915 and #2022 − 00732), the Swedish Alzheimer Foundation (#AF-930351, #AF-939721, #AF-968270, and #AF-994551), Hjärnfonden, Sweden (#ALZ2022-0006, #FO2024-0048-TK-130 and FO2024-0048-HK-24), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-965240 and #ALFGBG-1006418), the European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236), the Alzheimer’s Association 2021 Zenith Award (ZEN-21-848495), the Alzheimer’s Association 2022–2025 Grant (SG-23-1038904 QC), La Fondation Recherche Alzheimer (FRA), Paris, France, the Kirsten and Freddy Johansen Foundation, Copenhagen, Denmark, Familjen Rönströms Stiftelse, Stockholm, Sweden. R-V.P. was supported by São Paulo Research Foundation (FAPESP, grants 2019/20110-1 and #2017/18808-5). A.G-G. was supported by a PhD fellowship (grant CIACIF/2021/426) funded by the Conselleria of Education, Culture, Universities and Employment (Generalitat Valenciana) and co-funded by the European Union through the Fondo Social Europeo (FSE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Srr2-dependent SOX2 levels govern the chromatin and transcriptional landscape of adult neural stem cell fate decisions in mouse

  • Cruces-Salguero, Sara
  • Jordán-Pla, Antonio
  • Domingo-Muelas, Ana
  • Morante-Redolat, Jose Manuel
  • Rizzoti, Karine
  • Matheu, Ander
  • Fariñas, Isabel
  • Lovell-Badge, Robin
  • Moncho-Amor, Veronica
21 páginas, 4 figuras, Background: Stem cell maintenance and lineage commitment in the nervous system require precise regulation of transcription factors, with SOX2 serving as a pivotal regulator. SOX2 expression is controlled by multiple enhancers, including the Sox2 regulatory region 2 (Srr2). However, the specific role of Srr2 in adult neurogenesis and chromatin regulation during neural lineage commitment remains incompletely understood. Results: To dissect the function of Srr2, we generate a CRISPR-Cas9 mouse model harboring a targeted deletion of this enhancer. Srr2 deletion reduce SOX2 levels in proliferating, but not differentiating, neurosphere cultures, while impairing both neuronal and oligodendroglial differentiation. Paired bulk RNA-seq and ATAC-seq during proliferation and early differentiation reveal that loss of Srr2 induces widespread chromatin compaction during proliferation, which partially converges toward wild-type states upon early differentiation. Multi-omic integration identifies a subset of neurogenic genes exhibiting persistent promoter closure and impaired transcriptional induction in proliferating mutant cells, despite being normally translated during neural differentiation. In vivo, subependymal zone cells of Srr2del/del mice exhibit lower SOX2 and FOXG1 expression, fewer ASCL1/OLIG2 progenitors, and reduced neuronal and oligodendroglial marker expression. Conclusions: These findings establish Srr2 as a critical enhancer of Sox2 required to maintain a chromatin environment permissive for neural differentiation during stem cell proliferation. Our study underscores the essential role of non-coding regulatory elements in coordinating chromatin accessibility, transcriptional programs, and stem cell fate decisions during adult neurogenesis., Open Access funding provided by The Francis Crick Institute. This work was supported by Instituto de Salud Carlos III (ISCIII) through the project (PI19/01355, PI22/01905, FORT23-00026, DTS24/00153 and PI24/01542) and co-funded by the European Union, and the Health Department of the Basque Country (2022111069, 023333041 and 2024333025). Work at the I.F’s laboratory was supported by grants PID2023-152962NB-I00, CB06/05/0086 (CIBERNED) from Ministerio de Ciencia e Innovación, Prometeo CIPROM/2024/57 from Generalitat Valenciana, and ERC Advanced Grant 101098241 from the European Commission. S.C-S received a predoctoral fellowship from the Ministry of Science, Innovation and Universities (FPU23/01973) and the Spanish Association against Cancer (AECC—PRDGU246336CRUC). V.M-A received a Miguel Servet contract from the Instituto Salud Carlos III (CP23/00111). A.D-M was a recipient of a FPU PhD contract from Ministerio de Educación, Cultura y Deporte (MECD) and her stay at R.L-B’s laboratory was supported by a MECD’s grant included in the FPU program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Deciphering the role of ammonia in MASLD: From a neurotoxin to a metabolic by-product, Descifrando el papel del amoníaco en el MASLD: de neurotoxina a subproducto metabólico

  • Zurita-Palomo, Carola
  • Martín, Franz
  • Maya-Miles, Douglas
  • Ampuero, Javier
  • Romero-Gómez, Manuel
  • Gallego-Durán, Rocío
Ammonia, a nitrogen-containing compound produced during amino acid catabolism, plays a key role in nitrogen homeostasis. The primary source of ammonia in humans is the gut, where it is produced from dietary sources, luminal bacterial urease activity and glutamine deamination in enterocytes.1 This gut-derived ammonia is transported to the liver via the portal vein, and because ammonia is potentially neurotoxic, rapid and efficient removal is essential. Among others organs, the liver is the main organ responsible for its detoxification via the urea cycle. Ureagenesis occurs specifically in periportal hepatocytes by the action of urea cycle enzymes (UCEs), which involves two mitochondrial enzymes (carbamoyl phosphate synthetase 1 (CPS1) and ornithine transcarbamylase (OTC)) and three cytosolic enzymes (arginosuccinate synthetase (ASS), arginosuccinate lyase (ASL) and arginase 1 (ARG1)). In health, ammonia is converted into urea, which is excreted by the kidneys maintaining the systemic nitrogen balance, The research leading to these results has received funding from Instituto de Salud Carlos III under grant agreements PI24/02008, PI22/01342, from Agencia Estatal de Investigación under grant agreement PID2024-162275OB-I00 and European Partnership for Personalized Medicine under grant agreement EPPERMED2024-496. RGD and DMM are both recipients of EMERGIA fellowships from Consejería de Universidad, Investigación e Innovación from Junta de Andalucía under grant agreements DGP_EMEC_2023_00394 and DGP_EMEC_2023_00472, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NGFR expression predicts tumor recurrence in radiotherapy/chemoradiotherapy-treated HPV-negative pharyngeal squamous cell carcinoma

  • García-Agulló, Juan
  • Santos, Vanesa
  • Garcia-Mayea, Yoelsis
  • de Luxan-Delgado, Beatriz
  • Bataller, Marina
  • Lleonart, Matilde Esther
  • Rodrigo, Juan P
  • García-Pedrero, Juana M
  • Álvarez-Fernández, Mónica
  • Peinado, Héctor
Supplementary data to this article can be found online at https://doi.org/10.1016/j.oraloncology.2026.108080, Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy with high mortality rates, often exhibiting resistance to conventional treatments such as radiotherapy (RT) or a combination of chemotherapy and radiotherapy (CRT). The nerve growth factor receptor (NGFR, also known as p75NTR or CD271) is a well-established cancer stem cell marker in melanoma, where it has been linked to resistance to multiple therapies. In HNSCC, NGFR has been reported as a poor prognostic marker, with its overexpression associated with disease progression. However, its contribution to therapy resistance in HNSCC remains unknown., Research in the laboratory of Dr Peinado is supported by grants from Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación / State Research Agencia Financiadora (AEI − Ministry of Science and Innovation: PID2020-118558RB-I00 (MICIU/AEI/https://doi.org/10.13039/501100011033), RETOS SAF2017-82924-R (AEI/https://doi.org/10.13039/501100011033/FEDER-UE), PDC2021-121102-I00 (MCIN/AEI/https://doi.org/10.13039/501100011033, European Union “NextGenerationEU”/PRTR), PID2023-147503OB-I00 funded by MCIU/AEI /https://doi.org/10.13039/501100011033 and by the European Union, ERDF “A way of making Europe”, Fundación Científica AECC (PRYCO223002PEIN, LABAE19027PEIN), the Mission Cancer within HORIZON EU Programme (PANCAID-101096309) and Fundación Ramón Areces. J.G.-A. was supported by Fundación Científica de la Asociación Española Contra el Cáncer (Predoctoral AECC 2021, PRDMA21602GARC). J.M.G.-P. and J.P.R. received funding from the Instituto de Salud Carlos III (ISCIII) through the project grants PI22/00167, PI25/00107 and CIBERONC (CB16/12/00390) and were co-funded by the European Union. J.M.G.-P. and J.P.R. are funded by the Government of the Principality of Asturias through the Agency for Science, Business Competitiveness and Innovation of the Principality of Asturias and co-financed by the European Union (IDE/2024/000778). M.A.-F. was supported by grant CNS2023-1444–73 funded by MCIU/AEI/https://doi.org/10.13039/501100011033 and “EuropeanUnionNextGenerationEU/PRTR” and by the Scientific Foundation of the Spanish Association against Cancer (LABAE235202ALVA). M.E. LL. received funding from the Instituto de Salud Carlos III (ISCIII) through the project grants PI24/00630 and AC24/00057, the latter under the umbrella of the Partnership Fostering a European Research Area for Health (ERA4Health) (GA N° 101095426 of the EU Horizon Europe Research and Innovation Programme)., Peer reviewed, Sin experimentacion animal ni uso de NAMs